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Abstract 
Diabetes distress (DD) refers to the negative emotional burden specifically 
related to living with and managing diabetes. Over one-third of people with type 1 
diabetes (T1D) report elevated DD, and this is associated with sub-optimal self-
care behaviours and blood glucose management. Among adolescents with T1D, 
research and clinical practice has primarily focused on assessing and treating 
general psychological distress, for example, depressive and anxiety symptoms, 
rather than DD. Thus, the aim of this program of doctoral research was to generate 
new knowledge about DD among adolescents with T1D.  
Specifically, the objectives were to: 1) identify the prevalence of clinically 
meaningful DD, 2) investigate the demographic, psychosocial and clinical 
characteristics associated with elevated DD, 3) examine the interrelationship 
between DD, depressive symptoms, and glycaemia (HbA1c), and 4) investigate 
change in DD following structured T1D education. Study methods included a 
systematic review of the published literature, a national, cross-sectional survey of 
psychological well-being and diabetes management among youth with T1D, and a 
quasi-experimental study of the impact of a novel structured T1D education 
program for adolescents on DD.  
Clinically meaningful cut points were validated for an adolescent-specific 
version of a DD measure (Problem Areas in Diabetes – Teen version [PAID-T]). 
Using these two cut points, moderate DD was reported by 13% to 18%, and high 
DD was reported by 23% to 36% of adolescents aged 13 to 19 years. Twenty-one 
percent experienced moderate-to-severe depressive symptoms. Multivariate 
analysis showed that DD was associated with female gender, higher HbA1c, lower 
ii 
 
diabetes management self-efficacy and greater diabetes-related family conflict but 
not with age or self-monitoring of blood glucose. Depressive symptoms were not 
associated independently with HbA1c. Following structured T1D education, mean 
DD did not change, although at three months, DD had decreased among youth who 
had reported moderate-to-severe DD at baseline. Diabetes management self-
efficacy increased, and this was associated with lower DD at 12 months.  
This program of research extends previous knowledge of DD among 
adolescents and corroborates the findings of studies in adults. These findings have 
several important implications for future research and clinical practice. This work 
highlights the value of using age-appropriate measures of DD (e.g. PAID-T) 
because adult measures may not identify issues that are relevant to young people, 
for example, body image. The cut points for identifying clinically meaningful DD 
will assist in interpretation of the PAID-T score when screening for DD, and for 
estimating the prevalence of elevated DD among young people. Among 
adolescents, the prevalence of moderate-to-high DD was double the rate of 
moderate-to-severe depressive symptoms, suggesting that clinical assessment of 
psychological well-being should include DD as well as depression. Structured T1D 
education for preventing and reducing DD, incorporating diabetes self-management 
and coping skills is promising. However, this study had limitations and few other 
intervention studies among adolescents have evaluated DD, so further research is 
needed to examine DD and strategies that engage youth with T1D, particularly 
those at high risk of psychological distress. The findings of this program of PhD 
research highlight the relevance of assessing DD among adolescents with T1D, and 
the need to address this largely unmet need with targeted, evidence-based 
interventions and clinical support.    
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Outline of Thesis 
 The aim of this program of PhD research was to investigate diabetes 
distress among adolescents with type 1 diabetes. Specifically, the objectives of this 
research were to: i) identify the prevalence of clinically meaningful DD, ii) 
investigate the demographic, psychosocial and clinical characteristics associated 
with elevated DD, iii) examine the inter-relationship between DD, depressive 
symptoms, and HbA1c, and iv) investigate change in DD following structured T1D 
education. 
This thesis comprises seven chapters, including five independent but related 
manuscripts (Chapters 2-6), reporting on data collected from three studies: (1) A 
systematic review of the literature, (2) Diabetes MILES (Management and Impact 
for Long-term Empowerment and Success) Youth–Australia, a national cross-
sectional survey, and (3) Teens Empowered to Actively Manage Type 1 Diabetes 
(TEAM T1), a quasi-experimental study.  
Chapter 1 (Introduction) describes type 1 diabetes (T1D) and the clinical 
and psychological impact of living with this chronic condition. The chapter 
introduces diabetes distress (DD), and provides an overview of structured 
education to enhance the skills for T1D self-management and quality of life. The 
life-stage of adolescence and the unique challenges faced by adolescents living 
with T1D diabetes are introduced, and the limitations of previous research into 
diabetes distress among adolescents are discussed. Finally, the direction of the 
research is described and a schematic overview of the studies comprising this 
program of PhD research is provided. 
xvi 
 
 Chapter 2 (Paper 1: Diabetes Distress Among Adolescents with Type 1 
Diabetes: A Systematic Review) summarises and appraises the available evidence 
among adolescents with T1D regarding the prevalence of diabetes distress, 
demographic, clinical, behavioural and psychosocial correlates of DD and 
interventions to reduce DD. The systematic review included literature that was 
published between 1995 and 2014. Relevant literature that was published 
subsequently has been incorporated into the following chapters (Chapters 3-6) and 
the Discussion (Chapter 7). 
 Chapter 3 (Paper 2: Diabetes MILES Youth–Australia: Methods and 
Sample Characteristics of a National Survey of the Psychological Aspects of Living 
with Type 1 Diabetes in Australian Youth and their Parents) describes the rationale 
and methodology for the Diabetes MILES (Management and Impact for Long-term 
Empowerment and Success) Youth–Australia study, including development of the 
study questionnaire, recruitment procedure and participant characteristics.  
 Chapter 4 (Paper 3: Cut Points for Identifying Clinically Significant 
Diabetes Distress in Adolescents with Type 1 Diabetes Using the PAID-Teen: 
Results from Diabetes MILES Youth–Australia) presents a quantitative study which 
sought to establish a clinically-meaningful threshold for elevated diabetes distress, 
and used this cut point to determine the prevalence of elevated diabetes distress 
among Australian adolescents with T1D. 
 In Chapter 5 (Paper 4: Diabetes Distress is More Strongly Associated with 
Hba1c than Depressive Symptoms in Adolescents with Type 1 Diabetes: Results 
from Diabetes MILES Youth – Australia) the relative contributions of diabetes 
distress and depressive symptoms to the variance in HbA1c are examined.  
xvii 
 
 Chapter 6 (Paper 5: Diabetes Distress and its Associations with Self-
Efficacy, Family Conflict and A1C Following the Teens Empowered to Actively 
Manage Type 1 (TEAM T1) Structured Education Program) describes the 
evaluation of a structured T1D education program for adolescents aged 13-19 years 
in terms of psychological and clinical outcomes, and examines the demographic, 
clinical and psychological factors associated with elevated diabetes distress at 
baseline and follow-up.  
 Chapter 7 (Discussion) presents a summary of the key findings and 
discusses the contributions of this thesis to current knowledge, in relation to the 
literature reviewed in Chapter 2, and the relevant literature that has subsequently 
been published. The strengths and limitations of this program of research are 
discussed, and the implications and recommendations for future research and 
clinical practice.  
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Chapter 1: Introduction  
Diabetes distress represents the negative emotional burden of living with 
diabetes (Polonsky et al., 1995). Over one-third of people with type 1 diabetes 
report elevated diabetes distress (Sturt, Dennick, Due-Christensen, & McCarthy, 
2015). Even at low levels, diabetes distress is associated with sub-optimal self-care 
behaviours and blood glucose management (Fisher et al., 2016a). This suggests that 
diabetes distress is a common and serious complication of diabetes. Although this 
construct has been investigated in adults for the past 25 years, little is known about 
diabetes distress among adolescents with type 1 diabetes. Beginning with an 
overview of type 1 diabetes, and its medical and self-management, this chapter 
introduces the psychological construct of diabetes distress and the life stage of 
adolescence.  
1.1 Type 1 Diabetes 
Type 1 diabetes (T1D) is an auto-immune condition that results in failure of 
the pancreatic beta cells to produce insulin, a hormone that regulates glucose 
metabolism (American Diabetes Association, 2016). Insulin deficiency causes 
elevated blood glucose (hyperglycaemia); symptoms include extreme thirst, 
increased urination, lethargy and weight loss. At the present time, T1D cannot be 
prevented or cured, and treatment involves life-long exogenous insulin replacement 
and blood glucose monitoring (American Diabetes Association, 2016) – this is 
discussed in further detail in Section 1.3. 
According to the National Diabetes Services Scheme (NDSS) (2018), 
118,800 people have T1D, representing 9% of people diagnosed with diabetes in 
Australia. T1D incidence is highest in youth; 53% of those with newly diagnosed 
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T1D are aged under 20 years, and onset peaks between ages 10-14 years (33 per 
100,000 population vs 12 cases per 100,000 population overall) (Australian 
Institute of Health and Welfare, 2017). T1D is the most common form of diabetes 
in children and adolescents, accounting for 93% of diagnoses of diabetes in this age 
group (NDSS, 2018).  
1.1.1 Diabetes complications 
Without insulin replacement, hyperglycaemia persists and diabetic 
ketoacidosis (DKA) may develop. DKA is a life-threatening acute complication 
that occurs at diagnosis in approximately 15% of adolescents with T1D (15-19 
years) (Rewers et al., 2008). It can also occur in those with established T1D, 
precipitated by an infection or illness or by (deliberate or inadvertent) insulin 
omission (Bui, Werther, & Cameron, 2002). Recurrent hospital admission for DKA 
occurs more frequently among adolescents with psychological and behavioural 
problems (Wolfsdorf et al., 2009).  
Hypoglycaemia (low blood glucose) is a common complication of insulin 
therapy, which limits the achievement of optimal blood glucose levels (i.e. in the 
range required to prevent chronic complications) (Cryer, 2002). Hypoglycaemia 
may be precipitated by an imbalance of insulin and food and/or physical activity, or 
drinking alcohol, although at times the cause is unexplained. Symptoms can 
include feeling faint, weak, hungry, sweating and headache. Mild, symptomatic 
hypoglycaemia can be self-treated with fast-acting glucose to increase glucose 
levels, followed by long-acting carbohydrate to maintain this. Severe 
hypoglycaemia may be accompanied by disorientation, coma or convulsions, and 
require urgent assistance from another person, and perhaps medical treatment 
(Clarke, Jones, Rewers, Dunger, & Klingensmith, 2009). Awareness of 
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hypoglycaemic symptoms may be impaired (IAH) in the presence of longstanding 
diabetes or frequent hypoglycaemia, (Geddes, Schopman, Zammitt, & Frier, 2008). 
Around 20% of adults (Geddes et al., 2008) and 29% of children and adolescents 
with T1D have IAH (Ly, Gallego, Davis, & Jones, 2009), which substantially 
increases the risk of a severe episode. Understandably, hypoglycaemia is a source 
of worry and fear for many people living with diabetes and their family/carers 
(Wild et al., 2007).  
Chronic hyperglycaemia is associated with serious chronic complications 
(Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions 
and Complications (DCCT/EDIC) Research Group, 2009). Micro- and 
macrovascular complications may affect the eyes, kidneys, feet, cardiovascular and 
nervous systems and sexual function (DCCT/EDIC, 2005; Donaghue, Chiarelli, 
Trotta, Allgrove, & Dahl‐Jorgensen, 2009). Sub-clinical microvascular changes are 
evident in children and adolescents within 6 years of diagnosis (Cho et al., 2011). 
People with T1D have reduced life expectancy relative to those without diabetes; 
prior to age 40, excess mortality is predominantly due to endocrine and metabolic 
disease and thereafter, cardiovascular disease is the main cause of death (Huo, 
Harding, Peeters, Shaw, & Magliano, 2016). Optimal management of glycaemia 
(HbA1c) can prevent or delay the development of complications (DCCT/EDIC 
Research Group,  2009) and medical advances continue to improve overall life 
expectancy (Huo et al., 2016). Nevertheless, the spectre of diabetes complications 
causes considerable fear and psychological distress for people with diabetes 
(Polonsky et al., 1995). 
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1.1.2 Psychological complications of diabetes 
Common responses at diagnosis of T1D are anxiety, sadness and 
withdrawal, with up to 30% of children developing an adjustment disorder within 
the first three months (Kovacs et al., 1985). For most, these difficulties resolve by 
12 months (Dantzer, Swendsen, Maurice-Tison, & Salamon, 2003), though 
psychological distress in children and families at diagnosis is a risk for future 
psychological dysfunction (Cameron, 2003; Dantzer et al., 2003; Northam, 
Matthews, Anderson, Cameron, & Werther, 2004; Thernlund et al., 1996). While 
most young people adapt to living with diabetes, higher rates of psychiatric 
disorders (Northam et al., 2004), depressive symptoms (Hood et al., 2006) and 
anxiety (Sinnamon, Caltabiano, & Baune, 2013) are found among youth with T1D 
than those without diabetes.  
Adults with T1D also report more severe depressive and anxiety symptoms 
than the general population (Roy & Lloyd, 2012; Smith et al., 2013). Gender 
differences are apparent, with women experiencing greater anxiety (Smith et al., 
2013) and depression (Petrak et al., 2003) than men with diabetes and both men 
and women without diabetes.   
Among adults and young people with T1D, greater psychological distress is 
associated with less attention to self-care and sub-optimal HbA1c (Fisher, Thorpe, 
DeVellis, & DeVellis, 2007; Hackworth et al., 2013; Northam, Lin, Finch, 
Werther, & Cameron, 2010). Some studies have shown a significant relationship 
between general psychological distress and diabetes-related outcomes (Hilliard et 
al., 2016), although recent research in adults suggests that diabetes-specific distress 
is more strongly related to diabetes outcomes than general psychological distress 
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(Fisher et al., 2016b; Strandberg, Graue, Wentzel-Larsen, Peyrot, & Rokne, 2014; 
Van Bastelaar et al., 2010).  
1.2 Introducing Diabetes Distress 
The depression literature has been superseded somewhat in recent years by 
the literature concerning diabetes distress (DD) (Fisher et al., 2015). DD refers to 
the negative emotions related to being diagnosed and living with diabetes, 
including feelings of frustration, guilt and fear with the daily self-care burden, 
worries about future health and complications (Polonsky et al., 1995). Distress may 
also arise from conflict with family and friends over diabetes management, feelings 
of failure and being overwhelmed by the demands of managing the condition 
(Polonsky et al., 2005). Frustration may result from fluctuating blood glucose 
levels despite the best attempts to self-manage, and a sense of helplessness related 
to the possibility of long-term complications, which is exacerbated at certain time-
points, such as at screening for, or at diagnosis of, complications (Polonsky, 2002). 
DD tends to be chronic and stable and may not improve without intervention 
(Fisher et al., 2016a).  
1.2.1 Assessing diabetes distress 
Specific measures have been designed to capture the scope and severity of 
DD, including the Problem Areas in Diabetes (PAID) (Polonsky et al., 1995), and 
the Diabetes Distress Scale (DDS) (Polonsky et al., 2005). Although they are both 
valid and reliable measures of DD (Fenwick et al., 2018; Schmitt et al., 2016), they 
have each operationalised the concept in slightly different ways (Dennick, Sturt, & 
Speight). For example, the PAID places somewhat greater emphasis on food-
related concerns and complications and eating and the DDS on self-care and 
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diabetes management (Schmitt et al., 2016). Cut points have been established to 
designate elevated DD (Fisher, Hessler, Polonsky, & Mullan, 2012; Welch, 
Jacobson, & Polonsky, 1997). Both scales are comprised of interrelated subscales 
reflecting sub-domains, for example emotional burden, interpersonal or treatment-
related distress (Polonsky et al., 2005; Snoek, Pouwer, Welch, & Polonsky, 2000).  
The DDS has been modified to reflect the specific concerns of people with 
T1D (DDS-T1), for example, fear of hypoglycaemia (Fisher et al., 2015). The 
PAID has been adapted for youth with T1D (PAID-Teen version; PAID-T) 
(Weissberg-Benchell & Antisdel-Lomaglio, 2011) and to capture the emotional 
burden for parents of a child with T1D (PAID-Parents Revised; PAID-PR) 
(Markowitz et al., 2011). 
1.2.2 Differentiating diabetes distress from depression 
Depressive and anxiety symptoms are generalised psychological disorders 
with established criteria for diagnosis. For example, depressive symptoms include 
persistent anhedonia and depressed mood (American Psychiatric Association., 
2013). By contrast, DD is specifically related to the demands of living with 
diabetes (Esbitt, Tanenbaum, & Gonzalez, 2013). Furthermore, although 
assessment scales have been validated and cut-off scores have been established to 
identify elevated DD, it is not a diagnosable psychiatric disorder. A recent review 
suggests that effective interventions can be delivered by generalists, i.e. reducing 
the burden of DD does not necessarily require specialist support from a qualified 
psychologist (Sturt et al., 2015). 
Studies in adults with T1D show that 11% to 30% experience moderate-to-
severe depressive symptoms (Fisher et al., 2016b; Handley et al., 2016; Van 
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Bastelaar et al., 2010), whereas DD is generally more prevalent, with 15% to 40% 
adults reporting moderate-to-severe DD (Fisher et al., 2016a; Van Bastelaar et al., 
2010). More importantly, Fisher and colleagues (2016b) have shown that DD is 
related to HbA1c, but depressive symptoms and clinical depression are not. The 
relationship between DD and HbA1c appears to be interrelated; longitudinal 
analyses have shown that elevated DD predicts more frequent missing/skipping of 
insulin doses, and reduction in DD is associated with lower HbA1c (Hessler et al., 
2017). However, no cross-sectional or longitudinal relationship was found between 
depressive symptoms/major depression and HbA1c or measures of self-
management. Others have found that co-morbid DD and depressive symptoms are 
associated with the highest HbA1c levels (Van Bastelaar et al., 2010). Thus, the 
recent literature shows that DD is more prevalent and is more strongly related to 
diabetes outcomes than depression in adults with T1D, and impairs emotional well-
being (Fisher et al., 2015). 
1.3 Management of Type 1 Diabetes 
The aims of T1D management are to prevent or minimise the acute and 
chronic complications of diabetes and to promote optimal quality of life and 
psychological well-being. This is facilitated by self-management education and 
person-centred healthcare provided by a multidisciplinary team (Acerini, Craig, 
Beaufort, Maahs, & Hanas, 2014).  
1.3.1 Medical management of type 1 diabetes 
The DCCT/EDIC Study (2009) unequivocally demonstrated that intensive 
insulin therapy reduces the risk of diabetes complications in adults and adolescents 
with T1D. This is currently achieved with multiple daily injections (MDI) (four or 
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more insulin injections per day) or continuous subcutaneous insulin infusion 
(CSII), also known as insulin pump therapy.  Glycated haemoglobin (HbA1c), a 
measure of average blood glucose over the preceding three months, is the 
standardised measure of treatment efficacy.  The HbA1c target is <53 mmol/mol 
(<7%) for adults, but is slightly less stringent for children and adolescents 
(<58mmol/mol (<7.5%) due to the increased risk of hypoglycaemia (Craig et al., 
2011).  
Intensive insulin therapy requires intensive self-management, which 
necessarily includes frequent self-monitoring of blood glucose (SMBG), counting 
carbohydrate (and other macronutrients) in order to calculate insulin doses, and 
attending regular medical appointments to monitor diabetes and health status. MDI 
and insulin pump therapy enable more flexibility with food/drink and lifestyle than 
conventional fixed dose insulin regimens (i.e. two to three times each day) 
(Bangstad et al., 2009). Nevertheless, frequent adjustments to food and insulin are 
generally necessary to avoid hyperglycaemia and hypoglycaemia. SMBG is 
performed by finger prick, typically four to six times per day, and more often when 
playing sport, driving, during illness or to prevent/manage hypoglycaemia (Rewers 
et al., 2014). SMBG is a particularly burdensome aspect of self-management, due 
to the inconvenience and discomfort of finger pricking (Wagner, Malchoff, & 
Abbott, 2005), negative self-evaluations of out-of-target levels (Hortensius et al., 
2012), and the attention it draws to having diabetes (Thomas, Peterson, & 
Goldstein, 1997). Recent diabetes technologies enable continuous glucose 
monitoring (CGM) without the need for frequent finger pricks. Although CGM and 
insulin pumps are convenient and can improve glycaemia (Brake, 2010; Pihoker et 
al., 2013), the financial cost discourages the widespread adoption of these 
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technologies (Australian Institute of Health and Welfare, 2012b). In 2017, the 
Australian Government introduced a new subsidy to make CGM accessible to 
eligible individuals under the age of 21 years (Australian Government Department 
of Health, 2017; Juvenile Diabetes Research Foundation (JDRF), 2017). However, 
use of CGM is still not widespread. This is likely to be because some people find 
these devices overwhelming and anxiety-provoking (Markowitz, Pratt, Aggarwal, 
Volkening, & Laffel, 2012), uncomfortable or intrusive (Naranjo, Tanenbaum, 
Iturralde, & Hood, 2016) and embarrassing in social situations (Ritholz et al., 
2007). 
1.3.2 The impact of psychological factors on diabetes management 
Despite considerable advances in treatments and technologies over the past 
30 years, most people with T1D are not consistently achieving target blood glucose 
levels (Family Medicine Research Centre, 2010). While ‘adherence’ to an 
individualised self-care regimen assists in the attainment of optimal glycaemia, in 
practice this is difficult to sustain for people with a complex, life-long condition 
(Datye, Moore, Russell, & Jaser, 2015; Hood, Peterson, Rohan, & Drotar, 2009). 
Among people with T1D, psychosocial factors explain a large part of the variance 
in glycaemia, although the underlying mechanisms that link psychological distress 
and HbA1c are not fully understood (Peyrot, McMurry, & Kruger, 1999). Evidence 
suggests that coping and self-management behaviours mediate the relationship 
between DD and glycaemia (Jaser et al., 2012; Peyrot et al., 1999). The use of 
disengagement and avoidant coping strategies for managing psychological distress 
have been associated with elevated HbA1c (Jaser & White, 2011; Seiffge-Krenke 
& Stemmler, 2003), whereas active coping strategies, for example problem solving 
and distraction, have been related to optimal self-management and lower HbA1c 
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(Jaser et al., 2012). Indeed, HbA1c is more strongly related to regimen-related DD 
than other aspects of DD, suggesting that the emotional burden related to treatment 
interferes with self-management (Joensen, Tapager, & Willaing, 2013; Strandberg 
et al., 2014). Health professionals need to pay attention to the emotional demands 
of living with diabetes, in order to optimise clinical management and quality of life 
outcomes in people with diabetes. Empowerment-based approaches to self-
management involve people with diabetes in decisions about their own treatment 
and promote engagement in self-care, and support them to develop skills to cope 
with the emotions that may interfere with effective management of their diabetes 
(Funnell & Anderson, 2004).   
1.3.3 Education to support self-management of type 1 diabetes 
Education is critical for acquiring the knowledge and skills to self-manage 
T1D, and to prevent and manage diabetes emergencies/complications (Craig et al., 
2011), and may be gained through individual health professional information and 
advice, via informal self-education and peer networks, or structured education 
programs (Diabetes UK, 2017). Structured education is characterised as: evidence-
based; having specific aims and objectives, and documented, theory-based 
curriculum and learning resources focused on self-management; delivered by 
trained educators; and quality assured, with consistency assessed independently 
and outcomes audited regularly (National Institute for Health and Care Excellence 
(NICE), 2015). Structured education programs are typically provided in groups, 
because they are less resource intensive and offer the opportunity for learning from 
others’ experiences and for peer support (Lange, Swift, Pańkowska, & Danne, 
2014). 
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Structured T1D education programs designed to develop the skills required 
for flexible, intensive insulin therapy were first developed in Germany in the 1980s 
(Mühlhauser et al., 1983). The 5-day inpatient Diabetes Teaching and Treatment 
Programme (DTTP), demonstrated improved glycaemia in adults (Sämann, 
Mühlhauser, Bender, Kloos, & Müller, 2005) and adolescents (Sämann et al., 
2008). The DTTP was subsequently modified for adults with T1D in the UK, 
where it is known as Dose Adjustment for Normal Eating (DAFNE) (DAFNE 
Study Group, 2002). A randomised controlled trial (RCT) demonstrated that 
DAFNE improves HbA1c and diabetes-related quality of life (DRQoL) (DAFNE 
Study Group, 2002) and real-world evaluations have demonstrated positive 
outcomes in routine clinical practice, in Germany (Müller et al., 1999), the UK 
(Cooke et al., 2013) and Australia (McIntyre et al., 2010; Speight et al., 2016). In 
contrast to intensive insulin therapy as practiced in the DCCT (1993), which 
produced a 3-fold increase in severe hypoglycaemia, studies have demonstrated 
that the flexible, intensive insulin therapy promoted by DAFNE does not increase 
the frequency of severe hypoglycaemia (Bott, Bott, Berger, & Mühlhauser, 1997; 
DAFNE Study Group, 2002), or cause weight gain (DAFNE Study Group, 2002). 
Importantly, the psychological benefits of DAFNE are sustained and HbA1c 
partially maintained over several years (Hopkins et al., 2012; Speight et al., 2010). 
Participants with elevated HbA1c, diabetes distress and anxiety have been shown 
to gain the greatest benefits in terms of quality of life and diabetes distress after 
DAFNE (Byrne et al., 2012). Further, modelling of HbA1c data from the DTTP 
and DAFNE has shown that these programs are cost effective due to predicted 
reduction in the rates of long-term complications (Kruger et al., 2013; Shearer, 
Bagust, Sanderson, Heller, & Roberts, 2004). 
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Other structured education programs based on the German DTTP have been 
developed for adults in the UK, including Bournemouth Type 1 Diabetes Education 
Programme (BERTIE); an audit of outcomes showed reduced HbA1c, maintained 
for two years (Everett, Jenkins, Kerr, & Cavan, 2003). Shorter duration programs 
have been trialled, for example, Brief Intervention in Type 1 diabetes, Education 
for Self-efficacy (BITES), but a RCT was unable to demonstrate clinical benefits, 
though participants reported greater treatment satisfaction and empowerment 
(George et al., 2008).  
In the UK, the National Institute for Health and Care Excellence (NICE) 
(2015) recommends structured education is offered to all adults with T1D within 
six to 12 months of diagnosis. The Australian national evidence-based guidelines 
for the care of people with T1D endorses self-management education in the context 
of intensive insulin therapy (Craig et al., 2011). Despite these recommendations, 
less than half of Australian adults surveyed in the Diabetes Management and 
Impact for Long-term Empowerment and Success (MILES) Australia study had 
ever been offered structured education (Speight, Browne, Holmes-Truscott, 
Hendrieckx, & Pouwer, 2011). In Australia, OzDAFNE has been available for 
adults since 2005, and attended by over 3,400 participants in all states/territories 
(E. Collins, personal communication, 27 July, 2018). However, structured 
education programs are not widely accessible for those outside metropolitan areas, 
or for children and adolescents with T1D. 
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1.4 Introducing Adolescence and Type 1 Diabetes 
 1.4.1 Adolescence as a life stage 
Adolescence is a key life stage, representing the transition from childhood 
to adulthood. It is a period of rapid physical, emotional and social development that 
begins around the onset of puberty (Sawyer et al., 2012). The contemporary 
definition includes early (age 10-14 years) and late adolescence (15-19 years), 
although maturation continues into young adulthood (20-24 years) (Sawyer et al., 
2012). In addition to the physical changes associated with puberty (e.g. sexual 
maturation, growth), neurodevelopmental changes, including the development of 
intellectual skills, abstract and moral reasoning and emotion control, continue to 
evolve into the mid-20’s (Sawyer et al., 2012). Impulsivity and risk-taking are 
characteristic behaviours displayed in mid-adolescence, as emotional maturity lags 
behind cognitive development (Blakemore, Burnett, & Dahl, 2010; Sawyer et al., 
2012). Experimenting with alcohol and consuming excessive amounts of alcohol is 
a common form of risk-taking and sensation-seeking behaviour in adolescence 
(MacPherson, Magidson, Reynolds, Kahler, & Lejuez, 2010).  
Adolescence is an important time for exploring identity and broadening 
social networks and relationships beyond the family. Peers become more 
influential, and social comparison can lead to body image concerns and low self-
esteem (Davison & McCabe, 2006). A recent national survey reported that stress, 
school performance, family conflict and body image were among the topmost 
concerns, and friends were the preferred source of support for older Australian 
adolescents (Bailey et al., 2016).  
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Certain health issues may arise during adolescence, which have 
implications for future physical and mental well-being. For example, alcohol 
consumption in early adolescence is a predictor of adult alcohol dependence 
(Sawyer et al., 2012). The initial onset of mental health problems most often occurs 
during adolescence or young adulthood (Kessler et al., 2005). After puberty, the 
incidence of depression rises steeply, and by late adolescence the annual prevalence 
is similar to the rate observed in adults (4-5%), with a female preponderance of 
about 2:1 of males (Thapar, Collishaw, Pine, & Thapar, 2012).   
Most young people transition through adolescence successfully and lead 
productive adult lives. However, some youth are more vulnerable to physical and 
psychological problems due to individual (e.g. congenital or acquired conditions) 
and environmental attributes, including lack of safe and supportive family, peer 
relationships and schools, exposure to violence, substance abuse and 
socioeconomic disadvantage (Viner et al., 2012). Psychological well-being and 
nurturing relationships are predictors of resilience in the face of such adversity 
(Ungar et al., 2007).  
1.4.2 Management of type 1 diabetes during adolescence 
As noted in Section 1.1, around half of people with T1D are diagnosed 
before the age of 20, and most often during early adolescence (Australian Institute 
of Health and Welfare, 2017). Adolescence is a challenging time for young people 
with T1D as they learn to self-manage their condition and use the adult healthcare 
system, whilst coping with the social, physical and emotional changes to become 
independent adults, and when concerns about body image and social conformity 
are heightened (Davison & McCabe, 2006).  
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Only 27% of Australian adolescents aged 12-18 years meet the 
recommended HbA1c target of <58mmol/mol (<7.5%) (Australian Institute of 
Health and Welfare, 2012a). HbA1c typically deteriorates during adolescence, due 
to the rise in pubertal hormones which induce a state of insulin resistance (Amiel, 
Sherwin, Simonson, Lauritano, & Tamborlane, 1986), compounded by rapid 
growth and weight gain (Dabadghao, Vidmar, & Cameron, 2001). These changes 
occur earlier in girls and by late adolescence, on average, girls have higher body 
mass index (BMI) and HbA1c than boys (Dabadghao et al., 2001). As young 
people become more responsible for their own diabetes and peers become more 
influential, T1D self-care may be neglected (Datye, et al., 2015).  Some adolescents 
may be reluctant to attend to their diabetes in social situations or at school, to avoid 
drawing attention to their diabetes and appearing to be different from their peers 
(Hains, Berlin, Davies, Parton, & Alemzadeh, 2006). Further, diabetes presents 
specific challenges at school (Newbould, Francis, & Smith, 2007) and in the 
workplace (Ruston, Smith, & Fernando, 2013); namely, insulin storage and privacy 
for injecting and SMBG, and managing hypoglycaemia. 
Adolescents whose parents are involved and supportive are more likely to 
remain engaged in, and have optimal, diabetes management (Anderson, 2004), 
although, the style of parenting has an important influence on these outcomes. 
Children whose parents are less controlling and more warm and supportive have 
lower HbA1c (Anderson, 2004, 2011) and higher diabetes-related QoL (Graue, 
Wentzel-Larsen, Hanestad, & Søvik, 2005) than those whose parents adopt 
authoritarian or permissive parenting styles. How well an individual and their 
family adapts to living with diabetes, and their emotional well-being also predict 
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clinical outcomes and quality of life (Rybak et al., 2016; Whittemore, Jaser, Chao, 
Jang, & Grey, 2012).  
1.4.3 Long-term outcomes for adolescents with type 1 diabetes 
Suboptimal HbA1c is associated with lower school performance (Cooper, 
McNamara, de Klerk, Davis, & Jones, 2016), and adults with T1D are more likely 
to have higher unemployment, and lower health-related quality of life (HRQoL) 
than the general population, regardless of education level (Nielsen, Ovesen, 
Mortensen, Lau, & Joensen, 2016). Even as young adults, all-cause mortality is 
higher among people with T1D than the general population (Cooper, Klerk, Jones, 
& Davis, 2014). Risk factors include female sex, high HbA1c, recurrent severe 
hypoglycaemia and low socioeconomic background (Cooper et al., 2014). Thus, 
fears for the future are well founded, and contribute to elevated DD among young 
people with diabetes and their parents (Markowitz et al., 2011; Weissberg-Benchell 
& Antisdel-Lomaglio, 2011).  
1.5 Psychological Distress in Adolescents with Type 1 Diabetes 
1.5.1 General psychological distress in adolescents 
Up to one-third of adolescents with T1D report high levels of general 
emotional distress, including depressive symptoms, anxiety and poor emotional 
well-being. Sub-optimal general emotional well-being, measured with the WHO-5 
Well-being Index, has been reported in 24% of youth (de Wit et al., 2012), and 15-
37% of adolescents with T1D have increased anxiety symptoms (Bernstein, 
Stockwell, Gallagher, Rosenthal, & Soren, 2013; Herzer & Hood, 2010; Moussa et 
al., 2005; Sinnamon et al., 2013). Elevated depressive symptoms were reported by 
15-17% of adolescents with T1D; double the rate of population norms (de Wit & 
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Snoek, 2011; Hood et al., 2006). Consistent with studies in the general population 
and adults, symptoms of depression and anxiety were more severe among girls than 
boys with T1D (de Wit & Snoek, 2011; Helgeson, Snyder, Escobar, Siminerio, & 
Becker, 2007; Hood et al., 2006; Lawrence et al., 2006; Rechenberg, Whittemore, 
& Grey, 2017).  
In addition to impaired psychological well-being and QoL (Lawrence et al., 
2012), elevated depressive symptoms have been associated with suboptimal HbA1c 
(Lawrence et al., 2006; Plener et al., 2015; Whittemore et al., 2002), more frequent 
DKA, severe hypoglycaemia and hospital admissions (Plener et al., 2015). 
Importantly, longer duration of depression has been associated with increased risk 
for retinopathy (Kovacs, Mukerji, Drash, & Iyengar, 1995). State and trait anxiety 
appear to affect different aspects of diabetes management; state anxiety is 
associated with elevated HbA1c, diabetes-related family conflict, and less frequent 
SMBG, whereas trait anxiety correlates with greater worry and fear of 
hypoglycaemia, more frequent hypoglycaemia and less frequent SMBG 
(Rechenberg et al., 2017).  
1.5.2 Diabetes distress in adolescents 
While there has been considerable research about DD in adults with T1D 
(see Section 1.2)1, until recently, there has been relatively little attention to this 
area in adolescents. Nevertheless, studies have found that over half of adolescents 
(54%) reported one or more serious problems related to living with diabetes 
                                                 
1 There has also been considerable attention paid to DD in adults with type 2 
diabetes (T2D) but it is beyond the scope of this PhD thesis to report it in detail 
here. 
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(Weissberg-Benchell & Antisdel-Lomaglio, 2011) and that elevated DD was 
associated with adverse diabetes-related outcomes (e.g. HbA1c) (Berlin, Rabideau, 
& Hains, 2012; Weissberg-Benchell & Antisdel-Lomaglio, 2011). However, the 
evidence is inconsistent, and some studies do not show a significant relationship 
with HbA1c or self-management (Grey, Boland, Yu, Sullivan-Bolyai, & 
Tamborlane, 1998; Nouwen, Urquhart Law, Hussain, McGovern, & Napier, 2009).  
DD correlates positively with depressive symptoms (Grey et al., 1998; 
Weissberg-Benchell & Antisdel-Lomaglio, 2011), yet the inter-relationships 
between DD, depressive symptoms and diabetes management have not been 
investigated in adolescents. Studies in adults have shown that DD mediates the 
association between depressive symptoms and HbA1c (Van Bastelaar et al., 2010), 
but no studies among adolescents had analysed these outcomes concurrently, 
revealing an important gap in the DD literature.  
Some studies show that girls reported more severe DD than boys 
(Delamater, Patiño-Fernández, Smith, & Bubb, 2013; Farrell, Hains, Davies, 
Smith, & Parton, 2004), although others have found no gender difference (Berlin et 
al., 2012; Law, Walsh, Queralt, & Nouwen, 2013). The personal characteristics that 
account for elevated DD have not previously been investigated or reviewed 
systematically, and this would assist in identifying youth at higher risk for DD, to 
offer supportive interventions. Psycho-educational interventions have been 
evaluated that assess DD and some of these demonstrate short-term decreases in 
DD (Ellis et al., 2005; Serlachius, 2011), but the interventions are heterogenous, 
and it is unclear which components may be associated with change in DD. No 
systematic review of the DD literature had been undertaken to consolidate this 
research in adolescents.  
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1.5.2.1 Assessing diabetes distress in adolescents 
Age-specific measures of DD have been developed for youth (Diabetes 
Stress Questionnaire for Youth (DSQY) (Delamater et al., 2013), and the PAID has 
been adapted for adolescents (PAID-Teen version; PAID-T) (Weissberg-Benchell 
& Antisdel-Lomaglio, 2011). Adult DD measures have been used with adolescents, 
but they may not capture concerns specific to their life stage, such as over-
vigilance by parents or body image concerns (Weissberg-Benchell & Antisdel-
Lomaglio, 2011). Although cut points have been established in adults for the PAID 
(Welch et al., 1997), and DDS-T1 (Fisher et al., 2015), the studies required to 
establish a threshold for clinically-meaningful distress in adolescents had not been 
conducted at the time of embarking on this program of PhD research. A validated 
cut point for an age-specific measure of DD would enable the prevalence of DD 
among adolescents to be estimated in study and clinical settings, in order to 
describe the problem of DD among this population, and to identify young people 
with elevated DD who may benefit from support.  
1.6 Education to Support Self-management of Type 1 Diabetes for Adolescents 
As discussed in Section 1.3.3, the DTTP has been implemented nationally 
in Germany for adolescents with T1D since the early 1990s. An audit of outcomes 
at one year showed that older adolescents and young adults experienced a reduction 
in HbA1c and fewer episodes of severe hypoglycaemia and DKA, whereas younger 
adolescents (aged 12-15 years) did not significantly benefit (Sämann et al., 2008). 
The authors concluded that better outcomes may have been achieved for younger 
adolescents if the program was adapted to their specific needs and developmental 
stage. Involving parents, who often retained some responsibility for daily diabetes 
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care, was also a recommendation for working with this age group.  Children and 
adolescents have different learning needs to adults and are more likely to self-
manage their diabetes successfully when supported by a knowledgeable and 
motivated family (Lange et al., 2014).  Thus, education programs that have been 
designed for adults may need substantial adaptation to be suitable for adolescents, 
including consideration of cognitive and psychosocial maturity and level of 
independence, while promoting ongoing involvement of parents (Lange et al., 
2014). Although DAFNE had positive effects in terms of psychological and clinical 
outcomes, and was well-established in Australia, it was not known whether 
DAFNE was appropriate or effective for adolescents when this program of research 
commenced.  
During the late 2000s, three structured education programs to teach 
adolescents the skills for flexible MDI were being developed and evaluated in the 
UK and Ireland. A pilot study of ‘Kids in Control of Food’ (KICk-OFF), a 5-day 
program based on the DAFNE principles of flexible insulin dose adjustment, was 
trialled among 48 adolescents aged 11-16 years (Waller et al., 2008). Although the 
pilot study showed no benefit in terms of HbA1c, body weight or hypoglycaemia 
frequency, general and diabetes-specific QoL, child responsibility for diabetes self-
management, treatment satisfaction and self-efficacy improved, and the program 
was acceptable to both youth and parents. KICk-OFF was subsequently evaluated 
in a RCT (Price et al., 2013), but the results were published after this program of 
research commenced, therefore this study will be examined in the Discussion 
(Chapter 7).  
The Carbohydrate, Insulin Collaborative Education (CHOICE) program 
comprised four weekly, 3-hour group sessions for adolescents aged 13 to 19 years 
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(Chaney, Coates, & Shevlin, 2010). Attendance was high and dietary management 
improved in the short term (3-6 months) among the adolescents randomly allocated 
to the intervention (n=80), but no other benefits were reported (Coates et al., 2013). 
Although liberalising the diet did not significantly cause weight gain or affect 
HbA1c in the short term, HbA1c had deteriorated after two years among the 
intervention group participants. The CASCADE Study (Child and Adolescent 
Structured Competencies Approach to Diabetes Education) was a multicentre, RCT 
of a structured psycho-education program for adolescents aged 8-16 years with 
T1D and suboptimal HbA1c, and their parents (Christie et al., 2009). Attendance at 
the four, monthly education sessions was low. There was no significant difference 
in outcomes between CASCADE and standard care at 12 or 24 months. As HbA1c 
did not change, the program was not likely to be cost effective (Christie et al., 
2014).  
At the same time as these initiatives were in development in the UK, an 
Australian team led by the author of this thesis, was adapting the DAFNE 
curriculum for adolescents aged 13 to 19 years. A pilot (pre-post) study of the 
Teens Empowered to Actively Manage Type 1 Diabetes (TEAM T1) program, 
involving 19 adolescents and their parents, demonstrated promising improvements 
over three months, including decreased HbA1c and DD (PAID-T) and increased 
diabetes management self-efficacy (Knight et al., 2010). However, these 
preliminary results must be viewed circumspectly due to the small number of 
participants, limited timeframe and absence of a control group. Nevertheless, this 
was the first time DD was assessed as an outcome of structured T1D education 
based on DAFNE principles among adolescents. In 2012, funding from the 
Australian Government Department of Health enabled further development of 
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TEAM T1, and evaluation of the program has provided the opportunity to 
investigate DD and other relevant outcomes in a larger sample of adolescents and 
over a longer timeframe. 
A wide range of educational interventions aimed at improving diabetes 
management and QoL outcomes have been trialled among adolescents, including 
self-management skills training, cognitive-behavioural programs, and family 
therapy (Couch et al., 2008). However, a systematic review found that most studies 
were limited by small sample sizes, heterogeneity of populations, interventions and 
outcomes, and low study quality, thus were unable to draw conclusions about their 
efficacy (Couch et al., 2008). Further, a more recent systematic review designed to 
inform the Australian T1D management guidelines, could not find consistent 
evidence of effectiveness to recommend any particular type of educational 
intervention for adolescents (Craig et al., 2011). Health professionals typically find 
it challenging to engage adolescents in their T1D management and in research 
studies; and even well-designed studies experience difficulties recruiting and 
retaining participants (Christie et al., 2016; Coates, Horigan, Davies, & Davies, 
2017; Murphy, Wadham, Hassler-Hurst, Rayman, & Skinner, 2012). Hence, 
evidence-based, structured education programs for adolescents have not been 
provided routinely in Australia.  
1.7 The Need for Investigation of Diabetes Distress Among Adolescents with 
Type 1 Diabetes 
There has been a growing body of research demonstrating the clinical 
significance of elevated DD among adolescents, but substantial gaps in the 
literature remain. At the time of embarking on this program of PhD research, little 
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was known about personal characteristics associated with DD. The prevalence of 
elevated DD in adolescents was unknown, and there were no validated or 
clinically-meaningful cut points with which to estimate this, and none using age-
appropriate measures of DD.  
The literature in adolescents with T1D has focused on depressive 
symptoms, and very few studies had examined depressive symptoms and DD 
concurrently. Moreover, none had examined the relationship between these 
constructs and HbA1c in adolescents, despite studies in adults with T1D 
demonstrating that DD may be more relevant to diabetes-related outcomes than 
depression. This finding has important implications for choosing the most 
appropriate strategies for psychological support that will improve both emotional 
and clinical outcomes.  
Some studies of interventions have assessed DD, yet little was known about 
which interventions or their components were associated with reduced DD. The 
results of such research may be used to inform the design of interventions to 
prevent or reduce DD. In addition, further development and evaluation of the 
TEAM T1 program provides the opportunity to examine DD among a clinical 
sample of Australian youth. 
1.8 Direction of Research in This Thesis 
1.8.1 Research questions 
To address the knowledge gaps in the evidence base, this program of PhD 
research set out to consider the following questions: 
Among adolescents with T1D:  
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a) What is the prevalence of clinically meaningful DD? 
b) What are the demographic, psychosocial and clinical characteristics 
associated with elevated DD? 
c) Is DD more strongly associated with diabetes outcomes (HbA1c) than 
general emotional distress (depressive symptoms)? and 
d) Is the level of DD reduced after a structured T1D education program? 
1.8.2 Studies included in this thesis 
The program of research to investigate these questions included several studies (see 
Figure 1.1):  
1) A systematic review of the published literature to locate and critically 
examine studies that have reported the prevalence and correlates of DD 
and educational interventions that have assessed diabetes distress as an 
outcome;  
2) A national cross-sectional survey of psychological well-being and 
diabetes management among adolescents with T1D; and  
3) A quasi-experimental study (pre/post-design) of a structured T1D self-
management education program adapted for adolescents from the 
DAFNE program (Teens Empowered to Actively Manage Type 1 
Diabetes (TEAM T1)).  
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Figure 1 1: Schematic representation of research studies, research aims and 
empirical papers.  
 
1.9 Summary 
T1D is a relentless, chronic medical condition requiring multiple daily 
insulin injections or insulin pump therapy and frequent self-monitoring of blood 
glucose. Management of diabetes during adolescence is often less than ideal, 
although optimal glycaemia is often difficult to achieve in this age group, due to 
physiological, psychological and social factors. If diabetes is not well managed, 
life-threatening complications can develop. Intensive insulin therapy reduces the 
risk of developing chronic complications but is difficult to achieve in practice, due 
to the heavy burden it places on self-management. Structured education to develop 
1) Systematic 
Review 
 
2) Diabetes MILES 
Youth – Australia 
Study 
 
3) Teens Empowered 
to Actively Manage 
Type 1 Diabetes 
(TEAM T1) 
a) Prevalence of elevated diabetes distress 
Paper 1   Paper 3   Paper 5 
b) Characteristics associated with diabetes distress 
Paper 1   Papers 3 & 4  Paper 5 
d) Change in diabetes distress after structured education  
Paper 1      Paper 5 
c) Relationship 
between diabetes 
distress, depressive 
symptoms and HbA1c 
Paper 4 
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skills for self-management of T1D has demonstrated improved HbA1c and 
psychosocial outcomes among adults in experimental conditions and routine 
clinical practice. Pilot studies in adolescents have shown promising results in terms 
of clinical and psychological benefits, including diabetes distress.  A substantial 
proportion of adolescents with T1D experience psychological distress, including 
elevated depressive symptoms, anxiety and diabetes distress. Diabetes distress 
represents an independent construct closely related to depressive symptoms, though 
measures of diabetes distress appear to be better predictors of diabetes outcomes in 
adults than measures of depression. The study of diabetes distress in adolescents 
has been somewhat limited, and the literature shows a predominant focus on 
depression. Further investigation of diabetes distress among adolescents is needed 
to understand the prevalence and impact of DD among adolescents. Thus, the aim 
of this program of PhD research was to a) to identify the prevalence of clinically 
meaningful DD, b) to investigate the demographic, psychosocial and clinical 
characteristics associated with elevated DD, c) to examine the inter-relationship 
between DD, depressive symptoms, and HbA1c, and d) to investigate change in 
DD following structured T1D education. 
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2.1 Abstract 
Diabetes distress (DD) refers to the negative emotions arising from living 
with diabetes and the burden of self-management. Among adults, the prevalence 
and significance of DD are well established but this is not the case among 
adolescents. This systematic review investigated among adolescents with type 1 
diabetes: the prevalence of DD; demographic, clinical, behavioral and psychosocial 
correlates of DD; and interventions that reduce DD.  Consistent with adult studies, 
around one third of adolescents experience elevated DD and this is frequently 
associated with suboptimal glycemic control, low self-efficacy and reduced self-
care. Three measures of DD have been developed specifically for adolescents, as 
those designed for adults may not be sufficiently sensitive to adolescent concerns.   
Interventions reducing DD in the short term include strategies such as cognitive 
restructuring, goal setting and problem solving. Further work is needed to 
investigate sustainability of effect. Rigorous research is needed to progress this 
field among adolescents. 
 
Keywords: Adolescent; Type 1 Diabetes; Emotions; Stress, Psychological; 
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2.2 Introduction 
Diabetes distress (DD) refers to the negative emotions (e.g. feeling 
frustrated, hopeless, angry, guilty, fearful), that arise from living with and 
managing diabetes [1]. DD is exacerbated by lack of understanding by, or 
unhelpful interactions with family, friends and health professionals, and feeling 
overwhelmed by the demands of managing the condition [2, 3]. Depression is 
characterised by disturbed thoughts, emotions and mood, accompanied by a range 
of symptoms including altered sleep, energy and appetite, lasting at least 2 weeks 
[4]. Anxiety, which often co-occurs with depression, is an emotional and physical 
response to stressful situations, and is considered a disorder if fears and symptoms 
are persistent and excessive [4]. In contrast to depression and anxiety, which are 
appraised in the absence of life-context or aetiology, DD is not a psychiatric 
condition [5]. Rather it is an emotional response to the specific challenges of 
diabetes. Although related, they are different constructs, which may occur 
concurrently. 
Adolescence is a challenging time, particularly so for young people with 
T1D, as they learn to self-manage their condition while coping with the social, 
physical and emotional changes to become independent young adults. Anxiety and 
depressive symptoms are greater among adolescents with T1D than their peers 
without diabetes [6, 7] and are associated with impaired diabetes self-management 
and suboptimal glycemic control [8-11].  DD is also apparent, with adolescents 
reporting feeling guilty about their blood glucose levels, and frustration with the 
complexity of managing diabetes, over-vigilance and intrusiveness of parents and 
friends [12].  
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In adults with type 1 diabetes (T1D), DD is associated with reduced self-
care and engagement with treatment, and suboptimal HbA1c [13]. Recent studies 
suggest that DD is a better predictor of glycemic control than depression [14, 15]. 
According to Fisher et al. [16], elevated depressive symptoms (sub-clinical 
depression) observed among people with diabetes may reflect the severe end of the 
DD spectrum.  The distinction between depression and DD is important because 
treatment for depression does not necessarily result in better diabetes management 
outcomes [17, 18], or reduction of DD, whereas interventions that target both DD 
and self-management improve both DD and HbA1c in adults with T1D [19-21]. 
Regimen-related distress is more strongly associated with HbA1c and self-
management than other DD domains [13]. Hence, a change in treatment or the 
development of diabetes self-management skills via the provision of structured 
diabetes education may have greater impact on DD than general approaches, such 
as medication or CBT that lacks a salient focus for change [22]. 
Several empirical studies have assessed DD and its relationship with self-
care and glycemia among adolescents with T1D [23, 24], and few interventions 
have been evaluated in terms of their impact on DD [25, 26]. These studies suggest 
that a significant proportion of adolescents are distressed about diabetes, and that 
distressed adolescents have suboptimal diabetes outcomes. However, the 
prevalence and clinical significance of DD in adolescents is not clear and little is 
known specifically about effective interventions to reduce DD in this age group. 
Therefore, we undertook a systematic review with three aims: (a) to determine the 
prevalence of DD among adolescents with T1D; (b) to investigate the 
demographic, clinical, behavioral and psychosocial correlates of DD; and (c) to 
55 
 
identify interventions targeting DD among their endpoints, and determine common 
characteristics of successful interventions.   
2.3 Materials and Methods 
Our review was conducted according to established PRISMA and MOOSE 
guidelines [27, 28].  
2.3.1 Data sources and searches 
We searched Medline, CINAHL, SCOPUS and PsycINFO electronic 
databases for observational and experimental studies, published in peer-reviewed 
journals, conference proceedings and dissertations, in which DD was assessed 
among adolescents with T1D. A combination of keywords were used to define the 
population: adolescen* with type 1 diabetes; intervention: education, 
psychotherapy; and outcome: emotion*, distress, stress, quality of life.  The full 
search strategy is available in Appendix G. We limited the search to the English 
language and to publications since 1994 because of the following: (a) diabetes 
management changed considerably after publication of the DCCT [29] and (b) the 
seminal paper about assessment of diabetes distress was published in 1995 [30]. 
We also searched conference proceedings published in the past 2 years.   
2.3.2 Study selection 
Following removal of duplicates, the titles and/or abstracts were screened 
(by VH), with a second reviewer (JSp) screening 10% of records (Figure 2.1). Full 
text was obtained for positively screened abstracts or when key study details (age, 
diabetes type, DD measure) were indeterminate from the abstract. We contacted 
authors as necessary to obtain additional information or a copy of scales. 
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2.3.2.1 Focusing on measures of diabetes distress 
To ensure that DD was being measured, we assessed the face validity of 
diabetes-specific psychosocial questionnaires identified during the search. 
Measures focused on the emotional impact of/reactions to a single, highly specific 
aspect of living with diabetes (e.g. fear of hypoglycemia, fear of injecting and 
finger-pricking, and blood glucose levels) were excluded because they do not 
encapsulate broader distress associated with various aspects of living with diabetes. 
Similarly, scales focused only on ‘worry’ were excluded because they do not 
capture the range of negative emotions that comprise distress, such as shame, guilt, 
anger or frustration. We also excluded scales rating cognitive appraisals of, or 
coping responses to stress, or the impact of diabetes on quality of life, as these do 
not focus specifically on emotions. The instruments we considered to be relevant 
measures of DD and included in the review are summarised (see Table 2.3 in 
Appendix G).   
2.3.2.2 Criteria for inclusion into the review 
 Studies were eligible for inclusion if:  
(a) The sample included adolescents (broadly defined as aged 10 to 20 years of 
age) with T1D; and  
(b) DD was measured, using any of the scales listed in Table 2.3; and  
(c) They were cross-sectional, observational or a randomized controlled trial 
(RCT); and  
(d) Published in a peer-reviewed journal article or dissertation; or published since 
2012 in conference proceedings (i.e. emerging evidence). 
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We excluded studies that: 
(a) Only included adults over 18 or children less than 12 years of age (or mean age 
<12 or >20 years) 
(b) Included only people with type 2 or gestational diabetes, or without diabetes 
(c) Were qualitative or case studies 
(d) Were intervention studies without a control group or with a sample size of N < 
20, as these are likely to over-estimate effect sizes or have insufficient power to 
demonstrate statistical significance 
(e) Published only as a conference abstract prior to 2012, as these do not provide 
sufficient information and could reasonably be expected to have been published in 
a peer-reviewed journal in the past 2 years; 
(f) If DD scores were not reported or the adolescents’ results were not reported 
separately from those of adults or children.  
2.3.3 Data extraction and quality assessment 
Study and participant characteristics were extracted (Tables 2.1 and 2.2). 
Mean DD scores (baseline scores for prospective studies) were recorded for the 
purpose of estimating the severity of distress. Prevalence of (severe or moderate) 
DD was determined by the proportion above the cut-off point (where reported). 
Other relevant data included associations between DD and participants’ 
demographic, clinical, behavioral or psychosocial variables. For RCTs, we 
extracted the intervention type and description, comparator, interventionist, change 
in DD scores and data quality considerations. Data from the same study cohort, 
published across more than one article, were reported together as a single study. 
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Selected papers were critically appraised for quality and scientific rigour according 
to published standards [31]. 
2.3.4 Data synthesis and analysis 
Data were analysed quantitatively, to assess the frequency of 
positive/negative and null correlations among study variables and DD. In the 
absence of validated clinical cut-offs for adolescents, we used the number of items 
and rating scale reported for each study, to grade mean DD scores into three levels 
of severity: low distress (mean score +1SD < mid-point); moderate distress (mean 
score within 10% of mid-point); and high distress (mean score −1SD > mid-point). 
In order to analyse change in DD, an effect size (ES) (Cohen’s d) was calculated 
from the available information (means and standard deviations), using the 
following formula [32]:  
Follow-up (xˉ 1 –  xˉ 2) – Baseline (xˉ 1 –  xˉ 2) /Baseline SDpooled 
Effect sizes were considered to be small (d=0.2), medium (d=0.5) or large (d=0.8) 
[33].  
2.4 Results 
2.4.1 Study selection 
The PRISMA diagram (Figure 2.1) summarises the results of the search, 
screening process and reasons for exclusion. Thirty-four articles met the initial 
inclusion criteria but seven were excluded: four due to small sample size (<20 
participants) [34−37]; one because DD scores for the 12+ age group were not 
reported separately from parent proxy reports for younger children [38]; two 
conference abstracts, which did not provide sufficient data and further information 
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was unavailable [39, 40]. In total, 27 articles reporting on 16 studies were included 
in the review.   
Five studies were reported in multiple papers: The ‘DEPICTED’ study in 
three papers [41−43]; a study of negative diabetes attributions in two papers [44, 
45]; two other studies published in both dissertation and article format [23, 26, 46, 
47]; the ‘ABCs of Diabetes’ Coping Skills Training study in seven papers 
describing various analyses and several follow-up studies [48−54].  
Study details and participant characteristics are provided in Tables 2.1 and 
2.2 (non-intervention and intervention studies). Sample sizes varied enormously (N 
= 21-417). Participants’ ages ranged from 8 to 20 years.  Of the 16 studies, ten 
were conducted in the USA [23, 24, 25, 44, 51, 55, 56, 57−59], three in the UK 
[41, 60, 61], and one each in Australia [26], Mexico [62] and New Zealand [63]. 
Participants were recruited almost exclusively from hospital clinics, as well as from 
‘diabetes camp’ [56, 59] and private clinics [24]. Participants were generally 
from mid-to-high socioeconomic backgrounds, although two studies targeted 
disadvantaged youth [25, 62]. 
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Figure 2. 1: Flow diagram of search results and reasons for exclusion 
 
2.4.2 Quality appraisal 
There were a number of potential biases among the studies. Studies rarely 
included participants from culturally diverse and low socioeconomic backgrounds 
[57, 58]. Several had low response rates [26, 41, 59, 61, 63], and three cross-
sectional studies had fewer than 50 participants [48, 62, 59], which may have 
reduced the statistical power. Sample size calculations for RCTs were based on 
HbA1c and not on DD. All RCTs used intention-to-treat analysis, although Grey et 
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al. [50] did not include two participants (3%) lost to follow-up at 12 months. 
Gregory et al. [41] and Serlachius et al. [26] reported high attrition (>25%) at 
follow-up and insufficient exposure to the intervention, which may have weakened 
their results. Ellis et al. [25] reported only post-intervention results.  None of the 
RCTs provided equal contact time to both groups in order to differentiate the effect 
of the intervention content from attention. The follow-up studies of the ABCs of 
Diabetes [49, 53] were not randomised.  
2.4.3 Level of diabetes distress 
Tables 2.1 and 2.2 provide the mean DD score (± SD) and possible scoring 
range (where reported) for each study. On average, adolescents reported a low level 
of DD, except in one study [62] where the mean score was in the moderate range. 
2.4.4 Prevalence of diabetes distress 
Three studies reported the proportion of participants experiencing severe 
DD. A Mexican study [62] used a Problem Areas in Diabetes (PAID) score of >43 
(upper tertile) to estimate that 67% (n=14) of their cohort (aged 14-17 years) 
experienced severe DD.  Fifty-four per cent of adolescents [24] experienced at 
least one serious concern about living with diabetes (PAID-Teen (PAID-T) item 
score 5-6), and participants reported an average of 3.3 ± 4.8 serious concerns. 
Using the Diabetes Stress Questionnaire (DSQ) [55], latent profile modelling was 
applied to estimate that 33% of participants experienced significant DD, 
predominantly within the interpersonal/peer or parental/family domains.  
Two studies [24, 62] reported the topmost concerns endorsed by 
participants. ‘Worrying about the future and the possibility of serious 
complications’ and ‘feeling guilty or anxious when getting off track with diabetes 
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management’ were among the most serious problem areas for Mexican adolescents 
(completing the PAID) [62]. ‘Worrying about weight’ was endorsed by 24% of 
PAID-T respondents [24]. Of the eight DSQ subscales, the highest mean scores 
were for ‘distress-worry’, ‘parental distress’ and perceived distress regarding 
hyperglycemia and hypoglycemia [55, 56].  
2.4.5 Diabetes distress and participant characteristics 
Participant demographic characteristics and correlations with DD are 
provided in Table 2.1. Of 10 studies in which the relationship between age and DD 
was analysed, six found no relationship. DD increased with age in two studies [60, 
63], while another [62] found that participants aged 14−18 years were more 
distressed than those aged over 18 years, and dietary-related distress decreased 
with age in another study [55]. Of the 11 studies examining DD and gender, three 
found that girls’ distress scores were higher than boys [23, 24, 56], while eight 
studies found no significant associations. In one US study [56], youth from 
ethnic minority backgrounds experienced greater distress-worry and peer distress 
than youth from the predominant (white) ethnic group, but no relationship was 
found between DD and socioeconomic status (SES). The other study reporting 
correlations with SES or ethnicity [25] found no association with DD but family 
composition (two-parents vs single) was positively correlated with DD. No other 
studies reported correlations with SES, ethnicity or family situation. 
2.4.6 Diabetes distress and clinical characteristics 
PAID scores decreased with diabetes duration in one study [61], although 
five studies [23, 25, 48, 54, 62] found no relationship. Distress about 
hyperglycemia was increased with longer duration of diabetes in two studies [55, 
56].  Perceived distress concerning hypoglycemia was also higher with longer 
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diabetes duration whereas dietary-related distress was lower [56]. None of the 
studies considered age of diabetes onset. 
There was a small-to-moderate positive correlation between HbA1c and 
DD (r=0.13−0.30, p<0.05), in eight of 12 studies [23, 24, 25, 44, 55, 56, 58, 
60] whereas four studies [48, 54, 57, 61] found no significant correlation. Two 
studies investigated HbA1c and specific aspects of DD; higher HbA1c was 
associated with greater parental and dietary distress (using DSQ) [56, 55] and 
adherence-related distress [55]. 
Insulin regimen and DD was reported in two studies, which found no 
association between DD and intensive insulin therapy [62], and no difference in 
DD between adolescents using an insulin pump or multiple daily injections [49].  
2.4.7 Diabetes distress and behavioral factors (self-care) 
DD was correlated negatively with diabetes self-care behaviors in two 
studies [23, 57], although another [61] found no association with dietary self-care. 
Three studies [23, 25, 62] found no correlation between DD and frequency of self-
monitoring of blood glucose (SMBG).  
2.4.8 Diabetes distress and psychosocial outcomes 
Self-efficacy: Among four studies, DD was negatively correlated with 
dietary-related [60, 61], diabetes-related [54] and medical [48] self-efficacy. In the 
latter, no association was found between DD and diabetes-related or general self-
efficacy. 
Mood and quality of life: DD correlated strongly with more depressive 
symptoms and poorer diabetes-specific quality of life (QoL) [24, 48, 54], but 
lower state anxiety [24]. One study [57] correlated depressive symptoms and DD 
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with self-care and HbA1c. Poorer self-care was moderately associated with both 
PAID and depressive symptoms (both p<0.01) and, although HbA1c was not 
significantly related to either, the trend was stronger for DD than depressive 
symptoms (r=0.16, p=0.12 vs. r=0.02, p=0.82).  
Health beliefs: Adolescents with greater DD held more negative beliefs 
about the consequences of diabetes [60, 61]; perceived diabetes self-management 
as difficult [54] and expected difficulties in following their self-care regimen in 
social settings [44, 45, 58].  
Family and teacher support: Less family support was associated with 
greater DD in two studies [24, 63] but family adaptability and cohesion [54] and 
discrepancies about family responsibility [60] were unrelated to DD. Greater DD 
was also related to negative perceptions about the reactions of teachers to diabetes 
[45].  One study [57] found a negative correlation between DD and parents’ 
perception of their child’s competence with self-management but no association 
with their child’s responsibility for self-management. Furthermore, greater 
psychosocial maturity (but not age) strengthened the association between DD and 
both parental perceived self-management competence, and HbA1c, although 
adolescents with less maturity and higher distress scores had lower HbA1c. 
2.4.9 Interventions and change in diabetes distress  
Four RCTs assessed DD as a secondary outcome [25, 26, 41, 51]. The 
interventions and results are summarised in Table 2.2. Gregory et al. [41] 
conducted a cluster RCT (‘DEPICTED’ study) involving 26 UK pediatric diabetes 
clinics to investigate the effect of motivational interviewing training for diabetes 
health professionals on HbA1c and a range of psychosocial outcomes among 
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children and adolescents (aged 11-16 years) with T1D. There was no difference in 
DD scores between groups at 12-month follow-up. Ellis et al. [25] achieved a 
significant improvement in DSQ score (d=0.44) and HbA1c at the end of a 6-
month intensive multicomponent program targeting adolescents with chronically 
sub-optimal glycemic control. There were no differences in outcomes by age, 
gender or ethnicity. Following a 5-week coping skills program among Australian 
adolescents [26], intention-to-treat analyses revealed no effect on DD; per protocol 
analysis revealed a small, significant difference between groups at 3-month follow-
up (d=0.15), which was unsustained at 12 months.  Grey et al. conducted a series of 
analyses among adolescents participating in the ‘ABCs of Diabetes’ coping skills 
training program. There was an initial large effect (d=0.74) on Issues in Coping 
with Diabetes (ICD) ‘upset’ score at 3 months [51]; however, subsequent analyses 
showed the effect did not remain significant among a larger cohort or over longer 
follow-up [50, 52]. There was an increased incidence of severe hypoglycemia and 
weight gain during the 12-month follow-up period. Follow-up trials conducted 
among this cohort found no impact on DD of insulin type [53] or delivery mode 
[49].  Grey et al. also measured the effect of coping skills training on DD and 
depressive symptoms; DD improved at 3 months, whereas there was no 
improvement in depressive symptoms.    
  Apart from the two studies with an initial moderate-to-large difference 
between groups [25, 51], effect sizes were negligible. Common strategies among 
the successful interventions were cognitive restructuring, goal setting, problem 
solving, conflict resolution and communication skills training. There was no 
commonality among effective interventions regarding delivery mode or facilitator 
type. However, Robling et al. [43] noted that maintaining the motivational 
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interviewing skills of clinicians was a particular challenge that diluted the 
intervention. Although HbA1c improved in four of the seven papers [25, 49−51], 
Ellis et al. [25] noted that this effect was not mediated by DD in their study.
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Table 2. 1: Non-intervention studies: participant characteristics, diabetes distress and its associations 
Author, date, 
country, study 
design 
Participant 
characteristics: 
age, diabetes 
duration (years) 
mean (range) 
Diabetes 
distress 
measure 
(scoring 
range)a 
DD score 
(mean±SD) 
(female/ 
male) 
 
Correlation with DD (effect size (r); p value) 
HbA1c Age Gender Other outcomes associated with DD 
Berlin et al. 
2012 [55] USA  
Cross-sectional 
N = 199; Age 
13.9 (10-18); 48% 
male 
HbA1c 8.7% 
Diabetes duration 
NR 
DSQ  
(NR) 
2.06 ± 0.56  
 
 
r = 0.28,  
p < 0.01 
Parental & 
dietary 
factors r = 
0.38, 
adherence 
r = 0.24, 
all p <0.05 
NS NS Diabetes duration and distress about 
hyperglycemia (r = 0.16, p <0.05); Age 
and lower dietary distress (r = −0.15,  
p < 0.05)   
Parent/family related distress profile had 
the highest HbA1c (9.5%) vs. interpersonal 
and low stress profiles (8.2%, p < 0.001) 
Boland et al. 
1999 [48] 
USA  
Longitudinal 
study 
N = 40; Age 14.7 
(12-20); 48% 
male 
20% CSII, 12% 
MDI 
Diabetes duration 
8 ± 3 
ICD 
(11-33) 
NR NS 
 
NS NR Depressive symptoms (CDI) (r = 0.49,  
p < 0.05), QoL (DQOLY) impact r = 0.46; 
and worry r = 0.52 (p < 0.05), satisfaction  
(r = −0.48, ns). Self-efficacy related to 
medical situations (r = −0.45, p < 0.05). 
Perceived difficulty coping with diabetes 
(ICD) (r = 0.52, p < 0.05).   
NS: diabetes duration, general or 
diabetes-specific self-efficacy,  diabetes 
family behaviors (DFBS) 
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Author, date, 
country, study 
design 
Participant 
characteristics: 
age, diabetes 
duration (years) 
mean (range) 
Diabetes 
distress 
measure 
(scoring 
range)a 
DD score 
(mean±SD) 
(female/ 
male) 
 
Correlation with DD (effect size (r); p value) 
HbA1c Age Gender Other outcomes associated with DD 
Delamater et 
al. 2013 [56] 
USA 
Cross-sectional 
N = 417; Age 
14.9 (9-20) 
50% male 
Diabetes duration 
5 ± 4 
DSQ  
(0-3) 
1.0 ± 0.5 
(1.14/0.95) 
(subscales 
0.8-1.3) 
 
Total DSQ 
NS. 
Parental  
& dietary 
factors  
r = 0.13,  
p < 0.03 
NS t=−3.85 
p < 
0.001 
Diabetes duration - dietary distress  
(r = −0.11, p < 0.04) perceived distress 
concerning hyperglycemia (r = 0.12, p < 
0.04), distress about hypoglycemia  
(r = 0.12, p<0.04); distress-worry and peer 
stress scores higher in ethnic minority 
youths (p < 0.01) NS: SES 
Farrell et al. 
2000, 2004 [46] 
USA 
Cross-sectional 
N = 143; Age 
14.5 (11-18) 
52% male 
HbA1c 8.8% 
Duration 6 ± 4 
DSQ  
(0-195) 
63.8 ± 33.9   
(75.3/53.5) 
 
r =0.31,  
p < 0.01 
NR r = 
−0.33  
p <0.01 
General life stress (LISRES-Y) (r = 0.37, 
p < 0.01); Self-care (DCQ) (r = −0.24,  
p < 0.01). More cognitive distortions 
(CNCEQ) (regarding social, athletic and 
academic domains) predicted higher DD  
(r = 0.29, p < 0.01) and general life stress 
(r = 0.37, p < 0.01). DD directly affected 
HbA1c, whereas general life stress affected 
HbA1c through less adherence and SMBG. 
NS:  diabetes duration, frequency of 
SMBG. 
Franklin, 2009 
[57] USA  
Cross-sectional 
N = 98; Age 14.3 
(10-18);  
48% male; 
HbA1c 8.9% 
PAID-20 
(NR) 
1.85 ± 0.72 
(1.98/1.71) 
r = 0.16, 
NS 
 
NS NS 
 
Adherence to self-care (SCI) (r = −0.52,  
p ≤ 0.005). Parent perception of child’s 
diabetes competence (DIS) (r = −0.27,  
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Author, date, 
country, study 
design 
Participant 
characteristics: 
age, diabetes 
duration (years) 
mean (range) 
Diabetes 
distress 
measure 
(scoring 
range)a 
DD score 
(mean±SD) 
(female/ 
male) 
 
Correlation with DD (effect size (r); p value) 
HbA1c Age Gender Other outcomes associated with DD 
Diabetes duration 
6 ± 4 
p ≤ 0.05). NS: Family responsibility 
(DFRQ) 
Grey et al. 
1998b 
[54] USA 
Cross-sectional 
N = 52; Age 16.1 
(12-20) 
51% male; 
HbA1c 9.8% 
Diabetes duration 
8 ± 4  
ICD 
(11-33) 
17.6 ± 3.5 r = 0.01, 
NS 
NS NR Depressive symptoms (CDI) (r = 0.50,  
p < 0.001). Perceived difficulty coping 
with diabetes (ICD difficulty subscale) 
(r = 0.66, p < 0.001); QoL (DQOLY) after 
controlling for personal and social factors, 
impact (p < 0.003) and worry (p < 0.001) 
but not QoL satisfaction (p = 0.26), Self-
efficacy (SED) (r = −0.53, p < 0.01) 
Family warmth (DFBS) r = −0.45,  
p < 0.01). NS: Diabetes duration, coping 
behaviors (ACOPE) or Family 
adaptability and cohesion (FACES II) 
Hains et al. 
2006  
[58] USA 
Cross-sectional 
N = 104; Age 
13.9 (10-18) 55% 
male; HbA1c 
8.6%; Diabetes 
duration 6 ± 4 
DSQ 
(NR) 
2.01 ± 0.58 r = 0.28,  
p < 0.01 
NR NR Negative attributions of reactions by 
friends indirectly related to DRD (r = 0.28, 
p < 0.01) and mediated by Anticipated 
adherence difficulties among friends 
(r = 0.40, p < 0.0001) 
Hains et al. 
2007 [44],  
2009 [45] 
N = 102; Age 
13.9 (10-18) 
DSQ 
(NR) 
2.12 ± 0.54 r = 0.23,  
p < 0.05 
NR 
 
NR Negative attributions of reactions by 
friends (r = 0.25, p < 0.05) and peers  
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Author, date, 
country, study 
design 
Participant 
characteristics: 
age, diabetes 
duration (years) 
mean (range) 
Diabetes 
distress 
measure 
(scoring 
range)a 
DD score 
(mean±SD) 
(female/ 
male) 
 
Correlation with DD (effect size (r); p value) 
HbA1c Age Gender Other outcomes associated with DD 
USA 
Cross-sectional 
40% male; 
HbA1c 8.3% 
Diabetes duration 
6 ± 4 
(r = 0.34, p < 0.01) and teachers (r = 0.42, 
p < 0.01). Anticipated adherence 
difficulties among friends (r = 0.24,  
p < 0.05) and peers (r = 0.29, p < 0.01). 
Friends support moderated the relationship 
between stress and HbA1c.  
Law et al. 2013 
[60] UK 
Cross-sectional 
 
N = 203; Age 
14.5 (11-18) 
46% male; 
HbA1c 9.5% 
30% MDI/  
6% CSII  
Diabetes duration 
6 ± 4 
PAID-20 
(1-6) 
 
2.3 ± 1.0 
 
r = 0.30,  
p < 0.001 
r =0.15, 
p <0.05 
NS Dietary self-efficacy (r = −0.39, p <0.001)  
Perceived consequences of diabetes 
(PMD) r = 0.33, p < 0.001, Parent distress 
(r = 0.46, p < 0.001). NS: Discrepancy 
about family responsibility for diabetes 
(DFRQ)  
Lerman-
Garber et al. 
2003 [62] 
Mexico 
Cross-sectional 
N = 21;  
Age 14-17 
57% male; 40% 
HbA1c >9%; 
43% IIT; 
Diabetes duration 
6 ± 4 
PAID-20 
(0-100) 
52.7 ± 17 
67% PAID 
>43 
NR 
for age 
group 
p <0.02 NS Higher education level (OR = 0.09,  
p =0.03) Severe hypoglycemia within the 
past year (OR = 0.3, p = 0.06) 
NS:  Treatment regimen, diabetes 
duration or SMBG 
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Author, date, 
country, study 
design 
Participant 
characteristics: 
age, diabetes 
duration (years) 
mean (range) 
Diabetes 
distress 
measure 
(scoring 
range)a 
DD score 
(mean±SD) 
(female/ 
male) 
 
Correlation with DD (effect size (r); p value) 
HbA1c Age Gender Other outcomes associated with DD 
Nouwen et al. 
2009 [61] 
UK 
Cross-sectional 
N = 151; Age 
14.4 (12-18);  
46% male  
HbA1c 9.1%; 
22% MDI; 
Diabetes duration 
0.5-17 
PAID-20 
(1-6) 
2.1 ± 0.9 r = 0.01, 
NS 
NS NS Diabetes duration (r = −0.19, p < 0.01); 
Dietary self-efficacy (SSCAS) (r = −0.31, 
p < 0.01). Perceived consequences (PMD) 
(r = 0.33, p < 0.01). NS:  short-term 
perceived treatment effectiveness (IPQ) or 
dietary self-care 
Singh et al. 
2013 
[63] NZ 
Cross-sectional 
N = 58; Age 17.6 
(16-19); 48% 
male;  
HbA1c 9.0% 
Diabetes duration 
NR 
DDS 
(1-6) 
2.65 ± 1.2 NR r =0.31, 
p <0.05 
NS Support - Healthcare team non-support 
(DHTBC) (r = 0.42, p < 0.01) and a trend 
for family non-support (DFBC) (r = 0.24, 
p < 0.07). NS: Age at diagnosis  
Wagner, 2005 
[59] USA 
Pre-post study 
N = 38; Age 12.4 
(8-15) 
40% male; 
HbA1c 8.2%; 
63% CSII  
Diabetes duration 
6 ± 3 
PAID-20 
(20-120) 
39.8 ± 16.8 NR NR NR NR 
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Author, date, 
country, study 
design 
Participant 
characteristics: 
age, diabetes 
duration (years) 
mean (range) 
Diabetes 
distress 
measure 
(scoring 
range)a 
DD score 
(mean±SD) 
(female/ 
male) 
 
Correlation with DD (effect size (r); p value) 
HbA1c Age Gender Other outcomes associated with DD 
Weissberg-
Benchell et al. 
2011 [24] 
USA 
Cross-sectional 
N = 130; Age 
15.5 (11-19);  
54% male 
HbA1c 9.1% 
Diabetes duration 
NR 
PAID-T 
(26-156) 
60.5 ± 25.9 
(70.1/60.1); 
54% ≥1 
serious 
concern 
r = 0.26,  
p < 0.006 
NR p <0.04 Depressive symptoms BDI r = 0.61,  
p < 0.0001, CDI r = 0.76, p < 0.0001 
Anxiety SAIC r = −0.18, p < 0.04  
QOL (DQOLY) r = 0.29, p < 0.007  
QOL worry r = 0.69, p < 0.0001  
QOL satisfaction r = −0.67, p < 0.000. 
Diabetes family behavior (DFBC)  
r = −0.33, p < 0.01, warm caring 
interactions r = −0.37, p < 0.003 
CSII: continuous subcutaneous insulin infusion; DD: diabetes distress; IIT: intensive insulin therapy; MDI: multiple daily injections; NR: not 
reported; NS: not significant (p>0.05); SMBG: Self-monitoring of blood glucose 
a The range of possible DD scores according to the scoring method reported in the study 
 
  
73  
Table 2. 2: Intervention studies: participant characteristics, description and outcomes 
Author, 
date, 
country, 
Study 
design, 
Length of 
follow-up  
Participant 
characteristics 
N (intervention/ 
control group); 
Age, diabetes 
duration: mean 
(range) years 
Diabetes 
Distress 
measure  
(scoring 
range)a 
Baseline DD 
score  
mean ± SD 
(intervention 
/control 
group) 
Outcomes 
associated 
with DD: 
effect size 
(r) p value 
Intervention description Intervention outcomes 
Intervention / control group 
(effect size: Cohen’s d) 
Boland et al. 
1999 [49] 
USA 
Preference 
trial 
6 & 12 
months 
N = 75 (CSII=25/ 
MDI=50)  
Age: 12-20 
CSII 13.8/MDI 
14.6; 42% male;  
HbA1c 8.4%;  
CSII 33%; 
Diabetes duration: 
CSII 8 ± 4/ 
MDI 10 ± 4 
ICD 
(11-33) 
CSII  
16.79 ± 5.1 
MDI  
17.98 ± 3.6 
NR ABCs of Diabetes – Real-
world follow-up. Participants 
chose to use CSII or MDI. 
The outcomes of the CSII and 
MDI treatment groups were 
compared 6 and 12 months 
after the ABCs coping skills 
program.  
The improvement in DD 
(ICD) was greater in CSII 
group at 6 months: CSII 
−1.71/ MDI −0.62, but NS  
(d = 0.2). Difference was 
maintained at 12 months: 0-
12 months CSII −1.92; MDI 
−0.82, NS (d = 0.25) 
Ellis et al. 
2005 [25] 
USA 
RCT 
Post-
intervention  
 
N = 127 (64/63) 
Age: 13.2 (10-17) 
48% male;  
HbA1c 11.3% 
10% MDI/ CSII  
Diabetes duration 
5 ± 4/5 ± 5  
  
DSQ 
54 items 
(54-216) 
59.6±29.5/  
57.4±25.9 
 
HbA1c  
r = 0.26,  
p < 0.01; 
two 
parents at 
home  
(r = 0.23, 
p < 0.05) 
NS: 
Multi-Systemic Therapy 
(MST): family & community-
centred using goal setting, 
CBT, BFST, to improve 
parental involvement, 
adherence, clinic attendance. 
Home visits with family 2-3 
times /week until goals 
achieved (average 5.7 
DD (DSQ) improved at the 
end of the 6-month 
intervention; −7.7/ +4.4,  
p = 0.004 (d = 0.44). 
HbA1c −0.77%, p<0.12 
attributed to increased SMBG 
not DD. Increased SMBG and 
reduced HbA1c not mediated 
by DD.  
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Author, 
date, 
country, 
Study 
design, 
Length of 
follow-up  
Participant 
characteristics 
N (intervention/ 
control group); 
Age, diabetes 
duration: mean 
(range) years 
Diabetes 
Distress 
measure  
(scoring 
range)a 
Baseline DD 
score  
mean ± SD 
(intervention 
/control 
group) 
Outcomes 
associated 
with DD: 
effect size 
(r) p value 
Intervention description Intervention outcomes 
Intervention / control group 
(effect size: Cohen’s d) 
diabetes 
duration, 
age, 
gender, 
ethnicity, 
family 
income, 
SMBG 
frequency 
months). Mean 48 visits 
completers; 9 non-
completers. Control standard 
care. 
Gregory et 
al. 2011 
[41]; 
McNamara 
et al. 2010 
[42]; 
Robling et 
al. 2012 [43] 
UK  
Cluster RCT 
12 months 
N = 212 (89/123)  
(13/13 clinics) 
Age 11-16; NR 
gender 
HbA1c 9.3% 
Diabetes duration 
NR 
PAID- 23 
items 
(23-115) 
 
35.0 ± 21.7/ 
33.6 ± 19.2  
 
NR The DEPICTED Study. 
Diabetes clinicians (non-
psychologists) (N = 79) 
trained to deliver 'Talking 
Diabetes Program': 
motivational interviewing, 
agenda setting, guiding 
communication style. Control 
sites provided usual care.  
No improvement in DD 
(PAID): +3.9/ +2.8, p = 0.46 
(d = −0.05) 
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Author, 
date, 
country, 
Study 
design, 
Length of 
follow-up  
Participant 
characteristics 
N (intervention/ 
control group); 
Age, diabetes 
duration: mean 
(range) years 
Diabetes 
Distress 
measure  
(scoring 
range)a 
Baseline DD 
score  
mean ± SD 
(intervention 
/control 
group) 
Outcomes 
associated 
with DD: 
effect size 
(r) p value 
Intervention description Intervention outcomes 
Intervention / control group 
(effect size: Cohen’s d) 
Grey et al. 
1998 
[51] USA  
RCT  
3 months 
N = 65 (34/31) 
Age: 15.8/15.0 (13-
20); 43% male; 
HbA1c 8.9% 
Diabetes duration: 
8 ± 4/9 ± 4  
ICD 
(11-33) 
18.1 ± 3.6/ 
16.9 ± 3.4  
NR ABCs of Diabetes – coping 
skills training (CST), social 
problem-solving, behavior 
modification, conflict 
resolution, delivered by nurse 
practitioner (trained in 
diabetes and psychiatry). 
Small groups of 2-3; 4-8 x 
1.5-hour weekly sessions, 
followed by monthly ‘booster 
session’ during 6-month 
follow-up period. Prior to 
randomization all participants 
received IIT using MDI or 
CSII. Control group received 
IIT only. 
DD (ICD) improved at 3 
months: −2.7/ −0.1, p = 0.001 
(d = 0.74) 
 
Grey et al. 
1999 
[52] USA 
RCT 
N = 77 (42/35)  
Age 16.2/16.6 
(12.5-20), 42% 
male; 32% CSII; 
ICD 
(11-33) 
17.7 ± 4.3 / 
17.3 ± 3.8  
 
NR ABCs of Diabetes 6-month 
follow-up  
 
 
DD (ICD) improved in both 
groups at 3 months: −1.0/ 
−1.1, NS, (d = 0.02), ICD 
scores did not change from 3 
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Author, 
date, 
country, 
Study 
design, 
Length of 
follow-up  
Participant 
characteristics 
N (intervention/ 
control group); 
Age, diabetes 
duration: mean 
(range) years 
Diabetes 
Distress 
measure  
(scoring 
range)a 
Baseline DD 
score  
mean ± SD 
(intervention 
/control 
group) 
Outcomes 
associated 
with DD: 
effect size 
(r) p value 
Intervention description Intervention outcomes 
Intervention / control group 
(effect size: Cohen’s d) 
3 & 6 
months 
Diabetes duration: 
8 ± 4/9 ± 4  
 
 to 6 months: change from 
baseline 1.0/−1.0, NS  
(d = 0.0) 
Grey et al. 
1999 [53] 
USA 
Non-
randomized 
CT 
6 & 12 
months 
N = 51 (35/16) 
Age 14.3/14.9  
(12-20) 
43% male 
Diabetes duration: 
8 ± 4/12 ± 3  
ICD  
(11-33) 
17.8 ± 3.5 /  
18.9 ± 3.8 
NR ABCs of Diabetes – Follow-
up study.6 &12 months after 
CST, participants using MDI 
and HbA1c above-target were 
allocated to a trial of rapid-
acting insulin analogue 
(intervention); those with 
HbA1c in-target continued 
regular short-acting insulin 
(control group).   
DD (ICD) improved in both 
groups at 6 months; −0.7/ 
−0.1, NS; and at 12 months: 
−1.2/ −0.5, NS, (d = 0.19) 
 
Grey et al. 
2000 [50] 
USA 
RCT 
12 months 
N = 75 (41/34); 
Age (12-20) 
43 male;  
HbA1c 9.1% 
Diabetes duration: 
8 ± 4/10 ± 4  
ICD 
(11-33) 
NR 
 
NR ABCs of Diabetes 12 months 
follow-up 
DD (ICD) improved for all 
participants over 12 months 
(F = 4.55, df = 3, p = 0.004) 
but no difference between 
groups (NR) 
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Author, 
date, 
country, 
Study 
design, 
Length of 
follow-up  
Participant 
characteristics 
N (intervention/ 
control group); 
Age, diabetes 
duration: mean 
(range) years 
Diabetes 
Distress 
measure  
(scoring 
range)a 
Baseline DD 
score  
mean ± SD 
(intervention 
/control 
group) 
Outcomes 
associated 
with DD: 
effect size 
(r) p value 
Intervention description Intervention outcomes 
Intervention / control group 
(effect size: Cohen’s d) 
Serlachius 
et al. 2011, 
2014 [26] 
Australia 
RCT 
3 & 12 
months 
N = 156 (73/74); 
PP (30/61) 
Age 14.4 (13-16) 
42% male 
HbA1c 8.6% 
29% CSII  
Diabetes duration: 
6 ± 3/6 ± 4  
DSQ  
(65-260) 
115.9 ± 28.6 / 
120.4 ± 34.1 
Gender 
NS 
The ‘Best of Coping’, group 
coping skills training 5 x 2-
hour weekly sessions 
delivered by a psychologist. 
Topics included cognitive 
restructuring, goal-setting, 
problem solving, effective 
communication, time 
management, conflict 
resolution, positive 
reinforcement, and diabetes-
specific information and 
resources. Control group 
received standard care. 
DD (DSQ) improved at 3 
months in both groups: −9.1/ 
−8.4; NS (d = 0.03). No 
change at 12 months: −10.2/ 
−9.6 (NS). ANCOVA at 3 
months F(1,78) = 4.067,  
p = 0.047, NS at 12 months. 
Per protocol analysis showed 
a difference between 
attenders and control group at 
3 months; p = 0.02 (d = 0.15), 
but not 12 months, p = 0.23. 
Dose response at 3 but not 12 
months.  
BFST: Behavioral family systems therapy; CBT: Cognitive Behavior Therapy; CSII: continuous subcutaneous insulin infusion; CST: coping 
skills training: DD: diabetes distress; IIT: intensive insulin therapy; MDI: multiple daily injections; NR: not reported; NS: not significant 
(p>0.05); PP: per protocol; RCT: randomized controlled trial; SMBG: Self-monitoring of blood glucose 
aThe range of possible DD scores according to the scoring method reported in the study 
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Questionnaire name abbreviations: ACOPE: Adolescent Coping Orientation for Problem Experiences scale; AQOL: Adolescent Quality of 
Life scale; BDI: Beck Depression Inventory; CDI: Children’s Depression Inventory ; CNCEQ: Children’s Negative Cognitive Error 
Questionnaire ; CSII: Continuous subcutaneous insulin infusion (pump) ; DCQ: Diabetes Compliance Questionnaire ; DDS: Diabetes Distress 
Scale ; DFBC: Diabetes Family Behavior Checklist; DFBS: Diabetes Family Behavior Scale; DIS: Diabetes Independence Survey ; DSQ: 
Diabetes Stress Questionnaire ; DQOLY: Diabetes Quality of Life for Youth Scale; FACES II: Family Adaptability and Cohesion Scale; 
ICD:Issues in Coping with Diabetes Scale – Upset subscale; IPQ: Illness Perception Questionnaire ; LISRES-Y: Life Stressors and Social 
Resources Inventory; SAIC: State Anxiety Inventory for Children; PAID: Problem Areas in Diabetes Scale; PMD: Personal Models of Diabetes 
Questionnaire; SED: Self Efficacy for Diabetes Scale; SSCAS: Summary of Self-Care Activities Scale 
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2.5 Discussion  
2.5.1 Main findings 
This systematic review reveals that a significant proportion of 
adolescents with T1D experience DD. Although the mean DD scores reported 
were generally low, when assessed according to cut points, around one third of 
adolescents with T1D experienced substantial DD, which is comparable to the 
rate of severe DD (20−30%) reported among adults (aged >18 years) with T1D 
[13, 64].  
Associations between diabetes distress and HbA1c were not consistent; 
eight of 12 studies found small-to-moderate positive associations between DD 
and HbA1c. Although the PAID was the most commonly used measure, a 
significant correlation with HbA1c was more likely when the PAID-T or DSQ 
were used to assess DD. As the PAID was developed for adults, the items may 
not be as relevant to adolescents or sufficiently targeted to their concerns; for 
example, body image and parental conflict were both noted as substantial 
concerns in studies where adolescent-specific measures were used [24, 55, 
56].  
Where subscales were reported in the adolescent studies, dietary, 
adherence and parent-related distress were associated with higher HbA1c [55, 
56]. Family conflict about diabetes, has previously been associated with sub-
optimal glycemic control and psychological distress [65, 66]. Emotional support 
and encouragement from parents appears to be associated with lower DD, 
whereas parents who perceive their child as less competent with diabetes self-
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management may be overly involved, inducing conflict, or inhibiting their child’s 
confidence to self-manage independently. 
Three out of five studies found no association between DD and self-care. 
A review among adults with T1D found greater DD was associated with 
unhealthy dietary and eating behaviors and insulin restriction, but not SMBG 
[13]. However, the impact of DD on self-care (diet or SMBG) in youth may be 
mediated by age and responsibility for self-care, as parents are likely to retain a 
(partial) role in supporting these behaviors. Furthermore, low levels of DD may 
increase attention to self-care, whereas severe emotional distress may suppress it 
[13]. In adults with T1D and T2D, DD has a greater impact on diabetes 
management when accompanied by depression [13].  
Among adolescents, DD was found to be strongly correlated with 
depressive symptoms, suggesting these constructs are inter-related or that the 
depression measures used also identify DD [16]. Whether DD is more strongly 
related to HbA1c than depressive symptoms among adolescents could not be 
answered by the current review, though a trend was evident in one study [57]. An 
unpublished study [39] among 16−19 year olds (excluded from the review) 
reports that depressive and anxiety symptoms are not associated with HbA1c, 
though HbA1c was higher among adolescents reporting DD than those not 
reporting DD (cut-off undisclosed).  The impact of generic versus diabetes-
specific distress on glycemic control needs further exploration in young people. 
Consistent with adult studies, age does not appear to be a significant 
predictor of DD among adolescents [14, 67]. There was also no consistent 
relationship with gender, which was unexpected, because DD is higher among 
women than men with T1D [13] and girls are known to report more depressive 
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symptoms than boys [68] . However, the onset and intensity of depressive 
symptoms (measured using the CDI) is moderated by age among girls; the 
difference arising around puberty [68]. These studies do not confirm whether girls 
are more distressed about diabetes than boys but this may also be due to the 
absence of adolescent-related concerns, such as body-weight, in the adult 
measures, because the three studies finding a correlation between gender and DD 
used a youth-specific measure.  Nevertheless, we could not determine whether 
these items tap into concerns that may be more relevant to girls. 
DD appears unrelated to diabetes duration but this needs to be confirmed 
with prospective studies. DD also appears to be unrelated to insulin delivery 
mode and intensity, although the studies were limited by (non-randomised) study 
design [49] and small sample size [62]. In contrast, an Australian study [69] 
found higher DD among young adults with T1D using pre-mixed insulin than a 
basal-bolus regimen or insulin pump. Rigorous experimental studies are needed 
to examine the impact of treatment regimen on DD, preferably using a partially-
randomised preference trial design [70], where those participants with a strong 
preference can choose their treatment group, while the remainder accepts random 
allocation. Thus, maximising recruitment uptake and minimising differential drop 
out (due to disappointment inherent with random allocation) this design increases 
the internal and external validity of studies [70].  
Several modifiable psychosocial factors (namely lack of self-efficacy and 
negative thoughts and perceptions) were associated with greater DD, which 
provides insight into potential interventions to alleviate distress. A review of 
psycho-educational interventions for youth with T1D supports this finding [71], 
concluding that cognitive-behavioral therapy and interventions that promote 
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parental involvement and self-efficacy were most effective for improving 
psychosocial outcomes. Furthermore, a recent study among adults with T1D and 
T2D demonstrated a significant benefit of cognitive behavioral therapy for DD 
[72].  
Four pilot studies [34-37] were excluded from the review due to quality 
limitations (e.g. small sample size, no control group). However, they indicate that 
CBT may have promise for improving DD and self-management among youths, 
and may be more successful when applied to personally salient diabetes stressors 
[35].  
In adults, sufficient RCTs have been conducted to enable meta-analysis, 
demonstrating that psycho-educational interventions have greatest effect in 
reducing DD [22]. In contrast, we found only four RCTs that had examined the 
impact of intervention on DD for adolescents with T1D, precluding meta-
analysis. Two studies investigated coping skills training  [26, 51] and two others 
aimed to overcome barriers to self-management using MI [41] or a family-based 
systems approach [25]. This review indicates that  psycho-educational 
interventions including cognitive restructuring, goal setting and problem-solving, 
strategies  alleviated DD, albeit a short-term effect. Although Ellis et al. did not 
report follow-up results for DD, initial improvements in HbA1c and self-care 
were not maintained [73], suggesting that DD may also have deteriorated, as 
treatment effects often diminish without subsequent reinforcement [74]. 
Theoretically driven interventions have been found to be more effective [75] and 
those interventions resulting in (short-term) reductions in DD [25, 26, 51] had a 
well-defined rationale linking psycho-educational strategies to distress and 
coping.  
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Among the ‘ABCs of Diabetes’ study cohort [50], the incidence of severe 
hypoglycemia increased during the 12-month follow-up, and was higher among 
intervention participants, which could have moderated the initial decrease in DD. 
Although Grey and colleagues did not assess the impact of severe hypoglycemia 
on DD, cross-sectional studies have reported greater DD among adolescents [62] 
and adults [76] with recent episodes. However, the correlation between acute 
complications and DD has not been investigated among adolescents.  
2.5.2 Limitations 
Limitations include the fact that we included only English language 
publications. Several studies used DD scales that had been designed for adults 
and we were compelled to include these given that they have been used in 
adolescent studies (even if not designed for them), and that few studies have used 
adolescent-specific DD measures. Consequently, these studies may underestimate 
DD among adolescents and miss important relationships between outcomes that 
may have been captured if appropriately targeted measures had been used. 
Various abbreviated [63] and non-standard versions of the DD instruments were 
used [41], methods of scoring varied and insufficient information was provided to 
interpret scores [44, 55, 57, 58], hence distress scores could not be compared 
across studies. We were unable to determine the prevalence of severe DD because 
cut point scores have not been validated for adolescents. The cross-sectional 
design of the observational studies could not show the direction of relationships 
or causation. The primary outcome in the intervention studies was HbA1c, 
therefore sample sizes may have been inadequate to detect change in DD, and the 
low baseline level of DD (floor effect) may have limited the potential for 
improvement.  
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2.5.3 Implications for clinical practice and future research 
• Depression, and to a lesser extent anxiety, have been the major focus of 
studies investigating emotional distress among adolescents with T1D, and 
have shown positive associations with HbA1c [6, 7]. This review could 
not confirm whether DD is more strongly related to HbA1c and self-
management than depression or anxiety and further investigation is 
required of these relationships with DD, while controlling for depressive 
and anxiety symptoms. Furthermore, a better understanding of the 
interaction between DD, self-care and HbA1c is needed, in order to 
inform the development of appropriate interventions to enhance self-
management while reducing DD.  
• Psycho-educational interventions designed for adolescents with T1D have 
been shown to provide short-term reductions in DD.  The effect of 
ongoing support to sustain psychosocial benefits needs to be examined.   
• Although measures of DD developed for adults, such as the PAID and 
DDS, have been used in adolescent populations, they may not be 
sufficiently sensitive to adolescent concerns, thus may not identify 
significant associations with HbA1c and other outcomes of interest.  
• Around one-third of adolescents with T1D experience severe DD 
(comparable to adults). However, a validated cut-off score is needed for 
the PAID-T and DSQ in order to confirm the prevalence of severe DD 
among adolescents, or indeed, whether a clinically significant threshold 
can be substantiated in this population.  
• This review highlighted that most of the studies of DD in adolescents with 
T1D were conducted in the USA, among predominantly white European 
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and socioeconomically advantaged populations. Thus, DD needs to be 
examined amongst adolescents from socioeconomically and ethnically 
diverse backgrounds. 
• The association between treatment regimen, acute complications and DD 
is an area that needs to be investigated among adolescents with T1D with 
rigorous prospective studies designed to examine such associations. 
2.5.4 Conclusions 
This first systematic review of DD in adolescents with type 1 diabetes 
corroborates evidence from adult studies: a substantial proportion experience 
elevated DD and that this is often associated with suboptimal glycemic control. 
Psycho-educational interventions have been shown to alleviate DD in the short 
term but further work is needed to investigate how to sustain these effects. 
Rigorous research, addressing the methodological limitations of the studies 
included in this review, is needed to improve understanding of, and reduce DD 
among adolescents and to progress this field among adolescents.  
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3.1 Abstract   
Background: Type 1 diabetes is a complex and demanding condition, 
which places a substantial behavioural and psychological burden on young people 
and their families. Around one-third of adolescents with type 1 diabetes need 
mental health support. Parents of a child with type 1 diabetes are also at increased 
risk of psychological distress. A better understanding of the motivators, behaviours 
and psychological well-being of young people with diabetes and their parents will 
inform improvement of resources for supporting self-management and reducing the 
burden of diabetes. The Diabetes MILES (Management and Impact for Long-term 
Empowerment and Success) Youth - Australia Study is the first large-scale, 
national survey of the impact of diabetes on the psychosocial outcomes of 
Australian adolescents with type 1 diabetes and their parents.  
Methods/design: The survey was web-based to enable a large-scale, 
national survey to be undertaken. Recruitment involved multiple strategies: postal 
invitations; articles in consumer magazines; advertising in diabetes clinics; social 
media (e.g. Facebook, Twitter). Recruitment began in August 2014 and the survey 
was available online for approximately eight weeks. A total of 781 young people 
(aged 10-19 years) with type 1 diabetes and 826 parents completed the survey. 
Both genders, all ages within the relevant range, and all Australian states and 
territories were represented, although compared to the general Australian 
population of youth with type 1 diabetes, respondents were from a relatively 
advantaged socioeconomic background.  
Discussion: The online survey format was a successful and economical 
approach for engaging young people with type 1 diabetes and their parents. This 
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rich quantitative and qualitative dataset focuses not only on diabetes management 
and healthcare access but also on important psychosocial factors (e.g. social 
support, general emotional well-being, and diabetes distress). Analysis of the 
Diabetes MILES Youth – Australia Study data is ongoing, and will provide further 
insights into the psychosocial problems facing young people with type 1 diabetes 
and their parents. These will inform future research and support services to meet 
the needs of young Australians with type 1 diabetes and their families. 
 
Keywords 
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3.2 Background 
Diabetes places substantial behavioural and psychological burden on 
young people and their families. Type 1 diabetes (T1DM) is the most common 
form among youth, and Australia has one of the highest incidences worldwide (24 
per 100,000, aged 10-19 years) [1, 2].  In 2014, there were 9856 Australians aged 
between 10 and 19 years living with T1DM [3].  
Managing T1DM is challenging at any age, and particularly so during 
adolescence. The transition from childhood into adulthood is characterised by 
significant physical, cognitive, social and emotional developments. These changes 
can affect diabetes management in several ways. Hormonal changes and changes in 
insulin sensitivity often lead to increased blood glucose levels [4].  Gaining body 
weight, more frequent among girls than boys with T1DM or peers without diabetes 
[5], can become a source of body dissatisfaction [6, 7]; and may be associated with 
weight control behaviours, including insulin restriction [8]. Performing diabetes 
self-care tasks requires cognitive maturity. If the young person is not ready to take 
on these responsibilities, but is expected to do so, this may lead to conflict (with 
family and health professionals) and disengagement from diabetes management.   
Social changes during this transition are substantial. It is a period of 
gaining independence on the one hand, but still needing support from parents. 
Parental authority diminishes and peers become more influential [9]. The 
adolescent spends less time at home, reducing parental supervision of their diabetes 
self-care. Being with friends more often is accompanied by changes in eating 
behaviours (e.g. fast food), engaging in sexual relationships, in risk-taking 
behaviours (e.g. experimenting with alcohol, smoking, other drugs) [10]. Friends 
may be very supportive and caring of the adolescent with diabetes; but some may 
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have a negative influence, leading to social pressure not to be “different” from their 
peers. All these changes can contribute to diabetes self-care being neglected [11], 
such as not checking blood glucose or skipping insulin doses, contributing further 
to sub-optimal blood glucose levels, thereby increasing the risk of complications 
[12]. 
Not surprisingly, these challenges during adolescence can compromise the 
young person’s emotional health and well-being [13, 14]. While most adjust well to 
living with T1DM, around one-third need mental health support [15, 16]. 
Compared with the general population, adolescents with T1DM experience more 
than double the rate of elevated depressive symptoms [17, 18]. Although less 
researched, diabetes distress also appears to be common, with over half of 
adolescents reporting at least one aspect of diabetes is a serious problem for them 
[19]. A review of studies in adults with T1DM found that 20-30% experience 
elevated diabetes distress, and indicated an association between diabetes distress, 
less attention to self-care and high HbA1c [20]. However, among adolescents the 
prevalence of diabetes distress is unknown and the relationship between distress 
and diabetes management is inconsistent, and needs further investigation using age-
appropriate measures [21]. Despite awareness of impaired emotional well-being 
among adolescents with T1DM, only a quarter of those who might benefit from 
psychological support actually receive it [18]. Moreover, unresolved mental health 
problems often carry into adulthood [22], so adolescence is an important stage for 
identifying problems and early intervention.  
With regard to parental well-being and concerns, most studies to date have 
focused on parents of a young child with T1DM, but less is known about the 
parents of adolescents. Among mothers of an adolescent with T1DM, clinically-
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significant levels of depressive and anxiety symptoms have been reported (18-26% 
and 13-55% respectively) [23, 24]. Among fathers, up to 13% have elevated 
depressive symptoms and 23% have anxiety [23]. While the burden of diabetes 
care may be higher for parents of a young child, the stress of parenting is unlikely 
to decline for parents as their child becomes an adolescent, thus depressive and 
anxiety symptoms may not lessen as their child grows up [25, 26]. Furthermore, the 
emotional burden for parents does not diminish with longer duration of living with 
diabetes [27], with diabetes distress apparent among parents of children and 
adolescents with T1DM [28, 29].  
Hypoglycaemia is a source of worry and distress for parents [27, 30].  
Parents who are very worried about hypoglycaemia check their child’s blood 
glucose more frequently [30]. However parental worry about hypoglycaemia is also 
associated with elevated HbA1c among children, suggesting that parents may 
overcompensate in their attempts to avoid hypoglycaemia (e.g. by reducing insulin 
doses) [30]. At the same time, worry about high blood glucose and future 
complications is a major concern for parents [29]. These concerns can lead to 
frustration and family conflict if the young person assumes responsibility for self-
management and their attention to this wanes [31]. Furthermore, unresolved family 
conflict [32] and impaired parental mental health [33] has been associated with 
adverse psychological and diabetes-related health outcomes among youth with 
T1DM.  
To date, no national survey has examined the psychosocial outcomes of 
Australian adolescents and parents living with diabetes. Thus, a better 
understanding of the psychological well-being, behaviours and support needs of 
Australian youth with diabetes and their parents is needed, to inform improvement 
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of services and facilities for supporting self-management and reducing the burden 
of diabetes.  
The Diabetes MILES (Management and Impact for Long-term 
Empowerment and Success) Study is an international collaborative co-led by 
Professor Jane Speight (Diabetes MILES - Australia) and Professor Frans Pouwer 
(Diabetes MILES - The Netherlands). The aim is to further promote understanding 
and awareness of the psychological and behavioural aspects of living with diabetes 
by conducting a series of national surveys of people with type 1 or type 2 diabetes 
in various countries (including Diabetes MILES – The Netherlands and Diabetes 
MILES – Flanders). In 2011, Diabetes MILES − Australia was the largest survey 
ever conducted of the psychosocial and behavioural aspects of living with type 1 or 
type 2 diabetes among Australian adults [34]. Completed by 3,338 adults, this 
national survey provided important insights into how Australians manage their 
diabetes, the support they receive and the impact of the condition on their 
psychological well-being and quality of life.  
The Diabetes MILES Youth – Australia Study (MILES Youth) provides 
the opportunity to address the research questions discussed above; in particular, to 
explore how diabetes distress is related to other psychological problems (e.g. 
depressive symptoms), and to diabetes management, as well as family and health 
professional support. Few data are available about parents of adolescents with 
T1DM, their own emotional well-being, their concerns about their child’s diabetes, 
or the impact of these factors on their child’s diabetes management, and almost 
none in the Australian context.  
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3.2.1 Aim  
The aim of the MILES Youth Study was to investigate psychological and 
behavioural issues in a large-scale, national sample of young people (aged 10-19 
years) with T1DM and their parents. In particular, the study focuses on:  
• The extent to which young people with diabetes are actively managing their 
condition, engaging with recommended self-care strategies and healthcare 
providers;  
• The perceived impact of living with diabetes (including its management and 
acute complications) on quality of life and emotional well-being, 
specifically assessing diabetes distress, anxiety and depression; 
• The extent to which young people with diabetes: (a) feel empowered to 
manage their condition, (b) perceive that their health professionals are 
supportive, (c) have access to and have accessed appropriate healthcare 
resources in the past year; 
• Aspects of positive mental health associated with ‘living well’ with 
diabetes, as well as identifying personal strengths and support from peers, 
family and healthcare professionals that mediate optimal outcomes.  
The findings will be disseminated to raise awareness of the psychosocial well-
being and unmet needs of Australian adolescents living with T1DM and of their 
parents, and to inform recommendations for the resources and services that would 
be of benefit.  
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3.3 Methods/Design 
3.3.1 Establishment and role of the reference groups and funding body 
A MILES Youth Study reference group was established comprising twelve 
academics and/or clinicians with relevant expertise, including paediatric 
endocrinologists, diabetes educators, clinical and health psychologists – four were 
based outside Australia. The purpose of the reference group was to advise on 
survey concepts and research questions and their operationalisation (including 
validated measures and discrete variables). The reference group members will 
continue to collaborate on publications and dissemination of the study results.  
The MILES Youth study was commissioned and funded by the National 
Diabetes Services Scheme (NDSS) Young People and Diabetes (YPD) National 
Development Programme. The NDSS is an initiative of the Australian 
Government, administered by Diabetes Australia. The NDSS YPD Expert 
Reference Group, comprising clinicians, academics, young adults with T1DM and 
administrators, reviewed the survey to ensure the content was relevant to young 
people with T1DM and their parents, the NDSS and the Australian context. The 
funding body played no further role in determining research questions, analysing 
data or interpreting findings.    
3.3.2 Phase 1: Survey design and selection of measures 
Informed by the approach of the previous Diabetes MILES Australia study 
(for adults) [34], the MILES Youth survey was developed by following three key 
steps: 
 
 
107  
3.3.2.1 Defining the survey topics 
MILES Youth reference group members were interviewed to identify 
current evidence gaps and survey concepts related to the aims of the study. Based 
on these consultations, the survey concepts were selected by the research team for 
both adolescents and their parents (Table 3.1). 
3.3.2.2 Identification and assessment 
For each concept, a search was undertaken for questionnaires appropriate 
for use in adolescents (aged 10-19 years) or parents/adults. Each questionnaire was 
considered with regard to its content and construct validity and internal consistency 
reliability, length, and previous use within an adolescent and/or diabetes-specific 
population. If relevant and appropriate validated measures were not identified, 
study-specific questions were created relating to these themes. Linguistic and 
literacy considerations were assessed, both by members of the research team and 
through pilot testing and cognitive debriefing (see below) with young people living 
with diabetes and their parents. This process resulted in an item bank that was 
reviewed by the reference groups during the subsequent consultation phase (see 
below). 
3.3.2.3 Consultation  
Reference group members provided feedback regarding suitability of the 
item bank. Questionnaires or individual items that were considered inappropriate 
for the purposes of the study were removed and alternatives suggested. This 
process continued for several iterations until no further modifications were 
suggested by the reference group. The reference groups expressed some concerns 
about survey length (for all age groups) and the sensitivity of some issues (e.g. 
eating behaviours, depression, diabetes distress) for younger respondents. In 
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addition, they were concerned about asking adolescents about suicidal ideation 
(item 9 of the PHQA-9).  
3.3.3 Phase 2: Pilot study and cognitive debriefing 
The aim of the pilot study was to ensure that the survey content was 
acceptable, relevant and suitable for young people with T1DM and their parents, 
and to determine how long it took for participants to complete the surveys.  
3.3.3.1 Recruitment 
Young people (aged 10 to 19 years) with T1DM and their parents were 
eligible. They were invited to take part in the pilot study via letter, social media or 
electronic newsletter distributed to members of Diabetes Victoria, the peak body 
for people with diabetes in Victoria. Potential participants contacted the research 
team by telephone or email, and were then sent (by email or post) a copy of the 
plain language statement, and a consent form to sign.   
3.3.3.2 Procedure 
Upon consent, volunteers were emailed a link to the online survey and 
posted a hard copy of the questionnaire to review. They were asked to complete the 
questionnaire online no more than one day prior to the interview and note their 
thoughts about the questions, the response options and instructions on the hard 
copy. Interviews were audio-recorded to enable reflection upon responses. During 
the interview, participants were asked structured questions about the survey’s 
suitability and relevance, the layout and length, the language and how easy it was 
to understand, and website usability. Interviews ranged from 15-60 minutes with 
adolescents and 20-35 minutes with parents. 
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Cognitive debriefing interviews were conducted with 13 people living in 
Victoria (12 via telephone, and one face-to-face): eight young people with T1DM 
(4 (50%) girls; three aged 11-12 years and five aged 16-18 years; all in full-time 
school education, except one boy) and five mothers of children with T1DM. Four 
of the mothers were parents of the participating youths and all had completed high 
school or tertiary education.  
Young people aged 11-12 years reported taking 15-20 minutes to complete 
the survey, whereas the completion time for older adolescents (who received the 
longer questionnaire) ranged from 20-60 minutes. The time reported by parents to 
read and complete the parent survey ranged from 20-35 minutes. Overall, young 
people and their parents were positive in their feedback about the survey, indicating 
they considered the topics relevant and meaningful and the language appropriate. 
Participants requested that a few terms should be defined and instructions 
shortened. Two adolescents stated that the survey was too long.   
3.3.4 Phase 3: Finalising survey content and study materials 
Several modifications were made to the survey in response to feedback 
received, including removing items to reduce length, simplifying instructions, 
providing definitions and rearranging the order in which items were presented (e.g. 
generic before diabetes-specific items; open-ended questions and personal 
information towards the end). In response to concerns expressed by the reference 
groups (Phase 1) and by parents (Phase 2), items relating to eating disorders were 
removed from the youth survey, body image questions were removed for younger 
children and the cut-off for the younger age group was raised to 12 years. Three 
new items concerning diabetic ketoacidosis (DKA) were added to the parent 
survey. The final suite of concepts investigated and the measures used in each 
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version of the survey are listed in Table 3.1. Approval to use the various measures, 
and a license (where required) was obtained from scale developers / copyright 
holders. Three versions of the survey were approved by the Deakin University 
Human Research Ethics Committee to be suitable for:  
 (i) young people aged 10-12 years (63 items) 
(ii) young people aged 13-19 years (169 items) 
(iii) parents of young people aged 10 to 19 years (176 items) 
 
Table 3.3 (see Appendix H) provides a description of the scales used in the 
Diabetes MILES Youth Study. 
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Table 3. 1: Concepts and measures (youth and parent surveys) 
Concept Measure or variable Number of items 
                                 Youth version 
Age group: years 
 Parent 
version 
 10-12  13-19  
About You 
Demographics Age, gender, family composition, 
language, education, employment 
12 13 12 
 Health insurance, financial status   3 
Stressful life 
events 
Items adapted from Recent Life 
Events Questionnaire [48] 
  14 
Diabetes history Diabetes type, treatment, duration, 
family history 
4 4 8 
Mood 
General quality 
of life 
Item from MIND Youth 
Questionnaire (MY-Q) [7] derived 
from Diabetes Quality of Life for 
Youth - Short Form [49] 
1 1  
Well-being WHO-5 Well-being Scale [7, 50-
52] 
5 5 5 
Depressive 
symptoms 
Patient Health Questionnaire for 
Adolescents (PHQ-A) [53, 54] 
 8  
Anxiety Generalised Anxiety Disorder Scale 
(GAD-7) [55] 
 7 7 
Feelings About Diabetes 
Diabetes 
distress 
Problem Areas in Diabetes – Teen 
version (PAID-T) [19] 
 26  
 Problem Areas in Diabetes - Parent 
of Teens version (P-PAID-T) [29] 
  26 
Family conflict Items from MY-Q [7] derived from 
the Diabetes Family Conflict Scale 
[56] 
2 2  
Responsibility 
for diabetes 
management 
Items from MY-Q [7] 2 2  
Items modified from the Diabetes 
Family Responsibility 
Questionnaire [57] 
  5 
Health & Health Checks 
General health Other health conditions  1 1 1 
 Weight, height 2 2  
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Perceived 
healtha 
Self-rated health  1  
Diabetic 
ketoacidosis 
(DKA) 
Incidence of diabetic ketoacidosis  1 3 
Worry about 
hyperglycaemia 
Items from the Hyperglycaemia 
Avoidance Scale [58] 
  3 
Diabetes Care 
Blood glucose 
monitoringa 
Self-reported frequency of self-
monitoring of blood glucose 
(SMBG) 
2 
 
2 
 
2 
 
HbA1c Self-reported HbA1c 2 2 4 
Insulin 
management# 
Insulin dose frequency 
Insulin forgetting & omitting 
adapted from MY-Q [7] and 
Adolescent Diabetes Needs 
Assessment Tool (ADNAT) [59] 
1 
 
1 
3 
1 
 
Hypoglycaemia 
Hypoglycaemia 
frequency 
Items adapted from Hypoglycaemia 
Awareness Questionnaire (HypoA-
Q) [60] 
 6 7 
Hypoglycaemia 
awareness 
Gold score [61]  
Item adapted from HypoA-Q [60]   
 1 
1 
1 
1 
Fear of 
hypoglycaemia  
Hypoglycaemia Fear Survey for 
parents (PHFS) and children 
(CHFS) [62] 
 25 25 
Technical/ 
medical 
supporta 
Technology and hypoglycaemia  
Communication with doctor about 
hypoglycaemia  
  2 
2 
Eating Habits 
Diabetes-
specific eating 
behaviours 
Diabetes Eating Problem Survey-
Revised (DEPS-R) [63]  
Binge eating frequency adapted 
from MY-Q [7]  
 16 
 
1 
 
Body image Gender-specific body image 
silhouettes from BMI-based 
Silhouette Matching Test (BMI-
SMT) [64, 65]  
 3  
Health Care Team 
Patient-centred 
communication 
PCC subscale of the Health Care 
Climate Questionnaire [66, 67]  
 5 5 
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Treatment 
satisfaction 
Items from MY-Q [7]; derived 
from the Diabetes Treatment 
Satisfaction Questionnaire 
(DTSQs) [68] 
3 3 3 
Health 
professional 
support# 
Free text: (what I wish health 
professionals knew…) 
1 1 1 
Transition Items adapted from Online 
Transition to Adulthood Surveys 
for Youth with Chronic Illness [69] 
  3 
Diabetes carea Child’s diabetes healthcare 
providers & attendance 
  7 
Support to Manage Diabetes 
Resilience Diabetes Strengths and Resilience 
Measure for Adolescents (DSTAR-
Teen) [70] 
12 12  
Self-efficacy Maternal Self-Efficacy for Diabetes 
Management Scale [71] 
  17 
Social supporta Free text: (what I wish friends/ 
teachers/general public knew about 
diabetes) 
(what friends / teachers do to help)  
(what would make it easier for you 
/ your child... ) 
2 
 
 
2 
2 
 
 
2 
3 
 
 
 
2 
Parental 
supporta 
2 free text: (what I wish my parents 
knew about diabetes; what my 
parent do to help me..) 
2 2  
NDSS support Free text   1 1 
Technologya Use of ‘apps’ for diabetes 
management 
5 5  
Final comments Free text  1 1 1 
Unique ID Child’s NDSS Number 1 1 1 
a designed by the research team in the absence of relevant and suitable 
standardised measures. 
 
  
114  
3.3.5 Phase 4: Data collection – national online survey 
3.3.5.1 Eligibility and recruitment 
 People were eligible to participate if they met the following inclusion 
criteria: 
• They were a young person (aged 10 to 19 years of age inclusive), with 
diagnosed T1DM; or if they were the parent of such a person 
• They had previously consented to the NDSS contacting them for research 
purposes (60% of registrants (or their parents if under 18 years) had done 
so) 
• They completed at least the ‘mood’ module of survey questions, considered 
to be the core dataset. 
 The purpose of the NDSS is to provide subsidised products (i.e. needles, 
insulin pump consumables, blood glucose test strips), information and support 
services for Australians diagnosed with diabetes. All young people with T1DM are 
registered with the scheme (N = 9,856 aged 10-19 years at the time of the survey) 
[NDSS, Personal Communication, October 2014]. Invitation letters were posted to 
all NDSS registrants (or their parents, if the registrant was less than 18 years old) 
meeting the first two of the above criteria. Thus, recruitment letters were 
distributed to 5,928 eligible NDSS registrants or their parents, inviting them to 
complete the online survey (or to request a paper version if preferred; no such 
requests were received).  The survey was also advertised via flyers in diabetes 
clinics, social media postings, at diabetes events, and notices in relevant 
publications (e.g. Diabetes Australia state and territory member magazines and e-
newsletters). All recruitment material indicated that completing the online survey 
would provide an opportunity for the respondent to be entered into a prize draw to 
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win a tablet computer. The survey was open for a period of eight weeks from 
August to October 2014. 
 A response rate of approximately 18% (N = 1,000) was anticipated, based 
on the response to the adult Diabetes MILES survey [34], which would offer 
adequate power for multivariate and subgroup analyses.   
3.3.5.2 Procedure 
 All surveys were administered online using QualtricsTM, a secure, online 
survey-hosting platform. Registrants and parents were directed to a webpage that 
provided additional information (plain language description) about the nature of the 
study. They were requested to give their consent to participate before proceeding to 
the survey. All respondents were asked to provide the young person’s NDSS 
registration number (a unique identifier), for the sole purpose of matching parent 
and child survey responses to enable dyad analyses. The researchers did not have 
access to the NDSS database, thus could not identify respondents from their NDSS 
registration number. At the end of the survey, all respondents were invited to 
provide their contact details: a) to enable entry into the prize draw, and/or b) to 
express their willingness to be contacted for further research. These contact details 
were entered into a separate database not linked to the main survey to ensure the 
survey dataset remained de-identified. It was not mandatory to provide contact 
details.  
3.3.6 Phase 5: Data handling and analyses  
All survey responses, both complete and incomplete, were logged by the 
QualtricsTM survey platform and downloaded at survey close (October 2014) into 
data files for analysis in the Statistical Package for the Social Sciences (SPSS) 
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(IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp). 
Descriptive statistics will be reported as counts and percentages (N (%)) for 
categorical variables and mean ± standard deviation (or medians and ranges as 
appropriate for data distributions) for continuous variables. Differences between 
groups will be analysed using χ2 tests for categorical data and independent samples 
t-tests or ANOVAs for continuous variables. More advanced analyses (e.g. 
multiple regression, factor analysis) will be applied as appropriate to specific 
research questions and will be reported in subsequent papers. The qualitative data 
will be analysed using thematic and/or content analyses, as appropriate to particular 
research questions.   
3.3.6.1 Response rates and exclusions 
 During the eight weeks the survey was available, 934 and 1,050 responses 
were collected in the young persons and parent surveys respectively. Consistent 
with the inclusion criteria, respondents’ completed surveys were excluded if:  
• they did not provide the youth’s age or the age did not meet the inclusion 
criteria (youth 8%, n = 79; parents 4%, n = 47);  
• they did not provide the youth’s diabetes type (youth 2%, n = 15; parents 
15%, n = 161);  
• the youth did not have T1DM, i.e. reported type 2 diabetes or an “other 
type”, e.g. Maturity Onset Diabetes of the Young (youth <1%, n = 8; 
parents < 1%, n = 5); 
• did not attempt the mood questions (youth 4%, n = 39; parents < 1%, n = 
3), since this was considered the core dataset.  
The final samples included:  
• N = 781 young people (aged 10-19 years) with T1DM; 
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• N = 826 parents of young people with T1DM. 
 
 Of these, 89% (n = 698) youth and 89% (n = 736) parents answered all 
questions in their survey version.  In total, N = 258 youth / parent dyads could be 
identified by matching the young person’s NDSS number to the NDSS number 
reported by a parent.  
3.3.6.2 Sample characteristics 
Respondents were from all states and territories, including metropolitan, 
regional and remote areas of Australia (Table 3.2). The representativeness of the 
sample was determined by comparing youth respondents on key characteristics, i.e. 
age, gender, socio-economic status (SES) and residential location, to NDSS 
registrants in the corresponding age group (Table 3.2). The Australian Bureau of 
Statistics (ABS) Index of Relative Socio-Economic Advantage/ Disadvantage 
(IRSAD) [35] was used to index SES. This measure summarises census data 
related to both advantage and disadvantage (e.g., income, education and 
unemployment) within a postcode area. An IRSAD decile code was computed for 
each respondent using the postcode they provided. Residential area was classified 
using the ABS remoteness areas structure [36]. Almost half the respondents were 
from a high socio-economic background and resided in a metropolitan area (Table 
3.2). Finally, more than a quarter (30%, n = 232) of all respondents used a mobile 
device (e.g., smartphone or tablet) to complete the survey (youth 30%, n = 232; 
parents 29%, n = 243).   
Young people with type 1 diabetes 
Of the 781 young people who responded, the mean age was 14 ± 3 years 
(range 10-19) and 61% (n = 474) were girls (Table 3.2).  The majority (92%, n = 
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715) were born in Australia and, for 97% (n = 759), English was their primary 
language. Fourteen respondents (2%) reported being of Aboriginal and/or Torres 
Strait Islander descent. Eighty percent (n = 624) of young people lived with both 
parents. Mean diabetes duration was 6 ± 4 years (range 0-18). Nineteen percent    
(n = 149) had been diagnosed with T1DM for less than one year. Fifty-two percent 
(n = 409) managed their T1DM using an insulin pump and 38% of respondents had 
self-reported a glycosylated haemoglobin (HbA1c; average blood glucose over the 
past 8-12 weeks) within recommended target range (<58 mmol/mol; <7.5%) [37]. 
Parents of young people with type 1 diabetes 
Of the 826 parent respondents, their mean age was 46 ± 6 years (range 30-
73), and 88% (n = 727) were mothers (Table 3.2). While 20% (n = 167) of parents 
were not born in Australia, only 2% (n = 18) did not speak English at home. A very 
small number of parents (1%; n = 9) reported being of Aboriginal and/or Torres 
Strait Islander descent. The majority (86%, n = 708) were married or in a de facto 
relationship, 93% (n = 686) of parents or their partners were in paid employment, 
and 37% (n = 264) had a total annual household income above $100,000. The 
characteristics of their children were similar to the youth respondents; mean age 14 
± 3 years; mean duration of diabetes 6 ± 4 years, 53% (n = 436) used an insulin 
pump and self-reported mean HbA1c 64 ± 16 mmol/mol (8.0 ± 1.4%), although 
fewer were female (n = 384, 47%) and only 7% (n = 56) had been diagnosed in the 
past year.  
Youth / parent dyads 
Among the youth, boys and girls were almost equally spilt in the dyad 
dataset (female 53%, n = 136). Compared to the overall sample, the mean age of 
the adolescents was lower (13 ± 2 years). Accordingly, the duration of diabetes was 
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shorter (5 ± 4 years). The dyad sample did not differ from the overall sample on 
other demographic characteristics: born in Australia (92%, n = 238); metropolitan 
location (64%, n = 166); socio-economic status (IRSAD: 17%, n = 43 low; 38%,    
n = 97 medium; 45%, n = 117 high SES); single-parent family 8% (n = 21). 
 
 
Table 3. 2: Demographic and clinical characteristics for youth with type 1 diabetes 
and parents 
 
Youth  
N = 781 
Parents  
N = 826 
NDSS 
Registrants 
aged 10-19  
N = 9,856a 
Gender–female  
    Child’s gender–female 
474 (61) 
− 
727 (88) 
384 (47) 
4,672 (47)   
-  
Age–years  
    Child’s age–years  
14 ± 3 46 ± 6 
14 ± 3 
16 ± 3 
Youth / child’s age group–years  
    10-12  
    13-15  
    16-17  
    18-19  
 
230 (29) 
277 (35) 
153 (20) 
121 (15) 
 
285 (35) 
292 (35) 
155 (19) 
94  (11)  
 
2,078 (21) 
2,986 (30) 
2,312 (23) 
2,480 (25) 
State / Territory 
    New South Wales 
    Victoria 
    Queensland 
    Western Australia 
    South Australia 
    Tasmania 
    Australian Capital Territory 
    Northern Territory 
 
211 (27) 
184 (24) 
182 (23) 
87 (11) 
68 (9) 
33 (4) 
15 (2) 
1 (<1) 
 
205 (25) 
248 (30) 
162 (20) 
92 (11) 
70 (8) 
21 (2) 
23 (3) 
4 (<1) 
 
2,980 (30) 
2,512 (25) 
2,139 (22) 
985 (10) 
743 (8) 
260 (3) 
179 (2) 
58 (<1) 
Geographical area   
    Major cities 
    Inner regional 
    Outer regional & remote 
(N = 755) 
517 (68) 
168 (22) 
70 (9) 
(N = 810) 
546 (67)  
192 (24) 
72 (9) 
 
6,692 (69) 
2,188 (22) 
876 (9) 
Socio-economic status – IRSAD 
    Low (1-3) 
    Medium (4-7) 
    High (8-10) 
(N = 754) 
130 (17) 
284 (38) 
340 (45) 
(N = 810) 
121 (15) 
319 (39) 
370 (46) 
 
2,210 (23) 
4,069 (42) 
3,468 (36) 
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Youth  
N = 781 
Parents  
N = 826 
NDSS 
Registrants 
aged 10-19  
N = 9,856a 
Cultural / ethnic background 
    Aboriginal or Torres Strait  
    Islander 
    Country of birth – Australia 
    Main language spoken at home 
   –English  
 
 
14 (2) 
715 (92)  
759 (97) 
 
 
9 (1) 
659 (80) 
808 (98) 
 
188 (2) 
(N=8,595) 
5,447 (87) 
(N=6,280) 
- 
Child lives with 
    2 parents (biological/adoptive) 
    2 parents – one a step-parent 
    Single parent family 
(N=758) 
624 (82) 
50 (7) 
85 (11) 
- 
 
 
 
- 
Youth / child’s diabetes 
    Age at diagnosis (years)  
    Diabetes duration (years)  
    Treatment regimen – CSII 
    Self-reported HbA1c –   
    mmol/mol (%) (N = 650) 
 
9 ± 4 
6 ± 4 (0-18) 
409 (52) 
65 ± 18 (8.1 
± 1.6%) 
 
8 ± 4 
6 ± 4 (0-16) 
436 (53) 
64 ± 16  
(8.0 ± 1.4) 
 
9 ± 4 
6 ± 4 (0-19) 
4,084 (41)b 
- 
Occupation 
    School student 
    Tertiary student (university) 
    Employed/self-employed; full/ 
    part-time 
    Apprenticeship or trade training 
    Unemployed/Looking for work 
    Homemaker/Carer/Volunteer 
    Other 
(N=773) 
676 (87) 
51 (6) 
22 (3) 
 
13 (2) 
11 (1) 
1 (<1) 
11 (1)  
(N = 739) 
0 
0 
570 (77) 
 
0 
22 (3) 
130 (18) 
17 (2) 
- 
Parents’ marital status 
    Married 
    De facto (living together) 
    Relationship (living apart) 
    Single  
    Separated/divorced 
    Widowed 
- (N = 823) 
651 (79) 
57 (7) 
9 (1) 
11 (1) 
84 (10) 
11 (1) 
- 
Parents’ highest level of 
education 
    ≤ year 10 
    Completed year 12 
    Trade / diploma 
    University 
- (N = 740) 
 
98 (13) 
103 (14) 
222 (30) 
- 
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Youth  
N = 781 
Parents  
N = 826 
NDSS 
Registrants 
aged 10-19  
N = 9,856a 
317 (43) 
Annual household income ($) 
    Up to 20,000 
    20,001 – 40,000 
    40,001 – 60,000 
    60,001 – 80,000 
    80,001 – 100,000 
    > 100,001 
    Prefer not to answer 
- (N=711) 
14 (2) 
47 (7) 
66 (9) 
87 (12) 
126 (18) 
264 (37) 
107 (15) 
- 
Unless otherwise stated, data are n (%) or mean ± SD (range) 
Total N reported in this table not always consistent with total sample size due to 
missing data on some items 
IRSAD: Index of Relative Social Advantage and Disadvantage 
CSII: Continuous subcutaneous insulin infusion 
aTotal number of NDSS Registrants with type 1 diabetes aged 10-19 years at 
November 2014;  
bAs at June 2014. 
 
 
3.3.6.3 Qualitative responses 
Open-ended questions with space for free-text responses offered 
respondents the opportunity to communicate their experience of living with 
diabetes in their own words and their feedback on the survey (Table 3.1). Most 
participants responded to at least one of the open questions; only 22 (3%) young 
people and 74 (9%) parents did not respond to any.  
3.4 Discussion 
The MILES Youth Study is the first large-scale, national survey of young 
Australians living with T1DM (and their parents) focused not only on diabetes 
management and healthcare access but also on psychosocial outcomes. In total, 781 
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young people with T1DM completed the survey, which represents 13% of the 
5,928 NDSS registrants with T1DM invited to take part. In addition, 826 parents of 
young people with T1DM aged 10-19 years responded to the survey. A sub-sample 
comprising of 258 parent/child dyads were matched using the youths’ NDSS 
registration number.  
The responses to the MILES Youth survey will provide insights into the 
main concerns and worries about living with T1DM for Australian adolescents. 
While previous studies suggest that most young people are likely to be coping well 
with diabetes and have optimal emotional well-being, the survey results will 
provide an indication of how many are experiencing elevated depressive and 
anxiety symptoms, elevated diabetes distress, and what is causing the distress.  We 
will also gain a better understanding of how these negative moods and feelings are 
related to individual and family characteristics, and in particular, whether there are 
differences in the expressed emotions and self-care behaviours of older and 
younger adolescents or girls and boys.  
The MILES Youth dataset allows us to identify risk and resilience factors 
for young people and their parents.  For example, hypoglycemia is a common acute 
complication of insulin treatment, yet in this age group (and in parents) in 
Australia, we know little about the frequency and severity of hypoglycaemia, 
impaired awareness of hypoglycaemia and the impact of hypoglycaemia on 
emotional well-being.  
The feedback of young people related to the perceived support they receive 
from parents, teachers, friends and healthcare professionals, and how this helps 
them in managing their diabetes, will inform the development of services and 
resources to better support young people with T1DM (and their families). For 
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example, greater awareness of the needs and concerns of adolescents (and their 
parents) as they approach adulthood and independence will assist diabetes services 
to improve the process of transition from paediatric to adult healthcare and reduce 
the number of young people ‘lost in transition’ [38]. The MILES Youth findings 
will also be used to raise awareness amongst clinicians and policy makers of the 
psychological and behavioural challenges that many young people and their 
families face and the current gaps in services to address these needs, and to 
advocate for resources and better access to care.  
To our knowledge, MILES Youth is the first national study with matched 
parent and child responses regarding living with T1DM. Analysis of the 
parent/child dyads will progress our understanding of family-related factors, and 
the interaction between parental well-being and support and youths’ self-care 
behaviours and psychological well-being. In-depth analysis of the dataset is 
ongoing, and peer-reviewed publications are planned. Half of the respondents 
(55%) indicated their interest in future studies. Using the NDSS number to link 
survey responses, and with appropriate ethics approval, future data collections 
could enable a longitudinal study to follow these young people into adulthood, to 
investigate the long-term impact of their behaviours and well-being on future 
outcomes.  
3.4.1 Strengths and Limitations 
Qualitative feedback from participants and the high proportion of complete 
datasets (89%) indicates the survey was relevant and addressed important issues for 
young people with diabetes and their parents. Young people found the language 
and topics resonated with their experience of living with diabetes. The online 
format was a successful and economical approach for engaging young people with 
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T1DM and their parents. Around one in four respondents used a mobile device to 
complete the online survey, suggesting the importance of mobile-friendly platforms 
when designing future online surveys and initiatives. 
The proportion of NDSS registrants who participated in the MILES Youth 
study was generally equivalent by state, with the exception of Northern Territory, 
where participation was very low, most likely related to relative socio-economic 
disadvantage [39]. The majority of respondents were living in metropolitan areas in 
New South Wales, Queensland and Victoria, which reflects the geographic 
distribution of NDSS youth registrants (Table 3.2), and the distribution of the 
broader Australian population. Among youth respondents, both genders and all age 
ranges were well-represented, although there was an over-representation of girls 
and younger registrants.  
Despite the fact that only one in three of the parent and child respondents 
were identified as being from the same family (N=258 dyads matched by NDSS 
registration number), parent responses were remarkably consistent with those of 
young people for the corresponding survey items, e.g., participant demographics, 
duration of diabetes, treatment type.  
The limitations of the study include self-selection bias. Invitations were 
sent to all those NDSS registrants who had consented to take part in research, 
which constitutes 60% of registrants. Furthermore, participants were those who 
volunteered to take part, thus the sample may not be fully representative of the 
broader population of young people with diabetes and their families. The survey 
was available only in English, which is likely to have prevented some people from 
completing the survey. Not having access to a computer or the internet may also 
have precluded some people from taking part. However, in 2011, it was estimated 
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that at least 79% of Australian households have internet access [40] and no-one 
requested a hard copy survey, even though it was explicitly advertised as being 
available.  
Limitations also exist in terms of the representativeness of the sample. 
Based on the IRSAD Index, respondents were from a relatively advantaged 
socioeconomic background compared to the total NDSS population aged 10-19 
years. Thirteen percent of youth lived with one parent, which is fewer than the 
national average (22%) for single-parent families (for children aged under 18 
years) [41]. Insulin pump use was higher among MILES Youth respondents than 
the Australian average for this age group (53% vs 41% respectively; Table 3.2) 
most likely reflecting SES, since pumps are more accessible for Australians with 
private health insurance and those who can afford to pay the ‘out of pocket’ 
expenses for the hardware and consumables. MILES Youth respondents more 
frequently self-reported an HbA1c within target (<58 mmol/mol; <7.5%) than the 
average for Australian paediatric diabetes centres (38% versus 27%) [42], although 
the mean HbA1c was only slightly lower than the average reported for 21 
international centres in 2005 (8.0 vs 8.2%) [43]. Nevertheless, HbA1c was self-
reported, thus we acknowledge it may be subject to recall and social-desirability 
bias.  
These indicators suggest that survey respondents may have better health 
literacy and access to healthcare services than young people with T1DM generally.  
Selection bias towards socially-advantaged families has been reported previously in 
a web-based study and was found to under-estimate the prevalence of 
psychopathology [44]. However, this bias is less likely to affect the relationships 
among study variables, which will be a key focus of our inferential data analyses. 
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The overall survey response rate of 13% was low, but cannot be compared with 
other studies as few in this younger age group have recruited in a comparable 
manner or have reported their response rate.  
Finally, we acknowledge that we originally designed a survey version to be 
suitable for, and attempted to recruit into the study, NDSS registrants with type 2 
diabetes and their parents (N=417; 56% of young people aged 10-19 with type 2 
diabetes registered with the NDSS). However, none took part in the pilot and only 
11 adolescents with type 2 diabetes and 8 parents responded to the survey: too few 
to analyse and report. Given the increasing prevalence of type 2 diabetes in 
younger people [45], the low response was disappointing but not unexpected, 
particularly given that many are likely  to be experiencing socioeconomic 
disadvantage and/or are from culturally and linguistically diverse backgrounds 
(including Aboriginal and Torres Strait Islander communities) [46]. Based on 
previous research [47], families living in disadvantaged circumstances are likely to 
have higher rates of distress, impaired well-being and less access to healthcare. 
Thus, investigating and raising awareness of the unmet needs of young people with 
type 2 diabetes and their parents remains a high priority, although it is evident that 
other strategies are needed to reach them. Direct approaches via diabetes clinics, 
general practitioners or community groups may improve engagement with these 
families. 
3.5 Conclusions 
The MILES Youth Study is the first large-scale, national survey of young 
Australians living with T1DM (and their parents) focused not only on diabetes 
management and healthcare access but also on a broad range of important 
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psychosocial factors (e.g., general emotional well-being, diabetes distress, social 
support and quality of life) implicated in living well with this chronic condition. 
The study also represents the first step towards establishing a longitudinal program 
of research focused on the unmet needs of this group. Subsequent publications will 
report in-depth analyses of this rich quantitative and qualitative dataset to inform 
future research and support services to meet the needs of young people with T1DM 
and their families.  
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4.1 Abstract  
Objective: To establish cut point(s) for the Problem Areas in Diabetes–
Teens (PAID-T) scale to identify adolescents with clinically meaningful, elevated 
diabetes distress.   
Research Design and Methods: Data were available from the Diabetes 
Management and Impact for Long-term Empowerment and Success (MILES) 
Youth – Australia Study, a national survey assessing various psychosocial 
indicators among self-selected National Diabetes Services Scheme registrants. 
Participants in the current study (n = 537) were (mean ± SD) 16 ± 2 years old, 
had type 1 diabetes for 6 ± 4 years, and 62% (n = 334) were girls. They 
completed measures of diabetes distress (PAID-T) and depressive symptoms 
(Patient Health Questionnaire for Adolescents) and self-reported their most recent 
HbA1c and frequency of self-monitoring of blood glucose (SMBG). Relationships 
between the PAID-T and the psychological and clinical variables were examined 
to identify a clinically meaningful threshold for elevated diabetes distress.  
ANOVAs were used to test whether these variables differed by levels of distress.  
Results: Two cut points distinguished none-to-mild (<70), moderate (70-
90), and high (>90) diabetes distress. Moderate distress was experienced by 18% 
of adolescents and high distress by 36%. Mean depressive symptoms, self-
reported HbA1c and SMBG differed significantly across the three levels of 
diabetes distress (all P < 0.001), with moderate-to-large effect sizes.  
Conclusions: Using the PAID-T, this study defined two clinically 
meaningful cut points to distinguish none-to-mild, moderate, and high diabetes 
distress in adolescents (aged 13-19). Based on these cut points, most respondents 
experienced at least moderate diabetes distress, which was clinically significant.  
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Establishing thresholds for elevated diabetes distress will aid clinicians and 
researchers to interpret PAID-T scores, prompt discussion and intervention for 
those with unmet needs, and enable the effectiveness of interventions to be 
evaluated.  
 
Keywords: Type 1 diabetes; adolescence; diabetes distress; depression; HbA1c; 
cut-off point 
 
  
143  
4.1 Introduction 
Many people living with diabetes feel burdened by the ongoing challenge 
of managing their condition, and experience periods of frustration, anger, fear and 
helplessness related to their diabetes; which is referred to collectively as ‘diabetes 
distress’ (DD) (1). For adolescents with type 1 diabetes, there are also various 
diabetes-specific issues related to age and stage of life (e.g., family conflict, 
parental over-vigilance and uncertainties about body image) (2). Approximately 
one-third of adolescents may experience elevated DD, although the prevalence is 
uncertain owing to the absence of a clinically valid cut point on adolescent-
specific DD measures (3).  
A threshold to indicate elevated DD enables the comparison of 
prevalence across populations for research purposes, the detection of people in 
clinical practice for whom intervention is needed to alleviate distress, and enables 
evaluation of the effectiveness of interventions.  A standardized score ≥40 (range 
0-100) on the Problem Areas in Diabetes (PAID) scale (derived from the mean +1 
SD) [4]) has been widely adopted as the threshold for elevated DD among adults, 
yielding prevalence rates of 19 to 31% in adults (5-7). It has also yielded a 
prevalence rate of 17% among adolescents, despite the measure not being 
designed specifically for this population (8). Yet, this cut point has not been 
validated clinically.  
Given the subjective nature of DD, there is no gold standard measure 
against which to validate elevated DD. Therefore, other empirical approaches are 
required to establish a cut point. In 1978 Rose and Barker (9) outlined four 
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approaches to determine a cut point on a continuous scale based on the intended 
purpose and available data:  
1. Statistical significance, which uses the age-specific mean +2 SD to define 
“abnormal” values; however, this method will result in a similar 
proportion (5%) of extreme values across populations and lacks clinical 
meaning (9);   
2. Prognostic significance, which assesses the future risk associated with the 
outcome;  
3. Operational significance, which defines the level above which 
intervention will improve symptoms or prognosis (both of these 
approaches are clinically meaningful and require longitudinal data); and 
4. Clinical significance which denotes the level above which the frequency 
of symptoms or complications increases.  
Fisher et al. (10) used the clinical significance approach to delineate cut 
points for the Diabetes Distress Scale (DDS) and the type 1 diabetes-specific 
DDS (T1-DDS) in adult populations (11,12). They examined linear and quadratic 
relationships between DD and clinical indicators of diabetes management (e.g., 
HbA1c, physical activity), to identify changes in the gradient that might indicate a 
threshold for elevated DD. Increases of 0.5 SD demonstrated clinically 
meaningful differences in variables between DD categories (10). Three cut points 
were established for the T1-DDS, designating ‘little or no DD’, ‘mild’, 
‘moderate’ and ‘high distress’ (11). However, subsequent analysis using spline 
regression to demonstrate a change in the bi-variate association with HbA1c, 
revealed a single threshold for elevated DD (12).  
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Given there is now a validated measure of DD designed specifically for 
adolescents with type 1 diabetes − the PAID-Teens (PAID-T) (2) − but no 
established threshold for identifying elevated DD, we aimed to address this 
research gap by investigating clinically meaningful cut point(s) for the PAID-T 
scale that may identify adolescents experiencing elevated DD. Three variables 
were chosen to evaluate the clinical significance of elevated DD: depressive 
symptoms (Patient Health Questionnaire for Adolescents [PHQA]-8), HbA1c and 
frequency of self-monitoring of blood glucose (SMBG). These were selected 
because they are important emotional and diabetes-specific indicators and 
behaviors correlated with DD among adults (11,12) and adolescents with type 1 
diabetes (3).  
4.2 Research Design and Methods 
The Diabetes Management and Impact for Long-term Empowerment and 
Success (MILES) Youth−Australia Study (MILES Youth) was a national survey 
assessing the effect of diabetes on various psychosocial outcomes of Australian 
youth with type 1 diabetes, and their parents. Full details of the survey methods 
were published previously (13) (Chapter 3). In brief, postal invitations to 
participate in a national, cross-sectional survey were sent to 5,928 registrants 
(59%) of the National Diabetes Services Scheme (NDSS) aged 10-19 years, who 
had previously consented to be contacted for research purposes. The NDSS is an 
Australian Government initiative, which provides subsidized products (e.g., 
insulin syringes, blood glucose test strips), information, and support services for 
Australians diagnosed with diabetes. All young people with type 1 diabetes are 
registered with the scheme and have access to subsidized multidisciplinary 
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diabetes care through public hospital-based services or private practitioners. The 
study was also promoted through diabetes clinics, social media and relevant 
diabetes magazines and newsletters.  Commencing in August 2014, the survey 
was available online for 8 weeks. Before proceeding to the survey, participants 
were required to indicate their consent to participate. The MILES Youth study 
received ethical approval from the Deakin University Human Research Ethics 
committee (reference number 2014-060).  
4.2.1 Participants 
The current study includes MILES Youth participants aged 13 to 19 
years with type 1 diabetes (n = 551) who had received the full survey, including 
the measures of DD and depressive symptoms. These measures were not 
presented to the younger group, aged 10-12 years (n = 230) owing to the nature of 
the survey method. The flow diagram of recruitment and inclusion / exclusion 
criteria is shown in Appendix I (Supplementary Figure 4.3).  
4.2.2 Measures 
4.2.2.1 Demographic and clinical characteristics 
Participants reported their age, sex, country of birth and postcode, which 
was used to index socioeconomic status (SES) (14). In addition, insulin delivery 
mode (pump or injections), diabetes duration, usual SMBG frequency (using an 
8-point scale, ‘less than once a day’ to ‘more than 7 times a day’) and most recent 
HbA1c were self-reported. Respondents were asked to indicate when their last 
HbA1c was checked (<3; 3-6; 7-12; >12 months; don’t know) and 69% indicated 
their HbA1c was measured within the previous 3 months. The minimum 
recommended SMBG frequency is four times daily. At the time of the survey, 
continuous glucose monitoring was not subsidized for this age-group and not 
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widely used and so was not included. Ten participants did not complete SMBG 
items and 80 did not report their HbA1c. HbA1c was excluded for participants with 
extreme values/outliers (n = 5).  
4.2.2.2 Psychological measures  
Diabetes distress; Participants completed the PAID-T, a 26-item scale 
adapted from the adult version, which assesses the perceived emotional burden of 
living with diabetes (2). Items are rated on a 6-point scale: 1-2, not a problem, 3-
4, a moderate problem, or 5-6, a serious problem. Item scores were summed to 
form a total score (range 26-156), with higher scores indicating greater DD (2). 
Because the adult version of the PAID is reported as a standardized score (0-100), 
we transformed the PAID-T using the formula (sum total – 26/130 x 100) so that 
the cut points were comparable.  The final cut points are reported for both the 
‘PAID-T total’ and ‘standardized PAID-T total’ scores. We examined the factor 
structure using principal components analysis, which supported a unidimensional 
construct, consistent with the original study reporting the psychometric properties 
of the PAID-T (2). The scree plot suggested one principal component, which 
accounted for 49.5% of the total variance (Eigenvalue: 12.9). The other 
components with Eigenvalues >1.0 explained 6.9% and 5.5% of the variance 
respectively. All items had high loadings onto a forced single component (all 
coefficients >0.50). The Cronbach  was 0.96, indicating very high internal 
consistency reliability.  
Depressive symptoms; The PHQA-8 (15) was used to assess the presence 
and severity of depressive symptoms. The suicidal ideation item was omitted, in 
accordance with accepted procedures in population surveys (16) and the 
previously reported problematic nature of this item in the adult version (17). The 
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eight items are scored from 0 (not at all) to 3 (nearly every day). Total scores 
range from 0 to 24, with higher scores indicating greater depressive symptoms. 
Cut points at 5, 10, 15 and 20 represent mild, moderate, moderately-severe and 
severe depressive symptoms respectively. The Cronbach  in this sample was 
0.90. 
4.2.3 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Sciences 
(SPSS), Version 23 for Windows (IBM Corp, Armonk, NY). Only complete data 
for the psychological measures were included. Data were checked for normality. 
Descriptive statistics are reported as mean ± SD or count and percentage. 
Associations between variables were examined using Pearson correlations and 
checked using nonparametric tests (Spearman rank) as appropriate for the data 
distribution.  
4.2.3.1 Cut point analysis 
After appraising various methods to establish a cut point, we adopted the 
clinical significance approach (9). We considered two methods for quantifying 
the level of DD: 1) the total number of items endorsed as ‘a serious problem’ (i.e., 
rated 5-6), and 2) the summed PAID-T score. To determine whether the number 
of items endorsed would adequately capture the variation in DD levels, 
scatterplots were used to examine the PAID-T total score and the number of items 
endorsed in each of the three categories (not a problem, a moderate problem, a 
serious problem).  
The pattern of the relationships between DD and the dependent variables 
(depressive symptoms, self-reported HbA1c and SMBG) were examined in 
separate multivariate regressions. Controlling for significant confounders (age, 
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sex and insulin pump use), we added linear and quadratic terms for DD in 
separate steps. Graphs of the quadratic regression fit lines were examined to 
identify one or more points of inflection that would indicate a potential cut point. 
The PHQA-8 summed score was logarithmically transformed before the 
regression analysis was performed to correct for a positively skewed distribution.  
To identify points at which the PAID-T showed a marked increase or the 
trajectory changed, we plotted the mean PAID-T at each increment of the 1) 
PHQA-8 score (0-24); 2) HbA1c levels (1.0% increments from 5.0-11.9%; and 
12.0-15.9%), and 3) SMBG frequency. Differences in variables were examined 
by level of DD using one-way ANOVA. Levene tests revealed that the 
homogeneity of variance assumptions were not met; therefore, we used the Welch 
F test, and the Games-Howell procedure for pairwise comparisons. Results were 
confirmed with nonparametric tests (Kruskal-Wallis and Jonckheere-Terpstra) but 
are not reported unless the results were different. Differences between means 
were considered statistically significant at P < 0.01, and clinically significant at 
>0.5 SD units or HbA1c >0.5%. Effect sizes were calculated using the Cohen d 
and considered to be small (d = 0.2), medium (d = 0.5) or large (d = 0.8) (18).  
4.3 Results 
4.3.1 Sample characteristics 
The study included 537 adolescents with type 1 diabetes (see Appendix I: 
Supplementary Figure). Their mean age was 15.7 ± 1.9 years, 334 (62%) were 
girls (Table 4.1). Mean diabetes duration was 6.5 ± 4.5 years, and 266 (50%) 
managed their diabetes with an insulin pump. The mean self-reported HbA1c was 
8.1 ± 1.5% (65 ± 16 mmol/mol). The mean PAID-T total score was 77 ± 30. 
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Table 4. 1: Participant characteristics 
 Total N = 537 
  
Age (years) 15.7 ± 1.9 (13−19) 
Female sex 334 (62) 
Born in Australia 497 (93) 
SES  
     Low (1-3) 92 (18) 
     Mod (4-7) 198 (38) 
     High (8-10) 230 (44) 
Diabetes duration (years) 6.5 ± 4.5 (0−18) 
Diabetes management  
     Insulin pump 266 (50) 
     HbA1c (%)* 
     HbA1c (mmol/mol)* 
8.1 ± 1.5 (5.1−15.5) 
65 ± 16 (32−146) 
     SMBG (checks per day)† 4.8 ± 2.1 
Psychological distress  
     Diabetes distress (PAID-T) 77 ± 30 (26−156) 
     Depressive symptoms (PHQA-8) 6.8 ± 6.0 (0−24) 
Data presented as n (%) or as mean ± SD (range). * N = 452. †N = 527. 
 
 
4.3.2 Bivariate associations with diabetes distress 
The PAID-T total score correlated positively with depressive symptoms 
(r = 0.62, P < 0.001), HbA1c (r = 0.34, P < 0.001) and negatively with SMBG 
frequency (r = −0.28, P < 0.001) (see Appendix I: Supplementary Table).  There 
was a small correlation between PAID-T and age (r = 0.17, P < 0.001) but no 
relationship with diabetes duration (P = 0.33). Girls reported higher DD than 
boys (83 ± 31 vs 66 ± 27, P < 0.001). There was no difference in PAID-T by 
insulin delivery mode (P < 0.99) or SES (P < 0.41). 
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4.3.3 PAID-T scale cut point analysis 
The scatter plots in Figure 4.1 show that adolescents who rated most 
items 1-2 (‘not a problem’) had a low PAID-T score (Figure 4.1a) and those who 
rated most items 5-6 (‘serious problem’) had a high PAID-T total score (Figure 
4.1c). However, items endorsed as a ‘moderate problem’ (rated 3-4) contributed 
substantially to the total PAID-T score (Figure 4.1b). Thus, quantifying the 
severity of DD using only items endorsed as a ‘serious problem’ would ignore 
some adolescents experiencing substantial levels of distress (i.e., through most 
items being rated as a ‘moderate problem’). Further, item-level analysis (Pearson 
correlations) (Appendix I: Supplementary Table ) showed that the PAID-T items 
most frequently endorsed as a ‘serious problem’ were not the most strongly 
correlated with the psychological and clinical variables of interest, suggesting that 
this method is not the most appropriate for determining clinical significance. We 
therefore used the total score rather than the number of items endorsed for the cut 
point analysis.  
There was a significant linear relationship between DD and log-
transformed PHQA-8 (R2 = 0.37, t = 14.18, P < 0.001), HbA1c (R
2 = 0.12, t = 
7.02, P < 0.001) and SMBG (R2 = 0.16, t = −6.38, P < 0.001). When added to the 
model, the quadratic term for DD was not significant for any of the dependent 
variables; therefore, the trend line did not indicate a cut point.  
The means plot in Figure 4.2a shows an increase in the mean PAID-T in 
relation to PHQA-8 scores, ≥70 and >90. PAID-T scores <70 corresponded with 
mean PHQA-8 ≤4 (Figure 4.2a), indicating none-to-minimal depressive 
symptoms; HbA1c <7.0% (Figure 4.2b); and average ≥6 SMBG checks per day 
(Figure 4.2c). PAID-T >90 corresponded with PHQA-8 scores >10 (moderate-to-
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severe depressive symptoms), high self-reported HbA1c (≥9.0%; >75 mmol/mol) 
and less frequent SMBG than recommended (≤2 checks per day). These two cut 
points differentiated young people with optimal and suboptimal self-management 
and with or without depressive symptoms. As determined from these thresholds, 
46% (n = 247) reported none-to-mild DD (PAID-T <70), 18% (n = 98) reported 
moderate DD (PAID-T 70−90), and 36% (n = 192) experienced high levels of DD 
(PAID-T >90) (Table 4.2).  Cut points using standardized PAID-T scores were: 
none-to-mild DD, <34; moderate DD, 34-50; and high DD, >50.  
There were statistically significant differences between DD categories for 
mean PAID-T (F2, 333.8 = 1173.2, P < 0.001), PHQA-8 (F2, 236.4 = 109.6, P < 
0.001), HbA1c (F2, 212.4 = 21.7, P < 0.001) and SMBG frequency (F2, 261.9 = 13.5,  
P < 0.001) (Table 4.2). Pairwise comparisons showed moderate-to-large effect 
sizes (Table 4.2). Differences between categories were >0.5 SD for depressive 
symptoms and HbA1c >0.5% for those with high DD, indicating that the 
thresholds distinguished clinically relevant differences in these variables. SMBG 
frequency was significantly lower among those with high DD.  
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Figure 4.1: Association between diabetes distress (PAID-T total score) and the number of items endorsed by category  
(a) not a problem; (b) moderate problem; (c) a serious problem 
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Figure 4.2: Association between mean PAID-T total score (95% CI) and (a) the 
range of PHQA-8 scores; (b) levels of self-reported HbA1c; (c) SMBG frequency  
Error bars represent 95% confidence intervals  
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Table 4. 2: Difference in mean scores and effect sizes for psychological and clinical variables by severity of diabetes distress 
 Total 
sample 
Severity of diabetes distress‡  Effect size  
None-to-mild Moderate High Difference (d) P 
N (%) 537 (100) 247 (46) 98 (18) 192 (36)    
Diabetes distress  77 ± 30 49 ± 12 80 ± 6 111 ± 15   <0.001 
Depressive symptoms  6.8 ± 6.0 3.5 ± 3.5 7.1 ± 4.3 10.8 ± 6.6 +3.6* 0.92 <0.001 
    +3.8† 0.66 <0.001 
HbA1c (%)  8.1 ± 1.5 7.7 ± 1.3 8.0 ± 1.4 8.7 ± 1.6 +0.2* 
+0.8† 
0.22 
0.47 
0.36 
0.001 
HbA1c (mmol/mol) 65 ± 16 61 ± 14 63 ± 15 72 ± 17 +3* 
+8† 
0.22 
0.47 
0.36 
0.001 
SMBG 4.8 ± 2.1 5.2 ± 2.0 5.0 ± 1.8 4.2 ± 2.1 -0.2* 0.11 0.72 
    -0.8† 0.41 0.002 
Data are mean ± SD or as indicated. ‡ None-to-mild (PAID-T <70); Moderate (PAID-T 70−90); High (PAID-T >90) 
*Difference between ‘none-to-mild’ and ‘moderate’ 
†Difference between ‘moderate’ and ‘high’ 
SMBG: self-monitoring blood glucose 
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4.4 Conclusions 
This study is the first to investigate the clinical significance of cut points 
to determine meaningful elevation of DD in adolescents (aged 13−19 years) with 
type 1 diabetes.  These cut points show that 18% of participants reported 
moderate DD and 36% reported high DD. These thresholds suggest that DD is 
associated with psychological and clinical factors at a relatively low level in 
adolescents compared with adults (standardized PAID-T vs standardized PAID: 
34 vs 40).  
The items with the highest mean scores (i.e., most frequently endorsed as 
a ‘moderate’ or ‘serious problem’) were not the most strongly correlated with 
psychological and clinical indicators, thus modal distribution and statistical 
approaches were not appropriate for determining a clinically meaningful cut point 
for elevated DD. Our analysis confirmed the original one-factor structure of the 
PAID-T (2). Further, the total score proved a better measure of elevated DD than 
items endorsed as a ‘serious problem’, which did not account for widespread 
‘moderate’ levels of distress that contributed substantially to the total score. A cut 
point was not found using the predicted mean, which increased linearly. 
However, we found a consistent trend in the relationships between the mean 
PAID-T total score and the three outcome variables, which enabled us to 
distinguish two cut points and three levels of severity.  
   Thresholds for elevated DD will be useful in a clinical setting for 
interpreting the PAID-T score and for initiating a conversation about DD. Young 
people with elevated DD had significant psychological impairment, which may 
affect their capacity to self-manage effectively. The adolescent age-group faces 
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multiple biological, psychological and social challenges, which can make 
managing diabetes especially difficult, and may need more support than is 
currently available to them. They may, for example, benefit from diabetes self-
management education and support, which can enhance coping skills and self-
efficacy (3), although such programs targeted at young people are not widely 
available in Australia.  Psychoeducation programs and cognitive behavioural 
therapy have been shown to reduce DD among adolescents (3) and adults with 
type 1 and type 2 diabetes (19−21). Referral to a mental health professional is 
warranted for depression or anxiety. However, more than half of adolescents may 
have elevated DD; therefore, all diabetes clinicians have a role in recognizing and 
minimizing distress. Assessing DD, by using age-appropriate tools such as the 
PAID-T, could be integrated into the diabetes education and management plan. 
Individual PAID-T items reveal the sources of distress, which can facilitate the 
conversation and shared decision-making about the most appropriate strategies 
for reducing DD and improving outcomes. 
In a research context, a cut point provides criteria for inclusion into 
studies and the means to identify the magnitude of the problem (to target research 
and funding) and the effect of the intervention. It also enables comparison of 
prevalence across populations. Although the moderate group was modest in size, 
the data clearly indicated a middle category. Consistent with a study in adults 
(12), even moderate levels of DD were associated with depressive symptoms. 
Although younger age and DD are correlated in adults with type 1 diabetes (11, 
22), Lašaitė et al. (8) reported higher DD in emerging adults than adolescents. 
Although differences may be attributable to the DD measures, methods of 
estimating thresholds, and the actual cut points, that there are real distinctions 
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related to age and life stage is likely, supporting the need to use age-appropriate 
measures. DD appears to be highest among adolescents and young adults, who 
are challenged with managing diabetes during important life transitions (23).  
Given the subjective nature of DD, there is no gold standard measure 
against which to validate the PAID-T. HbA1c was used as a clinical outcome 
because it is a standardized indicator of diabetes management and complication 
risk. A study using clinic-recorded HbA1c reported a threshold for increased 
mood disorders among children (8.7%) that was consistent with our findings (24). 
However, broader aspects of living with diabetes (e.g., social impact) may be 
unrelated to HbA1c. Although DD has a moderately-strong correlation with the 
PHQA-8 scale, the latter is a measure of general emotional distress, and unlikely 
to capture the full experience of living with diabetes. Further, a small proportion 
of people with type 1 diabetes who experience elevated depressive symptoms do 
not report high levels of DD (25). Thus, HbA1c and depressive symptoms both 
have limited validity as a gold standard in this context, but determining cut points 
with reference to both biomedical and general psychological indicators minimizes 
any bias that might be introduced with a single reference. Further research is 
needed to investigate the most appropriate indicators to explore DD cut points. 
The strengths of this study include the large national sample, the use of 
an adolescent-specific measure of DD, and the data-driven approach to defining 
thresholds for elevated DD. Several methodological limitations need to be 
considered and have been discussed in greater detail elsewhere (13). The MILES 
Youth study participants were self-selected, and the overall response rate was low 
(13%). Respondents were not representative of the Australian adolescent 
population with type 1 diabetes, because they were relatively advantaged 
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socioeconomically and boys were somewhat underrepresented (13). We found 
that DD was unrelated to SES, but girls reported higher DD than boys and this 
may have influenced our results. The mean PAID-T score for our sample (77 ± 
30) was consistent with the score in a recent U.S. study (73 ± 27), in a very 
similar age group (range 14−18 years) (26). Furthermore, similar sex differences 
in DD have been identified among adolescents in the U.S. (2,26). HbA1c and 
SMBG were self-reported and thus subject to recall and social-desirability bias, 
and a large number of respondents did not provide an HbA1c. Nonetheless, 
compared with meter download, self-reported SMBG has shown satisfactory 
reliability (27) and fewer-than-expected errors (28). The mean self-reported 
HbA1c among this sample was only slightly lower than that found in a clinic-
based study in a recent study in Victoria (8.1% vs 8.3%) (29), and the strength of 
the association between DD and HbA1c was similar to that observed in other 
studies among adolescents (3), despite not being collected concurrently with the 
PAID-T (69% of HbA1c checks had been conducted within the past 3 months). 
Any self-report and sample bias is minimized because the cut point analysis 
focused on those at greatest risk (SMBG <2 per day; HbA1c >9%). 
In summary, this study has established cut points for moderate and high 
DD, which will be useful for clinical and research purposes. Most of the 
adolescents experienced at least moderate DD, which was shown to be clinically 
significant. These cut points provide the opportunity, for the first time, to identify 
clinically significant levels of DD among adolescents with type 1 diabetes to 
enable interventions to be targeted for those most in need of support. 
Confirmation of these cut points in other populations and with other indicators is 
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warranted. Exploration of DD in longitudinal studies would be useful to assess 
the prognostic value of the cut points and their stability over time.  
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5.1 Abstract 
Background: Glycated hemoglobin (HbA1c) is higher during 
adolescence than at any other life stage. Some research among adolescents 
indicates that depressive symptoms are associated with suboptimal HbA1c. 
However, research among adults suggests diabetes distress is a stronger predictor 
of HbA1c than depressive symptoms. 
Objective: To determine the relative contributions of depressive 
symptoms and diabetes distress to explaining the variance in HbA1c among 
adolescents with type 1 diabetes.  
Participants and Methods: Diabetes MILES Youth Study respondents 
aged 13 to 19 years completed questionnaires assessing depressive symptoms 
(Patient Health Questionnaire for Adolescents: PHQA-8), diabetes distress 
(Problem Areas in Diabetes-Teen version: PAID-T), and self-reported socio-
demographic and clinical variables, including their most recent HbA1c. Stepwise 
hierarchical multiple regression was conducted to examine the contributions of 
depressive symptoms and diabetes distress to HbA1c. 
Results: Participants (N = 450) had a (mean ± SD) age of 15.7 ± 1.9 
years; diabetes duration of 6.9 ± 4.3 years; and 38% (n = 169) were male. 
Twenty-one percent (n = 96) experienced moderate-to-severe depressive 
symptoms (PHQA-8 ≥ 11) and 36% (n = 162) experienced high diabetes distress 
(PAID-T > 90). In the final regression model, HbA1c was explained by: diabetes 
duration (β = .14, P = .001), self-monitoring of blood glucose (β = −.20, P < .001) 
and diabetes distress (β = .30, P < .001). Following the addition of diabetes 
169  
distress, depressive symptoms were no longer significantly associated with HbA1c 
(P = .551). The final model explained 18% of the variance in HbA1c.  
Conclusions: Consistent with evidence from studies among adults, 
diabetes distress mediated the relationship between depressive symptoms and 
HbA1c among adolescents with type 1 diabetes. These findings suggest that 
clinicians need to be aware of diabetes distress.  
 
Keywords: Diabetes Mellitus, Type 1; Adolescent; Depression; Emotions; 
Hemoglobin A1c 
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5.2 Introduction 
Achieving optimal glycemic control, with the avoidance of hyper- and 
hypoglycemic excursions, is central to the prevention of long-term complications 
among people with type 1 diabetes (T1D). Glycated hemoglobin (HbA1c, a well-
established risk factor for future complications), is higher in late adolescence than 
during childhood, early adolescence or adulthood.1 This is due to the biological 
and psychosocial changes that accompany puberty and adolescent development.2  
Young people with T1D and mental health problems are at higher risk of adverse 
diabetes outcomes than those without such comorbidities, including more 
frequent episodes of diabetic ketoacidosis and higher rates of hospitalization.3 
Some studies in adolescents show a significant association between 
depressive symptoms and suboptimal HbA1c,
4,5 whereas others have found no 
independent relationship.6,7 Two case control studies (using clinical interview to 
determine depression incidence) found no association between glycemic control 
and severity of depression, despite up to 3-fold higher prevalence of severe 
depressive symptoms among adolescents with T1D than those without diabetes.8,9 
These contradictory findings may be due to inconsistent measurement and 
definition of depression across studies, and it has been noted elsewhere that the 
source and severity of distress appear to contribute to the variance in HbA1c.
10  
In studies among adults with T1D, depression is not independently 
associated with HbA1c when examined concurrently with diabetes distress.
11,12 
Diabetes distress explains a large proportion (39%) of the variance in depressive 
symptoms,12 suggesting there is overlap in these constructs.10  It is postulated that 
self-report depression measures also reveal diabetes distress because individuals 
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appraise depressive symptoms in the context of living with diabetes.11 Hence, 
those experiencing negative feelings related to their diabetes may also endorse 
depressive symptoms, but the depression measure does not attribute those 
symptoms to any particular source. Although closely correlated with depressive 
symptoms, diabetes distress is not the same construct. It is not a psychiatric 
condition, but rather reflects the experiences and negative emotions that arise 
from living with and managing diabetes.13 Measures of diabetes distress typically 
refer to issues such as worry about the future and complications, over-vigilance 
and lack of understanding by family and friends, and feeling guilty/anxious about 
diabetes management.13 Diabetes distress is a heterogeneous construct, and 
studies in adults indicate that regimen-related items are more closely related to 
HbA1c than other dimensions, and the relationship with self-management is bi-
directional.14 About 11 to 30% of adults with T1D are estimated to experience 
moderate-to-severe depressive symptoms11,12,15 and 15 to 40%  report moderate-
to-severe diabetes distress.11,12 Experiencing both depression and diabetes distress 
is associated with greater psychological distress and suboptimal diabetes 
management.12  
Depression has been studied widely in adolescents with T1D but less is 
known about diabetes distress and the inter-relationships between depressive 
symptoms, diabetes distress and HbA1c, because these constructs have not been 
examined concurrently in this age group. A systematic review found only 16 
studies that assessed diabetes distress in adolescents, but despite age-appropriate 
measures being available (e.g. Diabetes Stress Questionnaire for Youths [DSQ-
Y], Problem Areas in Diabetes-Teen version [PAID-T]) almost half (43%) of 
these had used adult measures (Problem Areas in Diabetes [PAID] or Diabetes 
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Distress Scale [DDS]), which have not been validated among adolescents and do 
not include age-related concerns (e.g. parental ‘nagging’ or body image 
concerns).16 Eight studies showed an association between diabetes distress and 
HbA1c and four found no association. A positive correlation was more likely 
when age-appropriate diabetes distress measures were used. Now that an 
adolescent-specific measure of diabetes distress (: PAID-T)17 has been validated 
among youth aged 11 to 19 years, the opportunity exists to investigate the 
interaction between depressive symptoms, diabetes distress and HbA1c robustly in 
this age group. Furthermore, clinically meaningful levels of diabetes distress can 
now be defined through established cut points.18 Therefore, the aim of this study, 
among adolescents with T1D, was to examine the interaction between depressive 
symptoms and diabetes distress and HbA1c, and to determine the extent to which 
severity of depressive symptoms and diabetes distress explain the variance in 
HbA1c.  
5.3 Research Design and Methods 
5.3.1 Protocol 
The Diabetes MILES (Management and Impact for Long-term 
Empowerment and Success) Youth – Australia Study (MILES Youth) is a 
national, cross-sectional survey of the psychosocial aspects of T1D. Full study 
methods were published previously.19 In brief, invitations to participate were 
posted to 5928 National Diabetes Services Scheme (NDSS) registrants with T1D 
aged 10 to 19 years, who had previously consented to be contacted for research 
purposes (59%). The NDSS is an initiative of the Australian Government, 
providing subsidized products (eg, insulin syringes, pump consumables, blood 
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glucose test strips) and support services for all Australians with T1D. The survey 
(available for online completion over 8 weeks) was promoted in diabetes clinics, 
and relevant print and electronic media. Deakin University Human Research 
Ethics Committee approved the study (2014-060). All participants (and parents 
for those aged under 18 years) provided informed consent. 
5.3.2 Participants 
In total, 781 (13%) adolescents with T1D completed the demographic 
and core question sets concerning emotional well-being and quality of life. 
Eligibility for the current study was limited to adolescents aged 13 to 19 years 
who completed the key measures of interest to this study; diabetes distress and 
depressive symptoms. These measures were not presented to those aged 10 to 12 
years due to concerns about asking such questions of this age group in an 
anonymous internet-based survey. 
5.3.3 Measures 
5.3.3.1 Demographic and clinical characteristics 
Participants self-reported their gender, age, and postcode, which was used to 
index socioeconomic status (SES), age at T1D onset, most recent HbA1c, and 
insulin delivery mode (pump or injections). They also reported their usual daily 
frequency of self-monitoring of blood glucose (SMBG), using a 9-point scale; 0 
(<once per day) to 8 (≥7 times per day), which was dichotomized for statistical 
analysis around the recommendation of SMBG at least 4 times per day: <4/day; 
≥4/day. 
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5.3.3.2 Psychological measures  
Participants completed the following self- report measures: The 26-item Problem 
Areas in Diabetes – Teen (PAID-T)17 is an age-specific (11-19 years) 
unidimensional measure of diabetes distress adapted from the adult PAID,13 
assessing the perceived emotional burden of living with diabetes. Items are rated 
on a 6-point scale: 1 to 2 (not a problem), 3 to 4 (moderate problem), 5 to 6 
(serious problem). Scores are summed (range 26-156), with higher scores 
indicating greater diabetes distress; based on recently validated cut points, 
distress can be categorised as none/minimal (26-69), moderate (70-90), or high 
(>90).18 Cronbach’s alpha in this sample was .96, indicating very high internal 
consistency. 
The 8-item version of the Patient Health Questionnaire for Adolescents 
(PHQA-8) was used to assess the presence and severity of depressive symptoms. 
Suicidal ideation (item 9 of the more commonly used PHQ-9) was omitted, in 
accordance with accepted procedures in population surveys20 and previously 
reported problems with this item.15 Items are rated 0 (not at all) to 3 (nearly every 
day). Scores are summed (range 0-24), with higher total scores indicating more 
depressive symptoms. Previously validated thresholds21 were used to categorize 
symptom severity: none/minimal (0-4); mild (5-10); moderate-to-severe (≥11). 
Cronbach’s alpha was .91, indicating satisfactory internal consistency.  
5.3.4 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Sciences 
(SPSS), version 24 for Windows (IBM Corporation, Armonk, New York). 
Individuals (N = 101) were excluded from analysis because they had missing data 
(SES, HbA1c, SMBG, PAID-T) or an extreme value/outlier (HbA1c < 5.0%; 31 
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mmol/mol, or >16%; 151 mmol/mol). Pearson’s correlation coefficients, 
Student’s t-tests and Analysis of Variance [ANOVA] or non-parametric tests as 
appropriate for the data distribution (Mann-Whitney, Kruskall-Wallis) were 
calculated to examine the relationships between self-reported HbA1c and 
demographics, SMBG, insulin delivery mode, depressive symptoms and diabetes 
distress. To determine associations with self-reported HbA1c, variables with 
significant univariate associations with HbA1c were entered stepwise into a 
hierarchical multiple regression:  Step 1: male gender, diabetes duration, SMBG; 
Step 2: depressive symptoms; Step 3: diabetes distress (as continuous variables). 
Multicollinearity was not considered to be a problem where the variance inflation 
factor (VIF) and tolerance values were <4 and >0.2 respectively.  A series of 
linear regression analyses were performed to determine whether age, gender or 
depressive symptom severity, moderate the relationship between diabetes distress 
and HbA1c, and whether the interaction between diabetes distress and SMBG 
contributes to the variance in HbA1c. Results are reported as mean ± SD or 
median and % (n). Differences were accepted as significant at P < .05 (2-sided).  
5.4 Results  
5.4.1 Participant characteristics 
A total of 551 adolescents (aged 13-19 years) completed relevant 
measures. Respondents with incomplete data were excluded (n = 101), most of 
whom (85%, n = 85) were missing self-reported HbA1c. Compared to participants 
with complete data, those excluded due to missing data had shorter T1D duration 
(P < .001), were more likely to use injections (P< .001), and have a higher SES 
(P = .07). 
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The characteristics of the final sample (N = 450) are detailed in Table 
5.1. They had a mean age of 15.7 ± 1.9 years; T1D duration of 6.9 ± 4.3 years; 
38% (n = 169) were male; and 53% (n = 240) managed their diabetes with an 
insulin pump. The mean self-reported HbA1c was 8.1 ± 1.5% (65 ± 16 
mmol/mol), and 69% had been assessed within the previous 3 months.  
Twenty-one percent (n = 96) reported moderate-to-severe depressive 
symptoms, while 36% (n = 162) had high diabetes distress. Forty-one percent     
(n = 183) adolescents experienced moderate-to-severe depressive symptoms 
and/or high diabetes distress; among these, 17% (n = 75) reported both diabetes 
distress and depressive symptoms, 19% (n = 87) reported only diabetes distress, 
and 5% (n = 21) only depressive symptoms.  
Compared to the group reporting none-to-minimal diabetes distress or 
depressive symptoms (59%, n = 267), the median self-reported HbA1c was 
significantly higher in the two groups with elevated diabetes distress (7.5%; 58 
mmol/mol vs 8.3%; 67 mmol/mol, P < .001, ‘only diabetes distress’; 8.5%; 69 
mmol/mol, P < .001, ‘both diabetes distress and depressive symptoms’), but not 
the ‘depressive symptoms only’ group (7.6%; 60 mmol/mol, P = .95).  
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Table 5. 1: Participant characteristics (N=450) 
 % (n) Mean ± SD (range) 
Age: years  15.7 ± 1.9 (13-19) 
Gender: male 38 (169)  
Socioeconomic status  
    Low 
    Mid 
    High 
 
19 (83) 
37 (164) 
44 (191) 
 
Diabetes duration: years  6.9 ± 4.3 (0-18) 
SMBG frequency: ≥4 checks / day 78 (349)  
Insulin delivery: pump 53 (240)  
Self-reported HbA1c % 
                                    mmol/mol 
 8.1 ± 1.5 (5.1-15.5) 
65 ± 16 (32-146) 
Depressive symptoms (PHQA-8) 
    None-to-minimal (<5) 
    Mild (5-10) 
    Moderate-to-severe (≥11) 
 
47 (213) 
31 (131) 
21 (96) 
6.6 ± 6.0 (0-24) 
 
Diabetes distress (PAID-T) 
    None-to-minimal (<70) 
    Moderate (70-90) 
    High (>90) 
 
46 (207) 
18 (81) 
36 (162) 
76.8 ± 30.4 (26-156) 
SMBG: self-monitoring of blood glucose 
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In univariate analyses (Table 5.2), there was a strong positive correlation 
between depressive symptoms and diabetes distress. Depressive symptoms 
explained 40% of the variance in diabetes distress (R2 = 0.40). The positive 
correlation between HbA1c and diabetes distress was stronger than that between 
HbA1c and depressive symptoms. HbA1c had a small positive correlation with 
diabetes duration but was not associated with age (Table 5.2). HbA1c was on 
average higher among girls than boys (8.3 ± 1.6%, 67 ± 17 mmol/mol vs 7.9 ± 
1.3%, 62 ± 15 mmol/mol, P = 0.04) and adolescents reporting less frequent 
SMBG (<4/day: 8.9 ± 1.6%, 73 ± 17 mmol/mol; ≥4/day: 7.9 ± 1.4%, 63 ± 15 
mmol/mol, P < .001). HbA1c did not differ according to participants’ SES (P < 
.85) or mode of insulin delivery (P = .32). Both depressive symptoms and 
diabetes distress were positively correlated with age but there was no association 
with diabetes duration (Table 5.2). Adolescents with less frequent SMBG 
reported higher mean depressive symptoms (9.5 ± 7.0 vs 5.8 ± 5.4, P < .001) and 
diabetes distress (89.2 ± 31.4 vs 73.2 ± 29.2, P < .001). 
 
Table 5. 2: Correlations between self-reported HbA1c, demographic and 
psychological outcomes  
 
Age 
Diabetes 
duration 
Depressive   
symptoms 
Diabetes   
distress 
HbA1c % 0.09 0.17
** 0.22** 0.34** 
Age  0.21** 0.28** 0.18** 
Diabetes duration   0.02 0.04 
Depressive symptoms    0.63** 
**P < .001
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Table 5. 3: Hierarchical multiple regression analyses predicting self-reported HbA1c 
 Step 1 Step 2 Step 3 
 b (SE) β t p  b (SE) β t p b (SE) β t p 
Gender: male -.36 (.14) -.12 -2.58 0.01 -.25 (.14) -.08 -1.74   0.083 -.12 (.14) -.04 -0.88 0.378 
Diabetes duration .05 (.02) .14 3.19   0.002 .05 (.02) .15 3.25   0.001 .05 (.02) .14 3.23   0.001 
SMBG  -.91 (.16) -.25 -5.65 <0.001 -.79 (.17) -.22 -4.73 <0.001 -.72 (.16) -.20 -4.44 <0.001 
Depressive 
symptoms 
    .04 (.01) .14 3.0   0.003 -.01 (.01) -.03 -0.60   0.551 
Diabetes distress         .02 (.003) .30 5.36 <0.001 
R2 0.11 0.13 0.18 
F(df1,df2) 17.97 (3, 446) p<0.001 15.96(4, 445) p<0.001 19.31(5, 444) p<0.001 
Abbreviation: SMBG: self-monitoring of blood glucose ≥4 /day; HbA1c entered as % 
b: unstandardised coefficient; β: standardised coefficient 
Diabetes duration, depressive symptoms, diabetes distress entered as continuous variables 
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In the multivariate analysis, diabetes duration and SMBG but not gender, 
remained significantly associated with elevated HbA1c (Table 5.3). In the final 
model, diabetes distress made the strongest independent contribution (P < .001), 
and the contribution of depressive symptoms became non-significant (P = .551). 
The model explained 18% of the variance in HbA1c (R
2 = 0.18, F(5, 444) = 19.31, 
P < .001).  
The interaction between age and diabetes distress explained a small, but 
significant contribution to the variance in HbA1c, (P = .025); (Table 5.4). The 
association between diabetes distress and HbA1c was not moderated by gender (P 
= .17), or depressive symptoms (P = .24). Diabetes distress moderated the 
association between SMBG and HbA1c among adolescents with elevated distress 
(P = .028). The simple slopes of the interaction terms are shown in Figure 5.1. 
Depressive symptomatology was not independently associated with HbA1c, 
therefore this relationship was not explored further.  
  
181  
Table 5. 4: Linear regression models of predictors of self-reported HbA1c 
(moderation analyses) 
 b SE t p  R2 
Model 1      
Age .02 .04 0.65 0.52  
Diabetes distress .02 <.01 7.83 <0.001  
Age x diabetes distress <.01 <.01 2.25 0.025 0.012 
Model 2      
Gender: male -.07 .14 -.50 0.62  
Diabetes distress .02 <.01 7.52 <0.001  
Gender x diabetes distress .01 <.01 1.36 0.17 0.003 
Model 3      
Depressive symptoms -.01 .02 -.34 0.73  
Diabetes distress .02 <.01 6.29 <0.001  
Depressive symptoms x  
diabetes distress 
<.01 <.01 1.18 0.24 0.003 
Model 4      
Diabetes distress .01 <.01 6.89 <0.001  
SMBG -.65 .17 -3.74 <0.001  
Diabetes distress x SMBG -.01 <.01 -2.21 0.028 0.009 
b: unstandardised coefficient 
Continuous variables are mean centred 
Self-reported HbA1c % 
SMBG: self-monitoring of blood glucose ≥4 /day 
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Figure 5. 1: Plots of the interactions between (A) diabetes distress and age, (B) 
diabetes distress and gender, (C) diabetes distress and depressive symptoms, and 
(D) diabetes distress and SMBG, predicting self-reported HbA1c.  
Diabetes distress: centred mean; 0 = mean PAID-T (76.8); data points 0 ± 1 SD 
(30.4); b: unstandardised coefficient; SMBG: self-monitoring of blood glucose 
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(A) The simple slope of the relationship between diabetes distress and HbA1c 
increased with age, but the association was stronger for older (b = .02, P < .001) 
than younger adolescents (b = .01, P < .001). (B) Gender did not moderate the 
relationship between diabetes distress and HbA1c (b = .006, P = .17). (C) The 
interaction between diabetes distress and depressive symptoms did not contribute 
significantly to the variance in HbA1c (b = .0004, P = 0.24). (D) The simple 
slope of the relationship between SMBG frequency and HbA1c was significant 
for those with elevated diabetes distress (mean +1 SD; b = −.98, P = < .001), but 
not for those with low diabetes distress (mean −1 SD; b = −.32, P = .22).  
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5.5 Discussion  
In this novel study examining the inter-relationships between depressive 
symptoms, diabetes distress and HbA1c in adolescents with T1D aged 13 to 19 
years, high diabetes distress was more prevalent than moderate-to-severe 
depressive symptoms (36% vs 21%). While depressive symptoms made an initial 
contribution to the variance in self-reported HbA1c, this was no longer significant 
when diabetes distress was added to the model, corroborating studies among 
adults with T1D.11,12 
In contrast to a study in adults,12 the association between diabetes distress 
and HbA1c did not change in the presence of depressive symptoms, even among 
adolescents with moderate-to-severe depressive symptoms.  After controlling for 
multiple variables, no gender difference remained for self-reported HbA1c. Nor 
did HbA1c differ by mode of insulin delivery, although those using pumps were 
more likely to recall their most recent HbA1c and were therefore, over-represented 
in the current study. Adolescents with longer duration of T1D reported higher 
HbA1c. Diabetes duration was unrelated to age or SMBG, suggesting that the 
difficulties young people experience trying to achieve and maintain optimal blood 
glucose over time may be explained by other metabolic and psychosocial factors. 
Indeed, the model explained only 18% of the variance in HbA1c. A previous 
longitudinal study found that HbA1c remained stable over time for most 
adolescents, whereas HbA1c increased steadily among adolescents experiencing 
emotional distress, peer conflict and who were less engaged in self-care.22 Lack 
of parental support and family conflict about diabetes are consistently associated 
with suboptimal glycemia.23,24 
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As expected, HbA1c was higher among those reporting less frequent 
SMBG,25 which may reflect less attention to self-care overall, or that less frequent 
SMBG provides fewer opportunities to fine-tune diabetes management.  
Furthermore, this association was enhanced as the level of diabetes distress 
increased. While our study was cross-sectional, longitudinal studies indicate that 
individuals who are struggling emotionally with diabetes may be less engaged in 
self-management or more likely to engage in suboptimal behaviors, while those 
who are less attentive to self-care may feel guilty or frustrated with their diabetes 
management.14,26 Furthermore, our previous analyses have demonstrated a 
stronger association between HbA1c and PAID-T items focused on regimen-
related distress than other PAID-T items.18 Thus, addressing self-management 
difficulties, and the psychological distress associated with these, may be more 
likely to improve HbA1c than interventions focused on depressive symptoms or 
diabetes management alone. Avoidant coping style has been found to predict 
diabetes distress among adolescents with T1D, which in turn influenced self-care 
and glycemic control.27 Interventions that focus on the development of self-
management skills, using cognitive-behavioral and empowerment approaches 
have improved both diabetes distress and HbA1c among adults
28 and youth with 
T1D29, although low attendance has limited the reach of such programs in the 
adolescent age group.30,31  
This study provides further evidence of the clinical significance of 
elevated diabetes distress, particularly among older adolescents, who may have 
greater responsibilities, but diminishing self-management support. Emerging 
adults may experience even greater diabetes distress than adolescents,32 thus 
adolescence is an optimal time to intervene, as unresolved problems may continue 
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in adulthood.33 Routine psychological assessment (including depression 
screening) is recommended for all young people with diabetes,34 though such 
recommendations do not currently include assessment of diabetes distress. 
However, focusing on depressive symptoms alone is likely to miss many young 
people experiencing diabetes distress, and may lead to inappropriate or 
ineffective intervention. Indeed, elevated diabetes distress was more common 
than depressive symptoms.  The high correlation and shared variance between 
depressive symptoms and diabetes distress indicates that there is a considerable 
overlap of these constructs among adolescents with T1D, and depressive 
symptom measures are most likely to be revealing diabetes-related stressors.11 
Our findings suggest that most adolescents with elevated depressive symptoms 
are also experiencing diabetes distress, which in many cases can likely be 
addressed by their diabetes health professionals. Age-appropriate measures are 
freely available and can be used in routine clinical practice to characterize 
specific sources of distress. Having a conversation about diabetes and emotional 
wellbeing can identify the areas where additional support is needed and may have 
psychosocial benefits.35 Offering support for self-management and developing 
coping skills, may have benefits in terms of both psychological well-being and 
diabetes management.29  
5.5.1 Strengths and limitations 
A strength of this study is that it is the first to examine the inter-
relationships between general and diabetes-specific emotional distress in 
adolescents. Other strengths are the large national sample, and the use of age-
specific measures. Over one-third (36%) of adolescents in this study experienced 
high levels of diabetes distress. The mean PAID-T is consistent with a closely 
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matched age group in a US study (77 ± 30 vs 73 ± 27 respectively).27 The rate of 
elevated depressive symptoms reported here is similar to age-matched (13-18 
years) clinic-based studies in youth with T1D (20%-23%), assessed with the 
Children’s Depression Inventory.4,36 Further comparison with the findings of 
other adolescent T1D studies is constrained by a lack of consistency in age 
groups and the use of measures and cut points. Moderate-to-severe depressive 
symptoms were 3-times more prevalent in our study than reported in a general 
adolescent population sample (aged 13-17 years) in the US (7%).37 
There are limitations to be acknowledged. Diabetes MILES Youth 
participants were self-selected and the overall response rate was low, although 
consistent with a previous study using similar methods in this population.38 Girls 
and young people from higher socioeconomic backgrounds were over-
represented,19 however these factors were unrelated to the study outcomes. 
Importantly, both HbA1c and SMBG were self-reported, thus they are potentially 
subject to recall and social-desirability bias, and almost one-third of respondents 
did not report their most recent HbA1c. Those using injections and with a more 
recent diagnosis of T1D were less likely to report HbA1c, thus they were under-
represented in the current study. The mean self-reported HbA1c was only slightly 
lower than clinic-recorded results in a recent Australian study (8.1% vs 8.3%) ,39 
and the strength of the association with diabetes distress was similar to other 
adolescent studies.16 The reliability of self-reported SMBG has been found to be 
satisfactory when compared with meter download.40 Another limitation is our use 
of an internet-based rather than a clinic-based study. Adolescents responding to 
internet surveys have previously been found to report more severe depressive 
symptoms than respondents to conventional surveys, for example recruited via 
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the school or clinic.41 Thus, the confidential nature of an internet-based survey 
may attract young people who are experiencing psychological distress, and over-
represent those who are depressed.41 However, others have reported lower 
prevalence of mental health problems among respondents to a web-based survey 
due to selection bias towards socially-advantaged families.42 Finally, an important 
limitation is that the data are cross-sectional.  
Clinical and psychological factors associated with HbA1c have been 
reported extensively among adolescents with T1D, but the relationship with 
diabetes distress had not been comprehensively investigated. In this study, we 
used self-reported HbA1c and SMBG, and it would be useful to replicate our 
study using clinical data and in a representative, unselected clinic sample, ideally 
using a diagnostic interview for depression to minimize confounding with 
diabetes distress, and to explore these relationships longitudinally. In summary, 
this study found that diabetes distress mediated the relationship between 
depressive symptoms and HbA1c. It corroborates the findings of previous adult 
studies, suggesting the importance of paying attention to diabetes distress among 
adolescents with T1D.  
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6.1 Abstract 
Introduction: The purpose of this study is to examine i) changes in diabetes 
distress among adolescents after participation in structured type 1 diabetes 
(T1DM) education delivered in routine care, and ii) psychological and clinical 
factors associated with diabetes distress at baseline and follow-up.  
Methods: Comparative pre-post design. Study setting: 11 pediatric diabetes 
centres in Australia. Adolescents aged 13-19 years (N = 207) completed a 5-day 
psycho-educational program (TEAM T1), which teaches participants the skills 
needed for flexible, intensive insulin therapy, and positive coping with diabetes. 
Most participants (57%) were female, mean age 15.9 years, and 11% used an 
insulin pump. Study measures included the Problem Areas in Diabetes Teen 
version (PAID-T), Diabetes Management Self-Efficacy scale, and two-items 
measuring Diabetes-Related Family Conflict. Clinical data were collected from 
medical records. Associations with diabetes distress (PAID-T) and change in 
outcomes following TEAM T1 were assessed at baseline, 3 and 12 months post-
program.  
Results: In total, 155 adolescents completed baseline questionnaires. One-third 
reported moderate-to-high diabetes distress at baseline. Diabetes distress 
decreased among adolescents with elevated baseline distress. Diabetes-specific 
self-efficacy improved at 3 months, but family conflict and AIC did not change. 
At baseline, diabetes distress was associated independently with female gender, 
A1C, and diabetes-specific self-efficacy and family conflict; while at 12 months, 
it was associated only with diabetes-specific self-efficacy.  
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Conclusions: Consistent with previous studies, elevated diabetes distress is 
prevalent among adolescents with T1DM, and is associated with various diabetes 
management outcomes. Self-efficacy increased after structured T1DM education, 
and this was associated with lower diabetes distress.  
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6.2 Introduction 
Despite advances in diabetes management, most adolescents with type 1 
diabetes (T1DM) do not have optimal glycaemia.1 Intensive diabetes management 
is necessary for long-term health,2 but unsurprisingly it is difficult to achieve and 
maintain in practice. In their quest to support young people with T1DM to 
achieve optimal diabetes management and quality of life, health professionals are 
increasingly paying attention to psychosocial factors. Around one-third of 
adolescents experience high levels of diabetes distress and this is associated with 
suboptimal diabetes management and self-care.3, 4 Diabetes distress (DD) refers to 
the negative emotional burden of living with diabetes.5 Specific sources of DD 
for adolescents include concerns about body weight, being ‘off track’ with 
diabetes management, and disagreements with parents about self-management 
responsibilities.6 
A review of the adolescent T1DM literature identified modifiable 
predictors of DD.4 These include negative perceptions about diabetes outcomes, 
low diabetes-related self-efficacy,7, 8 family conflict about diabetes management7 
and lack of parental support.6, 9 The review also concluded that psycho-
educational interventions focusing on self-management, as well as coping skills 
(e.g. cognitive restructuring, goal setting and problem-solving), demonstrated 
short-term reductions in DD10-12 and self-efficacy.10 Two recent studies showed 
that adolescents with elevated DD use more avoidant coping13, 14  and less 
problem-solving and positive thinking14 for managing diabetes-related stressors. 
This pattern of high DD and emotion-focused coping styles predicted future 
depressive symptoms,14 less attention to self-care and elevated A1C.13  In 
contrast, adolescents who are confident and have positive expectations regarding 
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their diabetes,15 and whose parents remain involved and supportive, have better 
diabetes management than those with too much responsibility or experiencing 
diabetes-related family conflict.16 Family-focussed interventions have 
successfully demonstrated continued parental support, reduced conflict and 
helped to sustain self-care among adolescents.17, 18 Without effective self-
management skills, young people may not have the capacity to manage an 
intensive insulin regimen (i.e. multiple daily injections (MDI)) and achieve 
optimal A1C, leading to negative expectations, frustrations and ‘giving up’. 
Interventions are needed that will engage adolescents in self-management and 
help them acquire the skills (e.g. self-care, coping) and self-efficacy to overcome 
the barriers to integrating intensive diabetes management into their lifestyles.15, 19 
The strongest evidence to date is for structured T1DM education that promotes 
self-efficacy and family involvement and is integrated into routine care.20 
Structured T1DM education has been available for adults in most 
states/territories of Australia since 2005, in the form of the Dose Adjustment for 
Normal Eating (DAFNE) program.21, 22 However, age-appropriate programs were 
not available for adolescents with T1DM. Improvements in DD and A1C were 
observed in adults attending DAFNE,21 thus, it was plausible that DAFNE may 
also benefit adolescents. Although programs for adolescents were in development 
in the UK,23, 24 these were still in the trial phase and would have required 
substantial adaptation in terms of food and terminology, whereas DAFNE had 
already been modified for Australians.21 Therefore, we undertook a rigorous 
adaptation of DAFNE to make it suitable for adolescents. The Teens Empowered 
to Actively Manage Type 1 diabetes (TEAM T1) program was designed to 
incorporate evidence-informed strategies (i.e. coping skills, problem-solving and 
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goal setting) to enhance adolescents’ self-management skills and self-efficacy, 
with the aim of improving diabetes management and emotional wellbeing. It was 
expected that reduction in DD would be associated with lower A1C.25 A parallel 
parent program was designed to promote positive autonomy support and reduce 
diabetes-related family conflict. Thus, the aims of this study were to examine 
among adolescent TEAM T1 participants: i) demographic, clinical and 
psychological factors associated with DD at baseline; ii) changes in diabetes 
distress, A1C and psychosocial variables from baseline to follow-up; iii) factors 
associated with change in diabetes distress at follow-up. 
6.3 Methods 
6.3.1 Research design 
A comparative pre-post design was used in order to maximise 
recruitment and evaluate outcomes in real-world conditions. Ethics approval was 
provided by Deakin University (2013-246) and each of the participating 
hospitals’ research ethics committees. 
6.3.1.1 TEAM T1 curriculum development and facilitator training 
A multidisciplinary expert advisory group (including diabetes nurse 
educators, dietitians, paediatric endocrinologist, educational, clinical and health 
psychologists, an adolescent with T1DM and their parent) advised the project 
team and provided feedback on curriculum content, clinical protocols and age-
appropriate learning resources. The TEAM T1 curriculum was developed in three 
phases, including: literature review and stakeholder consultation; pilot testing 
with 19 adolescents aged 14-19 years and 22 parents, demonstrating feasibility, 
acceptability and short-term improvements in A1C, diabetes management self-
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efficacy and DD 26; and substantial revision of the curriculum and learning 
resources based on pilot and advisory group feedback. The program goals, 
learning strategies and underlying theoretical models are shown in Table 6.1. 
Facilitator training involved observing a full program and attending a 2-day 
workshop. 
6.3.1.2 TEAM T1 program delivery  
Two TEAM T1-trained facilitators (a diabetes nurse educator and 
dietitian) delivered each program over five consecutive weekdays to a group of 6-
8 participants. Venues included hospital meeting rooms, church halls and school 
classrooms. Participants utilised a program-specific workbook, carbohydrate-
counting booklet and blood glucose diary. The 2-day parent program was held in 
a separate room at the same venue.  
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Table 6. 1: TEAM T1 goals, learning strategies, key topics, and underlying 
theoretical construct 
Behaviour-
change theory 
Program 
goals 
     Learning strategies / topics 
Social Cognitive 
Theory: 27 
personal 
experience, social 
persuasion, role-
modelling, 
problem-solving,  
goal setting, 
mastery 
Improved 
self-care 
knowledge 
and skills 
 
 
 
 
 
Goal setting 
- Blood glucose monitoring and targets 
- Carbohydrate counting practice 
(meals, snacks, eating out at a local 
cafe) 
- Dose estimation (using ratios and 
correction doses) 
- Exercise scenarios and activity 
- Sick-day management scenarios 
- Hypoglycaemia treatment practice 
- Goal setting  
Mastery and 
self-efficacy 
- Dose adjustment practice and 
feedback over 5 days 
- Trial and experimentation in a 
supportive environment 
- Group discussion and ‘hands-on’ 
activities 
- Normalising experiences 
Social support 
/ peer support 
- Small groups: 6-8 participants 
- Group discussions 
- Excursion (e.g. indoor rock climbing 
or ‘Laserforce’) and meal breaks 
- Normalising experiences 
Self-Regulation 
Model: 28 
Illness 
representations 
and outcome 
expectancies 
Reduced 
diabetes 
distress  
 
Enhanced 
coping skills 
- Positive, non-judgemental language  
- Daily discussion of individual blood 
glucose diary and dose adjustment 
practice and problem-solving 
- Group discussion of scenarios 
(parties, alcohol, peers, school)  
- Social problem-solving, stress 
management  
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6.3.2 Participants 
Adolescents were eligible for TEAM T1 if they met the following 
criteria: attended one of the participating hospitals for diabetes care; aged 13 to 
19 inclusive; T1DM (>1 month duration); using (or willing to use) MDI (i.e. 3 
insulin injections per day); and were proficient in English. Although adolescents 
using an insulin pump were not the primary target group, they were not excluded. 
Adolescents were precluded from attending if they had a diagnosed learning 
disability or major social or behavioural problem that could not be accommodated 
in the group setting, or an exacerbation of a diagnosed mental health condition 
(e.g. severe anxiety, depression, psychosis). Attendance of at least one parent at 
the parent program was strongly recommended but not compulsory. As TEAM 
T1 was delivered as a ‘real-world’ program, adolescents and parents were 
permitted to attend a TEAM T1 program without taking part in the evaluation 
study. 
6.3.3 Procedure 
TEAM T1 facilitators were responsible for participant recruitment and 
obtaining consent and clinical data for the evaluation study. Potential participants 
were identified during clinics or through clinical records. The program was 
advertised on noticeboards, in newsletters and the TEAM T1 website. Participants 
were eligible for the evaluation study if they returned a signed consent form (co-
signed by a parent if aged under 18 years) and attended at least one day of the 5-
day program. Adolescents were asked to complete questionnaires (online) pre-
program, and three and 12 months post-program and A1C was collected at clinic 
visits. If not completed online, facilitators provided a hard copy on the first day of 
the program and at clinic appointments for follow-up. In addition, the study 
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coordinators mailed a hard-copy questionnaire and reply-paid envelope to 
participants whose completed follow-up questionnaires were more than three 
months overdue.  
6.3.4 Measures 
Demographic information, including age, age at diabetes onset, postcode 
to estimate socioeconomic status (SES) 29 and A1C were obtained from the 
adolescents’ medical records. Adolescents completed the following measures: 
The 26-item Problem Areas in Diabetes-Teen version (PAID-T) is an adolescent-
specific measure of diabetes-related concerns. 6 Items are rated on a scale of 1 
(not a problem) to 6 (a serious problem). Higher total scores indicate greater DD 
(range 26–156; 70-90 moderate and >90 high DD).3 Cronbach’s alpha (0.95) 
indicated very high reliability in this sample. The 26-item adolescent-specific 
Diabetes Management Self-Efficacy Scale (DMSE) assesses confidence in self-
management of T1DM, for example adjusting insulin, self-monitoring of blood 
glucose (SMBG), dealing with hypo- and hypoglycaemia and self-care in social 
situations. 30 Items are rated on a scale of 1 (definitely not) to 5 (yes, definitely). 
Higher mean scores indicate greater self-efficacy (range 1–5); (α = 0.90). The 
mean of two items from the MIND-Youth Questionnaire (MYQ) 31 assessed 
perceived diabetes-related family conflict (DRFC). Items are rated on a scale of 1 
(all the time) to 5 (never) for arguing with parents about: i) ‘remembering to 
check blood glucose or give insulin’; and ii) ‘meals and snacks’. Higher mean 
scores represent less conflict (range 1-5). Reliability was acceptable (α = 0.78). 
Participants self-reported their average daily SMBG frequency over the past two 
weeks. This variable was dichotomised for statistical analysis around the 
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recommendation of SMBG at least four times per day (SMBG <4 vs ≥4 /day) due 
to a positively skewed distribution.  
6.3.5 Statistical analysis 
To include as many responses as possible, data were included within the 
following ranges: Time 0 (Baseline: –3 to 0 months pre-program), Time 1 (2–6 
months post-program), Time 2 (6–18 months). If less than 20% of item scores 
were missing on the PAID-T or diabetes management self-efficacy, the mean of 
all items was imputed. For all other variables, missing data were not replaced. 
Data were analysed using IBM SPSS (Statistical Package for the Social Sciences) 
for Windows version 24 (NY, USA).  Bivariate analyses were performed using 2 
tests or McNemar’s test for categorical variables and Spearman Rank correlation 
for continuous variables as appropriate for the data. The variance in baseline DD 
was examined using multiple linear regression; variables showing a significant 
bivariate correlation were included in a single step. Differences in mean / median 
scores were assessed using Student’s t-tests, Wilcoxon signed rank or Mann-
Whitney U tests as appropriate for the data. Psychological variables were 
available at all three time points for only 37 participants, therefore paired tests 
were used to compare change from baseline to Time 1 and baseline to Time 2. 
Linear mixed-effects regression was used to estimate the effects of diabetes 
management self-efficacy, diabetes related family conflict and A1C on DD at 
Time 1 and Time 2.  Restricted maximum likelihood estimation was used to 
estimate the mean difference in DD for each explanatory variable, adjusted for 
baseline DD. Model checks and goodness of fit were tested. This procedure was 
performed with Stata software (version 15.0; Stata Corp LP, Texas, USA). Data 
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are reported as percentages and counts and mean ± SD or median (IQR) as 
appropriate.  Results were considered significant at p < 0.05. 
6.4 Results 
6.4.1 TEAM T1 program delivery and attendance 
Between 2013 and 2016, 11 paediatric diabetes centres (regional and 
metropolitan hospitals) in five states/territories delivered a total of 38 adolescent 
and 36 parent programs (range 1-7 programs per centre) (see Appendix J: 
Supplementary Table 1). On average, six participants (range 2-10) attended each 
course. In total, 207 adolescents participated in TEAM T1; 86% (n = 179) 
attended the full program, 8% (n = 16) missed one day and 6% (n = 13) missed 
two or more days. For most adolescents (82%, n = 170), at least one parent 
attended the parallel parent program, 86% (n = 178) of whom were mothers. 
Eighty-six percent (n = 178) of adolescent TEAM T1 participants consented to 
the evaluation study. 
6.4.2 Participant characteristics 
Of the 178 adolescents consenting to the evaluation study, 155 (87%) 
completed all relevant study questionnaires. A minority of participants (n = 23) 
were excluded from the analysis because they had missing baseline data (PAID-
T, n = 14; DRFC, n = 12; DMSE, n = 23). Among the final sample, SMBG was 
missing for three participants and A1C was unavailable at baseline (n = 8); Time 
1 (n = 59) and Time 2 (n = 71) because the adolescent did not attend clinic during 
the relevant timepoints, or the data were not obtained from the medical records. 
The baseline characteristics of the final sample are detailed in Table 6.2. 
They had a mean age 15.9 ± 1.4 years; 57% (n = 88) were female, and 30% (n = 
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47) had high SES. Their mean T1DM duration was 5.9 ± 4.4 years, 11% (n = 16) 
used an insulin pump and 79% (n = 116) performed SMBG at least four times per 
day. Their mean A1C was 8.9 ± 2.0% (74 ± 22 mmol/mol); 76% (n = 111) had 
A1C ≥7.5% (≥58 mmol/mol). Moderate or high DD was reported by 13% (n = 
20; PAID-T 70-90) and 23% (n = 36; PAID-T >90) respectively (mean 71.8 ± 
24.7). Overall diabetes management self-efficacy was high (mean 4.2 ± 0.5). 
Around one quarter of adolescents reported arguing ‘often or all the time’ with 
parents about ‘remembering to check blood glucose or give insulin’ (27% (n = 
42); and ‘meals and snacks’ (25%, n = 38) (mean diabetes related family conflict 
3.2 ± 1.1).  
Follow-up data were available at Time 1: questionnaires (n = 77, 50%), 
A1C (n = 93, 60%), and Time 2: questionnaires (n = 63, 41%), and A1C (n = 81, 
52%). The only difference between Time 1 respondents and non-respondents was 
shorter diabetes duration (4.9 ± 4.4 vs 6.6 ± 4.2, p = 0.02). Adolescents with A1C 
available at Time 1 had higher baseline A1C (9.3 ± 4.2% vs 8.3 ± 4.2%, p < 0.01) 
and were less likely to come from a high SES background (24% vs 40%, p = 
0.03). There were no baseline differences between respondents to Time 2 
questionnaires and those lost to follow-up, or among those with Time 2 A1C 
results compared to those without.  
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Table 6. 2: Participant characteristics at baseline 
Adolescents N % (n) Mean ± SD 
Median 
(IQR) 
Age (years) 
     >15 years 
154  
53 (82) 
15.9 ± 1.4 15.8  
(14.9-17.0) 
Gender (female) 155 57 (88)   
Lives with both parents 152 76 (116)   
Parent(s) attended TEAM T1  87 (135)   
Socioeconomic status (IRSAD) 
       Low (1-3) 
       Moderate (4-7) 
       High (8-10) 
155 
 
 
 
24 (37)  
46 (71) 
30 (47) 
 
 
 
Diabetes duration 142  5.9 ± 4.4  5.7 (2.0-8.9) 
Insulin delivery: pump  11 (16)   
A1C mmol/mol 
             % 
147  74 ± 22  
8.9 ± 2.0 
68 (58-85) 
8.4 (7.5-9.9) 
Self-monitoring of blood 
glucose ≥4/day 
152 76 (116)   
Diabetes distress (PAID-T) 155  71.8 ± 24.7 69.0  
(52.0-88.0) 
Diabetes management self-
efficacy (DMSE) 
155  4.2 ± 0.5 4.3 (3.9-4.6) 
Diabetes-related family conflict 
(DRFC) 
155  3.2 ± 1.1 3.5 (2.5-4.0) 
IRSAD: Index of relative socioeconomic advantage and disadvantage 
PAID-T: higher scores indicate greater diabetes distress (range 26-156; >90 high) 
DMSE: higher scores indicate better diabetes-specific self-efficacy (range 1-5) 
DRFC: higher scores indicate less diabetes-related family conflict (range 1-5) 
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6.4.3 Demographic, clinical and psychological factors associated with 
diabetes distress 
At baseline, DD correlated positively with age and A1C, and negatively 
with diabetes management self-efficacy and diabetes related family conflict 
(Table 6.3).  Females reported greater DD than males (mean PAID-T: 75.8 ± 26.4 
vs 66.6 ± 21.3, p = 0.018); there were no other gender differences at baseline. 
Adolescents who performed SMBG less frequently (<4/day) reported higher DD 
(80.1 ± 27.3 vs 69.4 ± 23.3, p = 0.02). After adjusting for multiple variables, 
female gender, A1C, diabetes management self-efficacy and diabetes related 
family conflict were independently associated with baseline DD (Table 6.4). The 
model explained 44% of the variance in DD (R2 = 0.44; F(6, 137) = 17.96 p < 
0.001).  
 
Table 6. 3: Correlations among baseline demographic, clinical and psychological 
variables  
 
1 2 3 4 5 
1. Age      
2. Duration of diabetes  .23**     
3. A1C   .10  .23**    
4. Diabetes distress  .24**  .07  .33**   
5. Diabetes management self-
efficacy 
−.22** -.06 −.24** −.42**  
6. Diabetes-related family   
conflict 
−.13  .03 −.21* −.51**  .19* 
*p < 0.05; **p < 0.01 
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Table 6. 4: Multiple regression analysis predicting diabetes distress at baseline 
(N = 144) 
 
b SE β t p 
Age 1.62 1.18 .01 1.38 0.17 
Gender: female 9.58 3.14 .20 3.06 0.003 
SMBG: ≥4/day −2.23 3.77 −.04 −.59 0.56 
A1C: mmol/mol .20 .07 .19 2.76 0.007 
Diabetes management self-
efficacy (DMSE) 
−14.09 3.32 −.29 −4.25 < .001 
Diabetes-related family conflict 
(DRFC) 
−8.18 1.44 −.38 −5.67 < .001 
R2 0.44 
F(df1, df2) 17.96 (6, 137) p < 0.001 
B unstandardized coefficient; β: standardised coefficient 
SMBG: self-monitoring of blood glucose  
DRFC: higher scores indicate less family conflict (range 1-5) 
DMSE: higher scores indicate better diabetes management self-efficacy (range 1-5) 
Independent variables are all baseline values 
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6.4.4 Change in diabetes distress, A1C and psychosocial variables 
after TEAM T1 
Adolescents’ diabetes distress, diabetes-related family conflict and A1C 
did not change significantly following attendance at TEAM T1 (all p > 0.05) (see 
Appendix J: Supplementary Table 2), although those with moderate-to-high 
baseline DD had a significant decrease in mean DD at Time 1 (−9.9 ± 18.9, p = 
0.008, Cohen’s d = 0.55) but not at Time 2 (−5.5 ± 23.8, p = 0.29). There was a 
small increase in mean diabetes management self-efficacy at Time 1 (+0.1, p < 
0.01, Cohen’s d = 0.2). The proportion of adolescents who performed SMBG 
≥4/day did not change (t = 0.0, df = 1, p = 1.0). None of these outcomes differed 
by gender or age (all p > 0.1). Item-level analysis of the PAID-T at Time 1 
showed that four areas of DD had the greatest mean reduction at Time 1 (≥0.3 
points): ‘worrying about weight’ (−0.41, p < 0.01); ‘feeling that my friends and 
family act like diabetes police’ (−0.34, p = 0.09); ‘feeling unclear about exactly 
what and how much I should be doing to take care of my diabetes properly’        
(−0.30, p = 0.02); and ‘feeling like my parents worry about complications too 
much’ (−0.30, p = 0.06). No other items changed significantly.  
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Table 6. 5: Results from a linear mixed-effects regression model exploring factors associated with diabetes distress at Time 1 and Time 2 
 Mean difference in diabetes distress score at  
Time 1 
Mean difference in diabetes distress score at  
Time 2  
 N b (95% CI) SE p N b (95% CI) SE p 
Diabetes management self-efficacy (DMSE) 44 −5.4 (−18.8, 8.1) 6.9 0.43 38 -13.8 (−26.0, −1.6) 6.2 0.03 
Diabetes-related family conflict (DRFC) 44 −4.0 (−10.1, 2.0) 3.1 0.19 38 −1.3 (−7.2, 4.6) 3.0 0.66 
A1C mmol/mol 44 .2 (−.1, 0.4) .14 0.28 38 −.3 (−.6, 0.1) .20 0.20 
Estimates from a linear mixed-effects model using restricted maximum likelihood estimation and an unstructured correlation structure. 
Data are unstandardized coefficient (95% CI) 
PAID-T: higher scores indicate greater diabetes distress (range 26-156) 
DRFC: higher scores indicate less family conflict (range 1-5) 
DMSE: higher scores indicate better diabetes management self-efficacy (range 1-5) 
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6.4.5 Factors associated with change in diabetes distress at follow-up 
The only significant predictor of DD at follow-up was diabetes 
management self-efficacy at Time 2 (Table 6.5).  For each 1 unit increase in self-
efficacy, PAID-T decreased by 13.8 points (95% CI −26.0, −1.6), which was 
statistically significant. 
6.5 Discussion 
TEAM T1 is the first age-appropriate, structured T1DM education 
program to be implemented across Australia, reaching young people with high 
levels of DD and suboptimal A1C. Following TEAM T1, DD, diabetes-related 
family conflict and A1C did not change, although there was a small increase in 
diabetes management self-efficacy. Diabetes-related family conflict and self-
efficacy were the strongest independent predictors of baseline DD.  
One in four (23%) TEAM T1 participants experienced high levels of DD 
at baseline; lower than reported in the Diabetes MILES Youth Australia (MILES 
Youth) study (36%).3 A reasonable explanation of this discrepancy is that young 
people who were willing to attend the 5-day TEAM T1 program were less 
distressed about their diabetes than adolescents who self-selected for an online 
survey of psychological wellbeing. Although the two samples differ on other 
characteristics (i.e. insulin delivery mode, SES), neither of these were related to 
DD. Overall, 44% of the variance in DD was explained by gender, A1C, diabetes 
management self-efficacy and perceived diabetes-related family conflict. We 
have previously demonstrated that elevated DD is associated with self-reported 
A1C in adolescents,3 and this study corroborates that finding using clinic-
recorded A1C. In the current study, females experienced greater DD than males.  
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High DD has been reported among girls who wished their parents were 
more involved in their diabetes management, but this association did not apply to 
boys.9 Another study showed that psychosocial maturity, and not age, moderated 
the relationship between DD and parents’ perception of their child’s self-care 
mastery.32 Thus, parents may perceive that their daughters are more mature or 
confident, so are less involved in their diabetes management than boys. Diabetes-
related family conflict was the strongest independent predictor of DD for 
adolescents at baseline. This has previously been associated with suboptimal A1C 
and elevated depressive symptoms among youth with T1DM,33 whereas children 
of families with low levels of conflict may be more resilient to the effects of 
negative life stressors.34 Adolescents with greater self-efficacy appear to be 
protected from the detrimental effect of family conflict on diabetes 
management.35  
Although there was no overall change in DD following TEAM T1, DD 
improved among those with elevated DD. Further, mean item scores reduced in 
the specific problem areas targeted by the program content, with positive impact 
on family relationships and body weight concerns. The program promoted 
flexibility with food and eating, and strategies to prevent and treat hypoglycaemia 
precisely, thus reducing the need to eat when not hungry and avoiding over-
treatment of hypoglycaemia, which can lead to weight gain. Importantly, the 
increased emphasis on monitoring food and blood glucose did not worsen DD. In 
contrast to the focus on dietary restriction in diabetes management (which is a 
risk factor for disordered eating), the TEAM T1 approach may strengthen 
adolescents’ confidence that they can manage their diabetes without feeling 
deprived of food they enjoy. 36 Young adults have previously reported ‘hitting the 
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wall’ after an intensive self-management course,37 and enhancing parental support 
may have helped to avoid ‘burnout’.  
A small improvement in diabetes management self-efficacy was observed 
following TEAM T1, despite high baseline scores. Participants may report 
confidence in their skills before an educational intervention because they are 
unaware of what they do not know.38 Diabetes management self-efficacy was 
associated with lower DD at Time 2, but there was no evidence that increased 
self-efficacy predicted lower DD prospectively. In contrast, self-efficacy declined 
following a similar intervention in the UK (KICk-OFF).39 A greater proportion of 
parents attended TEAM T1 than KICk-OFF (82% vs 40%), and parental support 
may have promoted greater self-efficacy.  
Adolescents’ A1C did not change, which is consistent with other recent 
studies of structured T1DM education among adolescents,39-41 whereas 
comparable interventions in adults have improved DD and A1C.42, 43 It could be 
that physiological aspects, for example insulin resistance,44 attenuate the 
glycaemic response to intensified management in adolescents, or that a five-day 
intervention was not sufficient to sustain behaviour change. Participants were 
compelled to attend to their diabetes during TEAM T1, but on returning to school 
they may have resumed their previous self-management habits when confronted 
with barriers (e.g. not having ready access to meters and insulin pens, or 
perceived negative reactions of peers).45 We did not include a measure of 
carbohydrate counting and insulin dosing because of the lack of suitable brief 
measures, so we do not know whether behaviours observed during the program 
were maintained. Ongoing support is required to sustain behaviour change,46 but 
the type and frequency of follow-up with facilitators was not standardised or 
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documented consistently. Nonetheless, participation in interventions such as 
TEAM T1 may prevent deterioration in A1C during the adolescent years. 47 For 
example, A1C had increased after two years in the KICk-OFF study control 
group, whereas among intervention group participants with sub-optimal baseline 
glycaemia, A1C did not deteriorate.39 Frequency of SMBG did not increase after 
TEAM T1, but a dichotomous measure may not have been sufficiently sensitive 
to change. Diabetes-related family conflict also did not change. Measuring 
parental responses to perceived family conflict may have been appropriate given 
this topic was only presented to parents. Although females reported higher levels 
of DD than males, they did not experience any greater or lesser benefit from 
TEAM T1. Further research exploring gender differences in DD could inform the 
development of tailored interventions.  
6.5.1 Study strengths and limitations 
The strengths of this evaluation study include real-world implementation 
with a ‘typical’ group of adolescents. Interventions are often developed in 
isolation from the real-world contexts in which they will be delivered, whereas 
TEAM T1 was integrated into clinical care. TEAM T1 was developed from an 
evidence-based program for adults through consultation and collaboration with 
key stakeholders, which ensured that the curriculum reflected current best-
practice. Adolescents who use an insulin pump receive education for flexible, 
intensive insulin therapy, whereas those using MDI may not routinely have access 
to carbohydrate counting and dose adjustment education, and are unlikely to have 
the skills needed to optimise their diabetes management. However, difficulty 
engaging young people and their families is one of the barriers to implementing 
structured education for this age group 48 and some centres were more successful 
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with recruitment and retention than others. Most (95%) of the planned programs 
were run, and 86% of TEAM T1 participants attended the full program. In 
contrast, others have reported low attendance at weekly sessions,10,49 suggesting 
that delivering a program in a single ‘block’ may lead to better engagement than 
sessions dispersed over several weeks. 
There are several limitations to this study, most notably the absence of a 
control group. A randomised controlled trial (RCT) would have provided the best 
evidence of program effectiveness. However, given the funding model, with 
targets to implement and recruit nationally, a pragmatic, quasi-experimental (pre-
post) design was considered appropriate. Furthermore, others have found that 
RCT conditions impact negatively on participant recruitment and program 
scheduling.39,41 Another key limitation is the high loss to follow-up, despite 
multiple reminders. The use of incentives and personalised communication from 
the local healthcare team could possibly have enhanced retention, although such 
difficulties are not unique to this study.10,48,50 Anecdotal feedback from 
facilitators indicated that parent engagement was a critical factor for successful 
recruitment and is likely to have influenced the return rate of study 
questionnaires. In future, greater attention ought to be paid to parents’ attitudes 
to, and beliefs about structured education in order to maximise recruitment and 
retention. Those lost to follow-up had longer duration of diabetes, but otherwise 
they were no different to adolescents who completed questionnaires. Diabetes 
duration was unrelated to DD so the findings are likely to be generalisable. 
Young people from socioeconomically advantaged backgrounds and with lower 
A1C were less likely to have follow-up A1C results, most likely because those 
with optimal management need to attend clinic less frequently. Clinical data were 
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collected during routine care; thus some A1C checks were outside the acceptable 
data time-points. A1C was not collected at the same time as self-reported data, 
nevertheless the relationships among variables are consistent with previous 
evidence.4 The use of online questionnaires was less successful than expected. 
Some families lacked internet access or individual email addresses for creating 
database identities. Objective measures of self-care, (e.g. SMBG meter 
download) would have been useful to assess frequency of SMBG and glucose 
variability, and would be more reliable than self-reported data, which may be 
influenced by self-report / social-desirability bias. Nevertheless, previous studies 
have found self-reported SMBG and meter downloads correlate strongly.51 We 
had intended to download SMBG results from the participants’ meters, but this 
was not feasible for facilitators to do while preparing for the program. The 
facilitators were not experienced with formal evaluation or research, so better 
training and local study support may have improved data quality. 
6.6 Conclusion 
TEAM T1 is a rigorously developed structured education program 
specifically for Australian adolescents with T1DM. While programs were well 
attended, participant retention at follow-up timepoints compromised data 
collection. The study corroborates findings from previous studies that diabetes 
management self-efficacy and family conflict independently predict (baseline) 
DD, and elevated DD is associated with suboptimal A1C. Although overall 
diabetes distress, diabetes related family conflict and A1C did not change 
following TEAM T1, diabetes management self-efficacy increased marginally, 
and was associated with lower DD at 12 months follow-up. Clinical outcomes 
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were consistent with outcomes of RCTs evaluating T1DM education in this age 
group.  
6.6.1 Implications/relevance for diabetes educators 
Structured education to teach the skills of flexible insulin therapy is feasible and 
acceptable to adolescents and their parents, although considerable effort is 
required to engage and retain participants. This study provides further evidence of 
the high prevalence of DD among adolescents, and the association of diabetes 
distress with diabetes management outcomes (A1C). 
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Chapter 7: Discussion 
The overall aim of this PhD thesis was to undertake a program of research 
to investigate diabetes distress (DD) among adolescents with type 1 diabetes 
(T1D), with four objectives: i) to assess the prevalence of clinically meaningful 
DD, ii) to investigate the demographic, psychosocial and clinical characteristics 
associated with elevated DD, iii) to examine the interrelationship between DD, 
depressive symptoms, and HbA1c, and iv) to investigate change in DD following 
structured T1D education. 
This chapter comprises four sections. The first summarises key findings in 
relation to these four objectives, and discusses the original contribution of this 
program of PhD research to existing knowledge. The second section discusses 
strengths and limitations of the thesis.  Section three examines lessons learned 
and section four discusses the study implications for clinical practice and future 
research, for example, in regard to measurement and assessment of DD and 
interventions to reduce DD. Section five provides a brief conclusion.  
7.1 Overview of Key Findings and Contribution to Current Knowledge 
Although there is a large body of evidence demonstrating the prevalence 
and clinical significance of depression and anxiety among adolescents with T1D 
(Dantzer, Swendsen, Maurice-Tison, & Salamon, 2003; Subasinghe et al., 2015), 
few studies had previously examined DD among adolescents. For the first time, 
the prevalence of elevated DD among adolescents was reported using clinically-
validated cut points. Using these cut points established in the Diabetes MILES 
Youth Study sample, Chapters 4 and 6 reported that high DD was experienced by 
23% to 36% of adolescents aged 13 to 19 years. Chapter 5 and 6 demonstrated a 
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consistent association between DD and glycaemic management (HbA1c). 
Furthermore, Chapter 5 reported that depressive symptoms were not 
independently associated with HbA1c because this relationship was mediated by 
DD. Chapter 6 reported an increase in diabetes management self-efficacy after 
structured T1D education (Teens Empowered to Actively Manage Type 1 
Diabetes (TEAM T1), but no significant improvement in DD, diabetes 
management (HbA1c) or diabetes-related family conflict. Higher self-efficacy 
was related to lower DD at baseline and 12-month follow-up.  
7.1.1 Objective 1: Assess the prevalence and clinical significance of 
diabetes distress 
As described in Chapter 2, a systematic review of the adolescent literature 
found evidence from cross-sectional studies that around one-third of adolescents 
may experience clinically significant DD. However, most studies had used 
measures of DD that were not age-appropriate, and there was no validated cut 
point that could be used for clinical or research purposes to identify adolescents 
with elevated DD. Hence, the research described in Chapter 4 was the first to 
determine clinically meaningful cut points for an adolescent-specific measure of 
DD (PAID-T), and to use these thresholds to estimate the prevalence of elevated 
DD among Australian adolescents. This analysis demonstrated two cut points 
with statistically and clinically significant differences in outcomes (greater 
depressive symptoms, higher HbA1c and less frequent SMBG) with increasing 
severity of DD.  
Using these newly established cut points, the frequency of elevated DD 
was estimated in two different study samples; respondents to the Diabetes MILES 
Youth study national survey (described in Chapter 4), and participants recruited 
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via clinical settings to attend a structured education program (described in 
Chapter 6). Clinically significant DD was reported by a substantial proportion of 
adolescents in both studies; moderate levels of DD were reported by 18% and 
high DD by 36% of Diabetes MILES Youth survey respondents, and by 13% and 
23% of the TEAM T1 study participants respectively. The rate of high DD found 
in the Diabetes MILES Youth study is consistent with a previous estimate in 
adolescents (33%) (Berlin, Rabideau, & Hains, 2012) and severe DD in adults 
with T1D (PAID ≥40; 28% to 33%) (Amsberg, Wredling, Lins, Adamson, & 
Johansson, 2008; Fenwick et al., 2018; Hermanns, Kulzer, Krichbaum, Kubiak, & 
Haak, 2006; Lašaitė et al., 2016). A study using the adult version of the PAID and 
cut point (PAID ≥40), estimated that only 17% of adolescents were severely 
distressed (Lašaitė et al., 2016). However, the adult version of the PAID scale 
lacks face validity for adolescents, as it excludes items related to their specific 
concerns (e.g. body image, parental conflict). Furthermore, the validity of this cut 
point has not been assessed in adolescents, thus DD may be under-estimated in 
this study. 
The discrepancy in the prevalence of moderate and high DD between 
Diabetes MILES Youth study respondents (Chapter 4) and TEAM T1 participants 
(Chapter 6) can be explained by the different study designs and methods used in 
the two studies. The presence of an acute, psychological disorder (e.g. clinical 
depression or anxiety) was a specific exclusion criterion for attending a TEAM 
T1 program. Furthermore, young people who are severely distressed are at risk of 
disengaging from self-care (Iturralde, Weissberg-Benchell, & Hood, 2017),  so 
are unlikely to have volunteered to participate in TEAM T1. Diabetes MILES 
Youth study participants self-selected for an internet-based survey of diabetes and 
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psychological well-being, which may have attracted youth with elevated DD 
(Cuijpers, Boluijt, & van Straten, 2008), and the confidential nature of the online 
survey may have encouraged them to disclose negative emotions. In contrast, 
TEAM T1 participants were approached by their health professional to take part 
in a 5-day self-management program and were aware that the diabetes educator 
could view their questionnaire responses. The onerous nature of a 5-day program 
and the lack of anonymity are likely to have contributed to lower prevalence rates 
of DD in this study. Indeed, the facilitators were encouraged to discuss high 
scores with participants and to initiate a discussion or referral as appropriate, 
because the program was being delivered as part of routine clinical care. Further, 
most TEAM T1 participants were accompanied by a parent, which may reduce 
the risk of elevated DD, given that adolescents with greater family support report 
less DD than those without support (Forsander, Bøgelund, Haas, & Samuelsson, 
2017; Weissberg-Benchell & Antisdel-Lomaglio, 2011). Hence, severe DD may 
have been a barrier to TEAM T1 attendance.  
Other participant characteristics may have contributed to the discrepancy 
in DD between studies; for example, HbA1c (which is associated with elevated 
DD) was higher among TEAM T1 than Diabetes MILES Youth Study 
participants (mean 74 mmol/mol (8.9%) vs 65 mmol/mol (8.1%) respectively), 
notwithstanding HbA1c was self-reported in the Diabetes MILES Youth study. 
However, adolescents with elevated HbA1c may be over-represented in TEAM 
T1, because those with suboptimal glycaemia were recruited specifically to 
improve their self-management skills.  
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7.1.2 Objective 2: Examine the demographic, psychosocial and 
clinical characteristics associated with diabetes distress 
The second objective of this thesis was to examine participant 
characteristics associated with elevated DD. Data from both the Diabetes MILES 
Youth and TEAM T1 studies were relevant to this objective. Despite differences 
in the two study samples (i.e. higher SES, more frequent insulin pump use, longer 
diabetes duration, lower HbA1c, and greater DD, among Diabetes MILES Youth 
study respondents compared to TEAM T1 participants), the findings were 
remarkably consistent with regard to characteristics associated with DD.  
7.1.2.1 Age  
The mean PAID-T score was higher among older than younger 
adolescents, although in the TEAM T1 study, age was no longer related to DD 
after controlling for gender, HbA1c and psychosocial factors (i.e. self-efficacy, 
diabetes-related family conflict) (Chapter 6). As discussed in Chapter 2, the 
majority of previous studies among adolescents with T1D have not shown a 
significant association between age and DD, regardless of the age range or 
measure used. These findings were unexpected because there is a four-fold 
increase in the prevalence of depressive disorders from early to late adolescence 
in the general population (Thapar, Collishaw, Pine, & Thapar, 2012). However, 
the Diabetes MILES Youth study found that the correlation with age was weaker 
for DD than depressive symptoms (Chapter 5). A recent study in children with 
T1D aged 8-17 years (assessing a new measure of DD: the PAID-Peds) found no 
relationship with age, despite including pre-adolescent and older youth 
(Markowitz, Volkening, Butler, & Laffel, 2015). Studies in young adults suggest 
that the level of DD is even higher among this age group than among adolescents 
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(Lašaitė et al., 2016) or older adults (Joensen, Tapager, & Willaing, 2013; 
Kibbey, Speight, Wong, Smith, & Teede, 2013). Young adults have more 
autonomy but less support for T1D self-management than adolescents, are more 
cognisant of the consequences of suboptimal self-care, yet still feel self-conscious 
about diabetes in social situations, so may be more vulnerable to psychological 
distress (Balfe et al., 2013).  Thus, it is important to anticipate support needs and 
provide the most appropriate intervention to prevent elevated DD among young 
adults, by intervening during adolescence. 
7.1.2.2 Gender  
In both studies, females reported greater DD than males (described in 
Chapters 5 and 6). This finding is consistent with other studies in adolescents 
with T1D (Delamater, Patiño-Fernández, Smith, & Bubb, 2013; Lašaitė et al., 
2016; Shapiro et al., 2017; Weissberg-Benchell & Antisdel-Lomaglio, 2011) and 
adults with T1D (Sturt, Dennick, Due-Christensen, & McCarthy, 2015), although 
some studies have found no gender-related difference in distress (Berlin et al., 
2012; Jaser et al., 2012).  In the general population, gender differences in anxiety 
disorders begin to emerge in childhood (Lewinsohn, Gotlib, Lewinsohn, Seeley, 
& Allen, 1998), and around puberty for depression (Hankin et al., 1998), with 
young adult women experiencing approximately double the rate of depression and 
anxiety disorders than young men (Thapar et al., 2012). Among adolescents with 
T1D, girls also report more severe depressive symptoms (de Wit & Snoek, 2011; 
Hood et al., 2006) and anxiety (Rechenberg, Whittemore, & Grey, 2017a) and 
eating problems than boys (Wisting, Bang, Skrivarhaug, Dahl-Jørgensen, & Rø, 
2015). While those with anxiety or depression may experience greater diabetes-
related burden or worry than those who are not anxious or depressed, it is likely 
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that the psychosocial vulnerabilities that predispose girls to mental health 
problems also contribute to the higher risk for DD (Broderick & Korteland, 2002; 
Hankin & Abramson, 1999; Leadbeater, Blatt, & Quinlan, 1995; Thapar et al., 
2012). For example, studies have identified greater perceived stress and more use 
of emotion and avoidance coping styles among females than males, and these 
coping styles are associated with greater psychological distress (Leadbeater et al., 
1995; Matud, 2004). Among adolescents with T1D, avoidant coping style has 
been shown to predict elevated DD, although the effect of gender was not 
explored in that study (Iturralde et al., 2017). Several studies have demonstrated 
the benefit of ongoing family involvement in diabetes management during 
adolescence and a significant association between family support and lower DD 
(Forsander et al., 2017; Singh, Farruggia, & Peterson, 2013; Weissberg-Benchell 
& Antisdel-Lomaglio, 2011). One study found that girls who wished for more 
parental involvement in their diabetes management had elevated DD, but this was 
not so for boys (Forsander et al., 2017). Among TEAM T1 participants, fewer 
girls had a parent accompany them to the program than boys (Chapter 6). These 
findings suggest that parents may perceive daughters to be more independent and 
competent than sons, yet girls may want more support than they actually receive 
(Forsander et al., 2017). 
Another potential explanation for the gender disparity in DD relates to 
body image. Girls report more eating problems and concerns about being 
overweight than boys (Araia et al., 2017; Wisting et al., 2015), and girls with 
T1D are more likely to be overweight than boys with T1D (Dabadghao, Vidmar, 
& Cameron, 2001) and their peers without diabetes (Domargård et al., 1999; 
Fröhlich-Reiterer et al., 2014). In the Diabetes MILES Youth Study, ‘worrying 
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about my weight’ (PAID-T item 22) was the topmost concern for girls but not 
boys (Speight et al., 2015). The PAID-T is the only measure of DD that includes 
an item reflecting body weight concerns, thus studies among adolescents using 
the PAID-T may be more likely to find a significant gender difference in DD than 
studies using other scales. Nevertheless, as noted previously, female 
preponderance for distress was also found in studies using other measures. A 
recent study among adolescents and adults with T1D showed that DD was related 
to negative body image and eating disturbances (Powers, Richter, Ackard, & 
Craft, 2017), although this relationship is underexplored in adolescents. 
7.1.2.3 Socioeconomic status  
Neither the Diabetes MILES Youth nor TEAM T1 study found any 
association between DD and socioeconomic status. This finding is consistent with 
other studies among youth with T1D (Boland, Grey, Oesterle, Fredrickson, & 
Tamborlane, 1999b; Forsander et al., 2017), despite the fact that socioeconomic 
disadvantage is a risk factor for mental health problems in children and 
adolescents (Reiss, 2013). It is possible that the measure of SES (derived from 
postcode area) used in the current studies does not adequately reflect social 
disadvantage in this context.  In a study from the U.S.A., family income 
negatively correlated with DD (Shapiro et al., 2017). The Australian government 
subsidises the cost of diabetes supplies and healthcare, so the financial cost of 
diabetes may be less of a stressor for families in this country than in the U.S.A..  
7.1.2.4 Depressive symptoms  
As shown in the Diabetes MILES Youth Study, depressive symptoms 
moderately correlated with DD (described in Chapter 5). While this finding 
suggests that young people who are distressed may also be depressed, further 
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analysis revealed that although there is a large shared variance, for a small 
proportion of adolescents the source of distress may not be diabetes related. Van 
Bastalaar, et al. (2010) suggest that DD arises as a result of increasingly severe 
depressive symptoms. In contrast, Fisher and colleagues define emotional distress 
as having two dimensions; source (e.g. diabetes, bereavement, life stressors) and 
severity, where depressive or anxiety disorder is at the most severe end of the 
spectrum (Fisher, Gonzalez, & Polonsky, 2014). More recently, a longitudinal 
study among adults with T1D found an independent, bi-directional relationship 
between DD and elevated depressive symptoms (Ehrmann, Kulzer, Haak, & 
Hermanns, 2015). Studies in the general population have found evidence that 
anxiety may precede depression in youth ((Feehan, McGee, & Williams, 1993; 
Kovacs, Gatsonis, Paulauskas, & Richards, 1989; Strauss, Last, Hersen, & 
Kazdin, 1988; Strauss, Lease, Last, & Francis, 1988), cited in Seligman and 
Ollendick (1998), so it is possible that unresolved DD may progress to 
depression, and depression magnifies DD (Ehrmann et al., 2015). To this PhD 
candidate’s knowledge, only one longitudinal study has explored the relationship 
between these constructs prospectively (over 12 months) in adolescents (Jaser, 
Patel, Xu, Tamborlane, & Grey, 2016). In that study, diabetes-related stress 
predicted depressive symptoms indirectly through coping style (Jaser et al., 
2016). Historically, depression and other mental health problems have had more 
attention in adolescents with T1D, and DD has been recognised and researched 
only in recent years, despite an age-appropriate measure of diabetes-related stress 
first becoming available in 1993 (Boardway, Delamater, Tomakowsky, & Gutai, 
1993). Further research is needed to explore the relationship between these 
constructs prospectively in adolescents, because there are important implications 
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for clinical practice and choosing the most appropriate intervention to target the 
underlying emotional problem.  
7.1.2.5 Self-efficacy 
As described in Chapter 6, low self-efficacy related to diabetes 
management predicted elevated DD among TEAM T1 participants, corroborating 
previous studies among adolescents (Grey, Boland, Yu, Sullivan-Bolyai, & 
Tamborlane, 1998b; Law, Walsh, Queralt, & Nouwen, 2013; Nouwen, Urquhart 
Law, Hussain, McGovern, & Napier, 2009), suggesting that young people may 
need support and encouragement, regardless of age. Recent research has focused 
on the development of positive attributes, for example, resilience and engagement 
coping, and these strengths are associated with lower DD (Hilliard, Iturralde, 
Weissberg-Benchell, & Hood, 2017; Jaser et al., 2012; Yi-Frazier et al., 2015). 
Building resilience and coping may help to develop life-long skills to prevent and 
manage DD and depressed mood (Hermanns et al., 2015).  
7.1.2.6 Family conflict 
Perceived diabetes-related family conflict also contributed significantly to 
the variance in DD (Chapter 6). A study in pre-adolescent and adolescent children 
(Markowitz et al., 2015) using the full version of the Diabetes Family Conflict 
Scale (DFCS) (Hood, Butler, Anderson, & Laffel, 2007), corroborates the 
findings in the TEAM T1 study, which utilised a modified (2-item) version of the 
DFCS (De Wit & Snoek, 2009). Other studies suggest that family conflict may 
weaken resilience to negative life stressors (Holmes, Yu, & Frentz, 1999), 
whereas, higher self-efficacy may protect adolescents from the negative impact of 
family conflict on diabetes management (Noser, Huffhines, Clements, & Patton, 
2017).  
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7.1.2.7 Duration of diabetes 
Neither the Diabetes MILES Youth nor TEAM T1 studies found an 
association between diabetes duration and DD, which is consistent with most 
studies in the systematic review (Chapter 2). However, Delamater et al. (2013) 
observed that dietary concerns were lower and stress about hypoglycaemia and 
hyperglycaemia were higher among youth with longer diabetes duration. A total 
DD score may not reflect these adaptations to living with diabetes, whereas 
subscales or individual item scores may be useful for revealing such nuances. 
Longer duration of diabetes is a risk factor for elevated distress among adults 
with T1D (Sturt et al., 2015). However, average diabetes duration is longer in 
adults than adolescents, and may be confounded by disease severity and 
complications, which are less common in adolescents. 
7.1.2.8 Self-monitoring of blood glucose (SMBG) 
In multivariate analyses, frequency of SMBG was not associated with DD 
(Chapter 6), which is consistent with other studies in adolescents (Ellis et al., 
2005; Farrell, Hains, Davies, Smith, & Parton, 2004) and adults (Sturt et al., 
2015). However, DD moderated the association between SMBG and HbA1c 
(described in Chapter 5). Others have shown that diabetes-related stress was 
indirectly associated with HbA1c through self-management (Jaser et al., 2012), 
although these studies are cross-sectional and causality cannot be inferred. 
7.1.2.9 Glycaemic management (HbA1c)  
Despite differences in participant characteristics between the two studies 
(i.e. higher mean PAID-T and lower self-reported HbA1c among Diabetes 
MILES Youth Study than TEAM T1 participants), the strength of the correlation 
between DD and HbA1c was remarkably consistent (r = 0.33 and r = 0.34 
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respectively). The Diabetes MILES Youth study found a stronger association 
among older (16-19 years) versus younger adolescents (13-15 years) (Chapter 5). 
The strength of positive correlation with HbA1c was consistent with other studies 
using the PAID-T (r = 0.26–0.39) (Iturralde et al., 2017; Shapiro et al., 2017; 
Weissberg-Benchell & Antisdel-Lomaglio, 2011). Furthermore, out of 26 studies 
in adolescents published between 1995 and 2018, 18 reported a significant cross-
sectional association between HbA1c and DD (Berlin et al., 2012; Delamater et 
al., 2013; Ellis et al., 2005; Farrell, 2004; Forsander et al., 2017; Hains et al., 
2007; Hains, Berlin, Davies, Parton, & Alemzadeh, 2006; Iturralde et al., 2017; 
Jaser et al., 2012; Jaser et al., 2016; Kamody et al., 2014; Kamody et al., 2017; 
Law et al., 2013; Powers et al., 2017; Raymaekers et al., 2017; Rechenberg, 
Whittemore, Holland, & Grey, 2017b; Shapiro et al., 2017; Weissberg-Benchell 
& Antisdel-Lomaglio, 2011) and eight studies found no association (Berlin, 
Hains, Kamody, Kichler, & Davies, 2015; Boland, Grey, Mezger, & Tamborlane, 
1999a; Franklin, 2008; Grey et al., 1998b; Lašaitė et al., 2016; Nouwen et al., 
2009; Yi-Frazier et al., 2018), including a study using a new version of the PAID 
for youth (PAID-Peds) (Markowitz et al., 2015).  
As described in Chapter 6, in the TEAM T1 study DD was not associated 
with HbA1c at follow-up after adjusting for baseline levels. In longitudinal 
studies, food-related distress predicted elevated HbA1c 12 months later 
(Raymaekers et al., 2017), but another study found T1D-related stress was not 
associated with HbA1c at 12 months (Jaser et al., 2016). Further, DD did not 
mediate the reduction in HbA1c after a psychoeducation intervention (Ellis et al., 
2005). A prospective study in adults with T1D showed that DD predicted 
suboptimal self-care (missed insulin doses) but not HbA1c, although there was a 
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co-varying relationship between DD and HbA1c over time (Hessler et al., 2017). 
Another study in adults examining predictors of HbA1c over a period of one-to-
three years found no impact of DD on glycaemia after controlling for baseline 
HbA1c (Strandberg et al., 2015). Thus, high levels of DD are consistently 
associated with elevated HbA1c, but there is less evidence of a temporal 
relationship. 
7.1.3 Objective 3: Examine the interrelationship between diabetes 
distress, depressive symptoms and HbA1c 
The third aim of the thesis was to investigate the interrelationship between 
DD, depressive symptoms and HbA1c, and to determine the extent to which each 
construct was associated with diabetes management. The multivariate analysis 
presented in Chapter 5, showed that DD, but not depressive symptoms, remained 
an independent predictor of HbA1c. This finding corroborates prior research in 
adults (Fisher et al., 2016b; Hessler et al., 2017; Van Bastelaar et al., 2010) and a 
recent study in adolescents using measures of diabetes-specific and general stress 
(Rechenberg et al., 2017b). In adults, HbA1c was higher among those with 
elevated depressive symptoms and DD (Van Bastelaar et al., 2010). However, the 
Diabetes MILES Youth study (Chapter 5) showed that depressive symptoms had 
no effect on the relationship between DD and HbA1c in adolescents. Further 
research using the gold standard diagnostic interview may help to elucidate the 
significance of clinical depression, DD and HbA1c in adolescents.  
7.1.4 Objective 4: Investigate diabetes distress following structured 
T1D education  
The TEAM T1 study (described in Chapter 6) examined change in DD 
after structured T1D education and explored covariates of DD pre- and post-
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program. TEAM T1 is a self-management education program for adolescents 
adapted from the adult DAFNE (Dose Adjustment for Normal Eating) (DAFNE 
Study Group, 2002). Enhancements to the standard curriculum included coping 
and problem-solving skills training, and a 2-day parent program promoting 
positive family communication about diabetes.  
7.1.4.1 Diabetes distress after structured T1D education 
Mean DD did not change significantly at either time point (approximately 
three and 12 months) post-program. DD decreased at three months among youth 
with moderate-to-severe baseline DD, and item-level analysis indicated that 
improvement occurred in specific problem areas targeted by the program content, 
namely self-management and family support. Worrying about weight, a serious 
problem for one-third (37%) of adolescents (Chapter 4), also decreased. Dietary 
freedom and flexible insulin dosing may have enhanced perceived control over 
diabetes. Indeed, self-efficacy increased, and this was associated with lower DD. 
However, adolescents may not have control over many of the factors that cause 
them substantial distress (e.g., lack of understanding from friends and family, 
diabetes regimen, school/social environment), therefore they are unable to make 
behavioural changes that may alleviate their distress. Furthermore, adolescents 
may not have yet reached the stage in their cognitive development, whereby they 
believe their actions will result in change (Nouwen et al., 2009). Thus, 
interventions focused on coping with negative emotions may be more effective 
for preventing and managing DD than skills-based training, particularly for those 
with elevated DD. Psychoeducation programs to develop resilience/positive 
coping skills (e.g. cognitive restructuring, goal setting and problem-solving) have 
demonstrated promising improvements in DD (Ellis et al., 2005; Grey et al., 
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1998a; Hood, Iturralde, Rausch, & Weissberg-Benchell, 2018; Serlachius et al., 
2016) and have been delivered effectively face-to-face (Ellis et al., 2005; Grey et 
al., 1998a; Hood et al., 2018; Serlachius et al., 2016), and via the internet (Grey et 
al., 2013). However, few studies have assessed DD as the primary outcome. A 
recent study aimed at preventing depression and DD among youth (Supporting 
Teen Problem Solving [STePS]), found DD decreased more rapidly after a T1D 
resilience program than diabetes management education (Hood et al., 2018). 
Among adults with T1D, comparable (moderate) reductions in DD were observed 
after both an emotion-focused program (T1-REDEEM) and T1D education 
(Fisher et al., 2018). Moreover, Grey et al. (2013) showed that those adolescents 
who participated in both coping skills training and self-management education 
had the most optimal outcomes.  
The TEAM T1 curriculum included engagement coping strategies, 
although the facilitators in the current study were inexperienced and may have 
required more training and support than they received. By contrast, DD reduced 
significantly after the TEAM T1 pilot which was facilitated by proficient DAFNE 
educators (Knight et al., 2010), although, as noted in Chapter 6, there were other 
limitations to the TEAM T1 study, in particular, high attrition and the lack of a 
control group.  
Interventions that are tailored to specific participant needs or 
characteristics may be more effective than a one-size-fits-all approach. For 
example, in the TEENCOPE study, youth with elevated depressive symptoms had 
lower perceived stress after a coping skills program than diabetes management 
education, and boys had greater increases in QoL after the diabetes management 
program (Whittemore et al., 2012). Consistent with this finding, adults with 
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higher baseline DD and poorer emotion regulation and cognitive skills had 
greater reduction in DD after an emotion-focused intervention, than T1D 
education (Fisher et al., 2018).  
Other, individualised approaches aimed at promoting empowerment and 
self-management and integrated into routine clinical care, have been trialled, for 
example, ‘Guided Self-determination’ (Husted et al., 2014) and motivational 
interviewing (Gregory et al., 2011). These RCTs did not show a reduction in DD 
or HbA1c, although an intensive, multisystemic intervention for youth with 
chronically elevated HbA1c improved both DD and HbA1c (Ellis et al., 2005). 
This community-based program was focused on the family, community and peer 
networks to support optimal self-management. Interventions aimed primarily at 
improving diabetes management do not appear to exacerbate DD, despite 
increased focus on self-care. However, such attention may reduce self-efficacy 
(Gregory et al., 2011; Price et al., 2016). Although diabetes management self-
efficacy increased after TEAM T1, the curriculum may need to pay greater 
attention to emotions and developing coping skills to achieve a significant 
reduction in DD.  
7.1.4.2 Predictors of change in diabetes distress 
As described in Section 7.1.2, HbA1c, diabetes management self-efficacy 
and family conflict were predictors of baseline DD, but only self-efficacy was 
associated with DD at Time 2 (described in Chapter 6). Although the method of 
statistical analysis (linear mixed model)  accounted for missing data, there was no 
evidence of a prospective effect of any of the covariates on DD, and baseline 
distress was the most significant predictor of DD at follow-up. In adults, DD 
appears to be stable over time (Fisher et al., 2016a). Thus, without some form of 
247  
targeted support, distress is unlikely to decrease. Indeed, DD may even be higher 
among young adults than adolescents (Kibbey et al., 2013; Lašaitė et al., 2016).  
Although girls had higher levels of DD at baseline, they did not 
experience a larger reduction in distress than males or younger teens. Thus, 
greater benefits may be achieved if the excess emotional burden reported by girls 
could be reduced. Parents of girls were less likely to attend TEAM T1, which 
could signify that girls receive less parental support, but the numbers were too 
small to examine the effect of this confounder on study outcomes. Having a better 
understanding of the relationship between gender and DD may help to increase 
the effectiveness of interventions such as TEAM T1 by enabling tailoring of 
support to specific needs or coping styles (Forsander et al., 2017; Raymaekers et 
al., 2017; Whittemore et al., 2012). 
7.1.5 Summary of key findings 
This thesis extends previous knowledge of DD among adolescents and 
corroborates the findings of studies in adults. Notwithstanding the limitations 
noted within the preceding chapters, and expanded upon in Section 7.2, this 
program of PhD research has produced the first studies to: 
a) systematically review existing evidence of DD among adolescents with 
T1D 
b) establish clinically-validated cut points for an adolescent-specific version 
of a DD measure 
c) use those newly-established cut points to examine prevalence in a national 
sample and a clinical sample, and 
d) demonstrate that the association between HbA1c and depressive 
symptoms may be explained by DD in adolescents with T1D. 
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7.2 Strengths and limitations 
This program of PhD research has several strengths and limitations. The 
specific limitations of the systematic review and each of the empirical studies 
comprising this thesis are described in Chapters 2-6. The following section 
summarises the strengths and limitations of the PhD thesis as a whole, with 
reference to study design and measures, intervention fidelity, and conduct of 
research in real-world conditions.  
7.2.1. Strengths 
7.2.1.1 Study sample size and diversity 
A strength of this thesis is the inclusion of two diverse study samples. The 
Diabetes MILES Youth Study comprised a large, community-based sample, from 
metropolitan, regional and rural locations, reflecting the geographic distribution 
of the population. Furthermore, this was the first national study to examine 
psychosocial aspects of diabetes among adolescents in Australia. Positive 
feedback from participants in the pilot phase, and the high proportion of complete 
responses to the survey (Chapter 3) indicates that the issues assessed were 
relevant and important to young people. The large sample size enabled robust 
data analyses. TEAM T1 represented the first structured education program 
teaching flexible, intensive insulin therapy for Australian youths with T1D. The 
TEAM T1 cohort was drawn from a range of clinical settings, including 
metropolitan and regional hospital outpatient clinics. Having two different 
samples representing the same age-group provided the opportunity to compare 
and contrast findings and strengthened the generalisability of results. 
Age-appropriate measures were used; specifically, both studies used the 
PAID-T scale, a validated, adolescent-specific measure of DD. Although the 
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Diabetes MILES Youth Study utilised self-reported HbA1c, the findings were 
corroborated with clinic-recorded data that was collected for the TEAM T1 study.  
7.2.1.2 Consultation and feedback 
An expert advisory panel, comprising national and international experts in 
paediatrics, psychology and diabetes education guided the content of the Diabetes 
MILES Youth study, ensuring the research addressed current knowledge gaps and 
provided outcomes of interest to an international research community and people 
living with diabetes. TEAM T1was adapted from an evidence-based program for 
adults, Dose Adjustment for Normal Eating (DAFNE), which has been attended 
by over 40,000 people with T1D across the UK, Ireland and Australia (Dose 
Adjustment for Normal Eating (DAFNE), 2018). A multidisciplinary advisory 
group provided clinical and research advice into the adaptation of DAFNE for 
adolescents. TEAM T1 was successfully piloted prior to this study, which showed 
that structured T1D education was acceptable and feasible for adolescents 
(Knight et al., 2010). Another strength of this thesis is the manuscripts have been 
published (Chapters 2, 3-5) or submitted for publication (Chapter 6) in peer-
reviewed journals. Hence, the research has contributed to the literature and the 
awareness of DD globally.  
7.2.2 Limitations  
7.2.2.1 Study design  
The Diabetes MILES Youth study was cross-sectional, but a longitudinal 
study would have provided the opportunity to examine DD prospectively and the 
directionality of relationships. However, given the program of research planned, a 
follow-up study may not have been feasible in the timeframe to complete the 
PhD. Clinical data would have strengthened this study, but it was not possible to 
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do this in a feasible way nor within the study budget. The PAID-T scale had been 
validated in adolescents, but the measure was derived from the adult PAID and 
expert opinion, and not from qualitative data (Weissberg-Benchell & Antisdel-
Lomaglio, 2011). Thus, a qualitative study exploring DD in adolescents may have 
been useful to determine whether the current DD measures encompass all the 
concerns of young people, in particular Australian adolescents.  
Inclusion of the TEAM T1 study in the thesis was pragmatic. Funding had 
been awarded to deliver a program via diabetes centres in several states, so the 
intervention provided an opportunity for data collection and analysis relevant to 
the focus of the PhD. However, meeting the aims of both the PhD and TEAM T1 
project inevitably led to compromises, for example, a key limitation was the lack 
of a control group. Given the difficulty of recruiting and retaining adolescents in 
structured education (Christie et al., 2016; Coates, Horigan, Davies, & Davies, 
2017), the project would have been unlikely to succeed if implemented as a 
controlled trial. A single-site study to evaluate TEAM T1 might have been more 
feasible and manageable for a PhD candidate with regard to the project 
complexity and timeframe and may have provided greater consistency in program 
content and delivery, but none of the participating sites were large enough to 
accommodate this. While the ‘real-world’ implementation had advantages in 
terms of integration into clinical care and upskilling of diabetes educators, real-
world problems were encountered, including difficulties recruiting participants, 
incomplete data and loss of facilitators that were beyond the researchers’ control. 
7.2.2.2 Intervention fidelity  
Another consequence of the real-world conditions encountered during the 
TEAM T1 study was the challenge of maintaining intervention fidelity. Peer 
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review of facilitation was limited to one course at each site, because the centres 
were located in five states, and the distances to travel and associated costs 
prohibited further on-site visits. Thus, apart from any deviations reported by 
facilitators, it is unknown how well they adhered to the curriculum, and 
participant outcomes may have been affected by such inconsistencies. It was not 
possible to adequately adjust for centre differences in the analysis, owing to large 
discrepancies in the number of participants by centre (Chapter 6).  
7.2.2.3 Study measurement issues 
The PAID-T demonstrated very high internal consistency, suggesting 
possible redundancy of some items, so further psychometric evaluation of the 
scale may be warranted. Indeed, the PAID-T has since been revised, resulting in 
another, 14-item version (Shapiro et al., 2017). A short, reliable measure of 
diabetes self-care was not available, and self-reported SMBG frequency was the 
only measure used in both studies. The relationship with DD may vary for other 
aspects of self-management (Sturt et al., 2015). Self-report items relating to 
frequency and awareness of hypoglycaemia were adapted from adult measures, 
and had not been validated in adolescents, so the reliability of the data was 
uncertain, and therefore not used.  
A measure of coping styles would have been useful to examine the 
association with DD in the TEAM T1 study, given the focus on coping skills in 
the program. In addition, inclusion of a depressive symptom measure (i.e. PHQ-
A) would have enabled the findings from both samples to be compared. The 
TEAM T1 study commenced before the PhD, so decisions about study measures 
had already been made. Further, respondent burden needed to be considered, and 
there was a fall in the completeness of data within the questionnaire at each time 
252  
point. The research plan allowed for data to be collected at two years post-TEAM 
T1, but programs were implemented over three years, so there were too few 
responses for meaningful analysis.  
The NDSS Expert Reference Group in the Diabetes MILES Youth Study 
advised against including measures of DD and depressive symptoms among 
younger participants (aged 10-12 years), due to concerns about raising these 
issues in an anonymous online survey. Thus, the level of DD in this younger 
group could not be examined and the potential sample size for analysis was 
reduced. 
7.3 Lessons learned  
Lessons learned from this program of PhD research highlight two 
important considerations for future researchers conducting studies with this 
population, namely recruitment and retention of adolescents with T1D.  
7.3.1 Study recruitment and retention 
Diabetes MILES Youth study participants were invited to take part by the 
NDSS, a government-funded program with which participants (and their parents) 
had an ongoing relationship. The NDSS provides education, information, and 
subsidised diabetes supplies. Thus, recruitment via this channel might be 
expected to facilitate participation, but only 16% of those invited responded to the 
survey, and 13% had useable (core) data. This response rate is comparable to the 
12% of registrants aged 12-20 years from the Norwegian National Childhood 
Diabetes Registry who consented to take part in a postal survey of the 
psychological aspects of living with diabetes (Wisting, Bang, Skrivarhaug, Dahl-
Jørgensen, & Rø, 2016). Study fatigue may have limited uptake, as various 
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surveys about youth transition had been undertaken by the NDSS among 
Registrants in this age group over the preceding years. Hospital clinics were 
asked to promote the survey, but it is not known whether this occurred or how it 
affected recruitment. Greater awareness and promotion of the purpose and value 
of the study to clinicians and professional organisations, such as the Australian 
Paediatric Endocrine Group (APEG) may have improved the sample size because 
health professionals’ endorsement is widely recognised to improve engagement 
(Newington & Metcalfe, 2014). Gifts and payments as incentives are frequently 
used in paediatric trials to enhance recruitment and retention (Tishler & Reiss, 
2011). The chance to win an iPad was offered as an incentive to take part in the 
Diabetes MILES Youth Study (Chapter 3) and 69% of participants opted in to the 
draw (S. Trawley, personal communication, June 2018).  
Support from the health professional team was a critical success factor for 
TEAM T1. Anecdotally, centres who had the support of the medical staff and 
managers were more successful at recruitment and delivered more courses. A 
measure to assess organisational and team engagement and commitment would be 
helpful for future research; to use when selecting centres and for predicting the 
effect of centre differences on study outcomes. Recruitment was a challenge for 
even the most dedicated centres (Chapter 6). Barriers to individual participation 
in structured T1D education have been examined by researchers in the UK, where 
such programs are well established and widely available (Coates et al., 2017). 
Among the most commonly cited reasons for non-attendance by adolescents was 
the low priority afforded to diabetes education, the perception that additional 
education was unnecessary, logistical impediments and embarrassment among 
young people in a group setting. According to TEAM T1 facilitators, Australian 
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parents provided similar justification for refusing an invitation to attend TEAM 
T1 (data not reported, as beyond the remit of this thesis).  
A payment could potentially have improved the follow-up response to 
TEAM T1, but the ethics committees prohibited the use of incentives to 
participation, and payments were not factored into the project budget. Lotteries 
and prize draws, payments and the provision of personalised feedback on survey 
responses increase participation in online surveys (Maniaci & Rogge, 2014), and 
a monetary incentive almost doubles the response to postal questionnaires 
(Edwards et al., 2009). Other recommendations to promote return of study 
questionnaires were implemented in the TEAM T1 Study (Chapter 6), for 
example, personalised SMS messages and letters with reply-paid envelopes 
(Whittemore et al., 2016).  
Return of follow-up questionnaires may have been more successful with 
reminders coming from the local health care team rather than a central point. 
Nevertheless, difficulty with recruitment and retention were not unique to this 
study (Coates et al., 2017; Whittemore et al., 2016). Additional incentives may be 
required to optimise recruitment and retention among this age group and may 
need to be provided for in the research budget.  
7.3.2 Study procedures 
Research ethics and governance approval processes were complicated and 
inconsistent, and an impediment to timely commencement of the TEAM T1 
study. Although only a single national, ethics committee approval is required for 
clinical trials (e.g. pharmacotherapy), approval to conduct an educational 
intervention and collect participant data required approval from an ethics 
committee in each of the five states where TEAM T1 was conducted, in addition 
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to the usual approvals for research at each site. Had all the centres been recruited 
at the one time, this process may have been more streamlined. 
7. 4 Implications for Clinical Practice and Future Research 
The following section discusses the implications of the studies presented 
in this thesis for the assessment and management of DD in adolescents. Included 
in this discussion are implications of the findings in relation to clinical practice 
and strategies for reducing DD and suggestions for further research. 
7.4.1 Implications for assessment of DD and clinical practice 
7.4.1.1 Defining and measuring diabetes distress 
DD was defined in this PhD thesis as a heterogeneous construct reflecting 
the emotional burden related to living with diabetes, for example, emotional 
responses to diabetes self-management tasks and the consequences of diabetes 
and concerns about the future (Weissberg-Benchell & Antisdel-Lomaglio, 2011). 
Fourteen measures were appraised for inclusion in the systematic review, and of 
these, five were considered reflective of DD and relevant to the adolescent age 
group based on their face validity. Studies using these five measures were 
included in the review. The systematic review (Chapter 2) highlighted several 
limitations related to the assessment and measurement of DD in adolescents, 
which had implications for the studies undertaken as part of this thesis and for 
future research. These gaps included the frequent use of measures designed for 
adults, which are not validated in this age group, and may not adequately reflect 
the specific concerns of relevance to adolescents with T1D, for example, 
diabetes-related parental conflict and over-vigilance, and body image concerns 
(Weissberg-Benchell & Antisdel-Lomaglio, 2011). The second gap highlighted 
256  
by the literature review was the absence of a clinically meaningful threshold to 
distinguish elevated DD among adolescents.  
Given the inconsistent findings reported in the systematic review, where 
both adult-and adolescent-specific measures had been used (Chapter 2), it is 
recommended that an age-specific measure of DD is used in research and clinical 
practice. At the commencement of this research program, three age-specific 
measures of DD were available, but only the Problem Areas in Diabetes–Teen 
version (PAID-T) captured a broad range of emotions related to living with 
diabetes and was feasible in length to include in the study questionnaires 
(Weissberg-Benchell & Antisdel-Lomaglio, 2011). Other scales designed for 
adolescents were too lengthy (65 items) (Delamater et al., 2013) or, perhaps, not 
sufficiently comprehensive (12 items) (Kovacs, Brent, Steinberg, Paulauskas, & 
Reid, 1986). A new paediatric version of the PAID (PAID-Peds) has since 
become available (Markowitz et al., 2015). This 20-item scale was adapted for 
youth aged 8-17 years from the PAID-parent version (Markowitz et al., 2011). 
However, the PAID-Peds also lacks items relevant to emerging adults (e.g. 
control of eating and bodyweight, parental conflict), so it may not be ideal for use 
with older adolescents and does not necessarily represent an advancement in age-
appropriate assessment of DD.  
A limitation of the 26-item PAID-T is the absence of subscales. Subscales 
can be useful to identify the most prominent concerns at a particular stage or 
point in time, and highlight change over time, or areas that an individual or 
intervention may focus attention. Exploratory factor analysis conducted as part of 
the Diabetes MILES Youth Study (Chapter 4) did not support a multidimensional 
scale, which is consistent with previous psychometric analysis of the scale 
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(Weissberg-Benchell & Antisdel-Lomaglio, 2011). However, the psychometric 
properties of the PAID-T have recently been reassessed, resulting in a 14-item, 
three-factor version of the scale, with defined cut points for high DD (Shapiro et 
al., 2017). Thus, there is now a variety of age-specific measures of DD 
(Delamater et al., 2013; Kovacs et al., 1986; Markowitz et al., 2015; Shapiro et 
al., 2017; Weissberg-Benchell & Antisdel-Lomaglio, 2011) and validated cut 
points for both the 14-item (Shapiro et al., 2017) and 26-item versions of the 
PAID-T (Chapter 4).  The brevity and 3-factor structure of the 14-item PAID-T 
may make this version more suitable for research purposes, whereas the longer 
26-item scale may be more useful in clinical practice, where the emphasis is on 
exploring concerns more broadly and monitoring change over time.  
7.4.1.2 Disentangling diabetes distress from depressive symptoms 
A high proportion of the variance in DD was explained by depressive 
symptoms, suggesting the PHQ-A is reflective of DD (Fisher et al., 2007; 
Tanenbaum & Gonzalez, 2012).  
Studies in adults suggest that self-report depressive symptom measures over-
estimate depression, because they also reveal DD (Fisher et al., 2016b). While it 
is not possible to determine this from the current studies, the findings reported in 
this thesis are consistent with studies in adults, for example, that DD is 
independently associated with HbA1c, but depressive symptoms are not (Chapter 
5).  
7.4.1.3 The value of assessing diabetes distress in clinical practice 
Chapters 4 and 5 showed that elevated DD is common among adolescents 
with T1D; at least 1-in-4 experienced high DD (23%-36%) and 1-in-5 (21%) 
moderate-to-severe depressive symptoms. Nevertheless, some adolescents (5%) 
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reported moderate-to-severe depressive symptoms but no DD, whereas for one-
third (36%), diabetes was a source of high distress (Chapter 5). Consequently, it 
is important to assess both constructs in routine clinical care, so that the most 
appropriate support is offered. For example, depressive symptoms were not 
significantly related to HbA1c, therefore interventions aimed at improving 
diabetes management are unlikely to alleviate depression, whereas increasing 
self-management skills may assist DD (Grey et al., 1998a). Moreover, 
antidepressant medication is unlikely to decrease DD. Thus, the severity and 
source of distress should be assessed with the appropriate measures in order to 
offer the most appropriate management and support (Fisher et al., 2014; Snoek, 
Bremmer, & Hermanns, 2015). 
7.4.2 Interventions to decrease diabetes distress 
The TEAM T1 program did not demonstrate a decrease in DD (Chapter 
6); and even if it had, the study was uncontrolled, meaning that any reduction 
could have been attributed to the Hawthorne effect (Sedgwick & Greenwood, 
2015). So, the TEAM T1 program cannot be recommended as an intervention for 
reducing DD at the present time. Further refinement of the curriculum and more 
structured and longer follow-up may help to sustain change. The experience and 
skill level of the facilitator is likely to influence the effectiveness of the program, 
and some TEAM T1 facilitators expressed a lack of confidence in leading the 
sessions teaching coping skills (e.g., social problem-solving, stress management) 
despite receiving training (albeit a limited amount) (Data not reported, as beyond 
the remit of this thesis). Interventions that work in the research setting may not be 
as effective when delivered in routine clinical care. For example, motivational 
interviewing (MI) to reduce barriers to self-management was promising in a pilot 
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study and RCT when delivered by nurses with training in health psychology and 
MI techniques (Channon & al., 2007), but not effective when implemented more 
broadly by health professionals without substantial experience in MI (Robling et 
al., 2012). Similarly, TEAM T1 produced promising results in the pilot phase 
when facilitated by experienced educators (Knight et al., 2010), but has been less 
successful when implemented more widely (Chapter 6). One of the barriers to 
sustaining psychoeducational interventions in routine care is the ongoing skills 
maintenance and retention of trained facilitators (Robling et al., 2012), and this 
was a problem encountered in the TEAM T1 Study (Chapter 6).  
Although recruitment into structured education is a perennial challenge 
(Coates et al., 2017), group-based activities provide the opportunity for peer 
support.  Emotional support from peers has been shown to predict lower DD and 
indirectly, lower HbA1c (Raymaekers et al., 2017), whereas perceived negative 
reactions from peers regarding diabetes is associated with elevated DD and less 
adherence to self-care (Hains et al., 2007; Raymaekers et al., 2017). Diabetes 
camps also offer social support, but other methods of facilitating peer support, for 
example, via the internet or smartphone ‘Apps’ may be more feasible to integrate 
into routine care.  A RCT of an ‘App’ to support self-management (e.g. 
carbohydrate counting) with online ‘chatrooms’ did not impact DD (Castensøe-
Seidenfaden et al., 2018), but given the ubiquitous use of smartphones, the role of 
technology, social media and DD warrants further investigation.   
Technology to support self-management, including insulin pumps and 
CGM, do not appear to worsen DD (Boland et al., 1999b; Naranjo, Tanenbaum, 
Iturralde, & Hood, 2016) and no difference in DD according to insulin delivery 
mode was observed in the Diabetes MILES Youth Study (Chapter 4). Advanced 
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technology, such as the ‘bionic pancreas’ was shown to reduce regimen-related 
burden and fear of hypoglycaemia (Weissberg-Benchell, Hessler, Polonsky, & 
Fisher, 2016), although it is likely to be some time before these devices are 
affordable and accessible in routine care.   
7.4.3 Implications for future research 
Implications for future research that are relevant to each study of the 
thesis have been discussed within the relevant chapters. The implications 
discussed below, apply to the learnings from the PhD thesis as a whole, and fall 
into three main categories: measurement of DD, gender differences in DD and 
future interventions.  
7.4.3.1 Measurement of diabetes distress 
Many studies of depression among adolescents have used self-report 
measures rather than diagnostic interview (Blanz, Rensch-Riemann, Fritz-
Sigmund, & Schmidt, 1993; Buchberger et al., 2016). When this practice has 
occurred in research with adults with diabetes, Fisher and colleagues (2016b) 
suggest that this has over-estimated the prevalence of depression. The most recent 
studies in adolescents using the gold-standard diagnostic interview and a control 
group without diabetes are now over 20 years old (Blanz et al., 1993; Kokkonen, 
Taanla, & Kokkonen, 1997). No longitudinal studies have been undertaken in 
adolescents that concurrently assess clinical depression (using gold standard 
methods) and DD. Prospective research examining the trajectory of DD and 
depression, and their relationship to diabetes management, using both diagnostic 
interview and self-report measures, would advance our understanding of these 
interactions in adolescents with T1D. Furthermore, this knowledge could be used 
to inform the development of interventions aimed at the most appropriate 
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proximal risk factors for DD, with a view to improving overall emotional well-
being and quality of life in this vulnerable population.  
Studies in adults have for many years used the one version of the PAID or 
DDS to measure DD (Polonsky et al., 1995; Polonsky et al., 2005), but recently 
scales have been developed to focus on the issues relevant to the type of diabetes 
(Fisher et al., 2015). Given the increase in prevalence of type 2 diabetes among 
adolescents and young adults, an adolescent-specific version may be needed. 
Therefore, a focus of future research could include the development of a DD scale 
for youth with type 2 diabetes.  
7.4.3.2 Gender differences in diabetes distress 
Although girls reported higher levels of DD than boys, they did not 
experience any greater or lesser benefit from TEAM T1 (Chapter 6). This study 
also found that girls appeared to receive less support from parents (i.e. parent 
non-attendance at TEAM T1). Further research exploring predictors of distress 
for female and male adolescents would elucidate their specific risk factors and 
could inform the development of tailored interventions to optimise outcomes for 
girls and boys experiencing elevated DD. 
7.4.3.3 Interventions to prevent and reduce diabetes distress 
Future research could focus on trialling interventions to promote positive 
coping skills and to be delivered by health professionals as part of routine clinical 
care. Given the significant association between self-efficacy and DD observed in 
the TEAM T1 Study (Chapter 6), and previous studies indicating an interaction 
between family conflict and self-efficacy (Holmes et al., 1999; Noser et al., 
2017), the role of parental support in maintaining self-efficacy and minimising 
DD could be explored through qualitative and experimental studies.  
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7.5 Conclusions 
The overall findings of this research extend previous knowledge of the 
measurement, correlates and clinical significance of DD among adolescents with 
T1D. Using a rigorous approach, cut points were established for the PAID-T, 
demonstrating that a substantial proportion of adolescents experience clinically 
meaningful DD. This PhD thesis corroborated findings in adults that DD mediates 
the relationship between depressive symptoms and HbA1c, highlighting the 
importance of assessing both DD and depression in research and clinical practice 
and choosing the most appropriate support strategies. Further research to explore 
the interaction among general and diabetes-specific distress, self-management 
and HbA1c longitudinally, using diagnostic interview and self-report measures, 
would help to explain potential pathways in adolescents, as these may not be the 
same as for adults. A structured T1D education program modified for adolescents 
and aimed at improving self-care and coping skills and family communication 
about diabetes had no overall impact on DD but there was a short-term increase in 
self-efficacy. Although none of the study outcomes predicted change in DD, self-
efficacy and family support are important areas for further exploration.  Further 
research is needed in relation to gender differences in DD, and to identify and 
develop the most appropriate strategies for minimising DD, including tailored 
approaches for girls and boys. Although adolescents appear to benefit from the 
social aspects of group education, recruitment and retention of participants 
requires substantial attention and strategies for reducing DD that can be delivered 
in routine care need to be explored. The findings of this program of PhD research 
highlight the relevance of assessing DD among adolescents with T1D, and the 
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need to address this largely unmet need with targeted, evidence-based 
interventions and clinical support. 
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Appendix C: Diabetes MILES Youth Study Letter of Invitation, 
Participant Information Statement and Consent 
 
Diabetes MILES Youth Survey Letter of Invitation 
 
Dear <First Name>, 
I am inviting you and <child’s first name>7  to take part in an online survey to share your 
views on living with diabetes. 
Your feedback will help us to improve our services and resources and it is 
important we hear from young people with diabetes and their parents. 
The aim of the Diabetes MILES* Youth survey is to gain an understanding of the well-
being, health and needs of young people with diabetes and their parents. The survey will 
allow young people to express their opinions on how diabetes impacts them and what 
they would like to see in the future to help them manage their diabetes.  
The online survey will be available for one month from 11th August 2014 and can 
be found at www.milesyouth.com  
The survey is designed to ask you and your child different questions about your lives with 
diabetes. If your child is younger than 18, it is your decision whether you give them the 
survey.  You can view the survey questions before allowing your child to complete it. To 
find out more about the survey please visit the Frequently Asked Questions section on 
the Miles website. You will go into the draw to win an iPad Mini if you take part in the 
parents’ survey and if your child completes the survey they will also be entered into the 
draw to win an iPad Mini.  
Researchers at the Australian Centre for Behavioural Research in Diabetes (ACBRD) 
are conducting the online survey on behalf of the NDSS and Diabetes Australia. The 
survey has been approved by Deakin University Human Research Ethics Committee 
(project number: 2014-060), and participation is voluntary. 
We would like to assure you that your personal information has been protected and that 
your details have not been given to the research team. We respect your privacy and no 
identifying personal information will be linked to your responses. If you or your child have 
any questions, or would prefer to do the survey by telephone, please contact           Dr 
Steve Trawley by email at strawley@acbrd.org.au or by phone on (03) 9667 1706.  
Your feedback is valuable and will help us improve the information and services we 
provide for you and other families living with diabetes. 
If you do not wish to be sent information about future research opportunities, please call 
the NDSS Infoline on 1300 136 588 or visit the NDSS website, ndss.com.au, and see the 
‘Update Your Details’ section. 
Yours sincerely 
 
Renza Scibilia 
National Program Leader – Young People with Diabetes8 
                                                 
7 For children aged under 18 years the letter of invitation was mailed to parents.   
8 The Young People with Diabetes National Development Program is funded as part of the National Diabetes 
Services Scheme which is an initiative of the Australian Government administered by Diabetes Australia.  
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Diabetes MILES Youth Study Participant Information and Consent 
Tell us how you feel about living with diabetes. You may have been asked to do a 
lot of surveys, but this one really matters - so have your say!   
Whether you are managing well or struggling with diabetes, we want to know.  
The NDSS is asking all young people with diabetes aged 10-19 years to take part 
in the Diabetes MILES Youth (MY) Survey.  
MY Survey is online for one month starting 11 August 2014. It takes less than 30 
minutes to complete and everyone who finishes can enter the draw to win an 
iPad.  Taking part is voluntary. You do not have to complete the survey or answer 
every question if you don't want to. 
Please read the information below before giving consent to take part and starting 
the survey. 
 
Participant Information  
Who is conducting the survey?  
Researchers at the Australian Centre for Behavioural Research in Diabetes 
(ACBRD) are conducting the online survey on behalf of NDSS and Diabetes 
Australia. The Young People with Diabetes National Development Program is 
funded as part of the National Diabetes Services Scheme which is an initiative of 
the Australian Government administered by Diabetes Australia. Professor Jane 
Speight (Director, ACBRD) is the principle investigator and takes responsibility 
for this study (email: jspeight.acbrd.org.au, telephone: (03) 8648 1850).     
Who can take part?   
To take part in this study you must live in Australia, be aged between 10-19 years 
old with diabetes and be able to read and write English without assistance.     
Can I withdraw at any time?   
Yes, you are free to decide not to participate or withdraw from the study at any 
time without giving any reason. Doing so will not affect your relationship with 
the ACBRD, the NDSS, Deakin University, or Diabetes Australia. If you wish to 
be eligible to withdraw from this study later on, it is important that you provide 
your National Diabetes Services Scheme (NDSS) registration number (when 
asked at the start of the survey) so we can identify your survey responses. If you 
do not provide this information, your data will be completely anonymous and we 
will be unable to locate and remove your data. If you wish to have your data 
                                                 
Leadership for the Young People with Diabetes National Development Program is provided by Diabetes 
Australia - Vic. 
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withdrawn from the study after you have completed the survey, please contact the 
ACBRD team (email: diabetesmiles@acbrd.org.au, telephone: (03) 9667 1706).     
What does the study involve?   
Taking part in this study involves the completion of the Diabetes MILES-Youth 
online survey, which will take approximately 30 minutes. This survey invites you 
to ‘have your say’ and think about your experience of living with diabetes. 
Completion of the survey confirms that you have read this Participant 
Information Statement and agree to take part in this study. The Participant 
Information Statement form is for you to print and keep.   
Are there any benefits for me personally?   
There are no specific benefits to you. However, we appreciate that the online 
questionnaire booklet takes time to complete, so as a token of our appreciation, 
every completed questionnaire received by 4 September 2014 will be entered into 
a prize draw, with a chance to win an iPad mini.   
Are there any risks to me?  
 We don’t believe there are any risks to you from taking part in this study. Some 
of the questions ask about sensitive and/or personal information. We do not 
expect these questions to cause you any distress. However, if you do feel any 
distress or upset as a result of these questions, we encourage you to speak to your 
parents, your diabetes care team, GP or visit www.diabetescounselling.com.au.   
There will be no medical or blood tests involved in the study. By taking part you 
will be involved in research that will help us to understand more about how 
diabetes affects young people’s lives.   
What will happen to my information?   
This survey is hosted via Qualtrics. The computer at which you complete this 
survey will not be traced. All survey data will be downloaded to the ACBRD 
office, where the information will be stored in computer files accessible only by 
the ACBRD research team. In accordance with government requirements, all data 
and surveys will be kept for a minimum of six years after the completion of the 
Diabetes MILES-Youth study and then disposed of by erasing electronic files and 
shredding of paper copies.  Your responses will be analysed along with those 
from other people taking part in the Diabetes MILES-Youth Study. If you and 
your parent both enter your NDSS membership number we will match your 
results in our analysis. However, we cannot access any personal details from your 
NDSS number.  To enter the prize draw for the iPad you will need to provide an 
email address. At the end of the survey you will be directed to another web page 
where you can provide contact details for the prize draw. Please note this 
information will be kept in a separate database that can in no way be linked to 
your survey responses.  Your responses may also be used in the future to compare 
with future studies. Before future studies go ahead, we will apply for ethics 
approval. Any data made available to external research parties will be de-
identified, meaning that no-one will be able to identify you from the information. 
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Your personal details, such as NDSS registration number, will be kept in a 
separate ACBRD password-protected file which will never be made available to 
anyone outside the research team.   The overall results of the Diabetes MILES-
Youth Study will be published on the NDSS website, academic journals, 
conferences, and diabetes magazines and newsletters. No-one will be able to 
identify you from any of the information we publish or present. We will take 
great care to protect your identity. Your privacy is very important to us.     
Has this study been approved by an Ethics Committee?   
Yes. Approval to undertake this study has been given by the Human Research 
Ethics Committee of Deakin University (research project number 2014-060).     
Who can I contact about this study?   
If you have any complaints about any aspect of the project, the way it is being 
conducted, or any questions about your rights as a research participant, then you 
may contact: The Manager, Office of Research Integrity, Deakin University, 221 
Burwood Highway, Burwood Victoria 3125, Telephone: (03) 9251 7123, Fax: 
(03) 9244 6581.    
If you would like further information or have any questions about the study, 
please contact the ACBRD (email: diabetesmiles@acbrd.org.au, telephone: (03) 
8648 1844). You may also like to visit the NDSS website, or write to us at: The 
Diabetes MILES-Youth Study, The Australian Centre for Behaviour Research in 
Diabetes, 570 Elizabeth St, Melbourne Vic 3000 Telephone: (03) 9667 1706, Fax: 
(03) 9667 1778. 
I am ready to start completing the Diabetes MILES-Youth Survey: 
 I have read and understood the information above. 
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Appendix D: MILES Youth Study Questionnaire 
 
Thank you for agreeing to take part in the Diabetes MILES Youth Survey. You 
are now ready to start.  
The survey will take you about 30 minutes to finish all the questions. You can 
take a break if you need to and come back later. Make sure you use the same 
device (computer, tablet, mobile phone) when you come back so you will not 
need to start again. The survey will take you back to where you left off.       
Please read the instructions carefully and answer every question. Some questions 
ask you to consider different time periods (e.g. the past 2 weeks or the past 12 
months).  Questions that need an answer are marked *.You will be prompted to 
answer any missed items before moving to the next page.   
Remember: it is not an exam, so there are no ‘right’ or ‘wrong’ answers. This is 
about you and your diabetes. It is important to answer each question as 
thoughtfully and honestly as possible. 
About you9 
Please tell us about yourself ...     
1. Are you...?   Male   Female   
2. How old are you? ___________ years 
3. What state or territory do you live in? 
 ACT   NSW   NT    QLD  
 SA   TAS   VIC   WA 
4. What is your postcode? _______ 
5. Were you born in Australia? 
Yes  No, I was born in another country (please write) _______________ 
6. Are you or your family Aboriginal or Torres Strait Islander?  
 Yes    No  
7. What is the main language you speak at home? 
 English   Another language (please write)  ____________________ 
                                                 
9 This questionnaire only includes items used in the analyses reported in this 
thesis. For a description of all items included in the MILES Youth survey, refer to 
Chapter 3: Diabetes MILES Youth-Australia: Methods and Sample 
Characteristics of a National Survey of the Psychological Aspects of Living with 
Type 1 Diabetes in Australian Youth and Their Parents. 
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8. Which best describes your family? 
 Two parents (biological or adoptive parents)  
 Two parents, one being a step-parent 
 Single parent family  
 Other (please describe) ____________________ 
9. Think of where you live most of the time. Who lives there with you? 
(please tick all that apply) 
 Mum  
 Dad 
 Brother(s) / Sister(s)  
 Grandparent(s)  
 Friends / Housemates  
 Other person (please write) ____________________ 
 Step-mum 
 Step-dad 
 Other children 
 Stepbrother(s) / Stepsister(s)  
 Uncle(s) / Aunt(s)  
 Boyfriend / Girlfriend / Partner  
 Dad's partner  
 Mum's partner  
 Foster-parent(s) / Guardian / Carer  
 I live on my own  
10. Do you go to school?  Yes    No  
If Yes, what year level are you in at school? 
 Year 4   Year 5   Year 6   Year 7   Year 8  
 Year 9   Year 10   Year 11   Year 12  
11. If you are not at school, please tell us what you are doing? (Please tick the 
main one only) 
 Apprenticeship or trade training  
 University student  
 Working full/part-time 
 Looking for work  
 Home duties / carer  
 Other (please write)  ____________________ 
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My Diabetes 
These questions ask about how you (and your parents / carer) take care of your 
diabetes. Please answer each question as honestly as you can. 
12. What type of diabetes do you have?* 
 Type 1  
 Type 2  
 Other type of diabetes (please write)  ____________________ 
 Don't know / unsure  
 
13. How old were you when you got diabetes?* ________ years 
14. How do you manage your diabetes?* (Tick only the main one) 
 I take insulin injections  
 I use an insulin pump  
 I take diabetes tablets (to lower blood glucose)  
 
The next few questions are about your HbA1c level – a blood test to measure 
your average blood glucose over the past 2-3 months. 
15. When was your last HbA1c check? 
 Less than 3 months ago 
 3-6 months ago 
 7-12 months ago 
 More than 12 months ago 
 I don't know  
 
16. What was your HbA1c the last time it was checked?   ______ %  
 
17. How often do you (or a parent / carer) usually check your blood glucose 
EACH DAY? 
 1 
 2  
 3  
 4  
 5  
 6  
 7  
 More than 7 times a day 
 I don’t check it every day 
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18. If you don't check your blood glucose every day, how often do you 
usually check it? 
 A couple of times a week  
 A couple of times a month 
 Almost never 
 I don't check my blood glucose 
 
19. On a usual day, what times of the day do you have insulin? (Tick all that 
apply) 
 At breakfast  
 At lunch  
 At dinner  
 Evening / bedtime  
 With snacks  
 Other time(s) (please write)  ____________________ 
 
My Moods - This section is about your moods and feelings in general.  
20. Over the PAST 2 WEEKS, how often have you been bothered by the 
following problems?   
 
Not at 
all  
 
0 
Several 
days 
 
1 
Over 
half the 
days  
2 
Nearly 
every 
day  
3 
Feeling down, depressed, irritable, or 
hopeless 
    
Little interest or pleasure in doing 
things 
    
Trouble falling or staying asleep, or 
sleeping too much 
    
Feeling tired or having little energy      
Poor appetite, weight loss or overeating     
Feeling bad about yourself or that you 
are a failure or have let yourself or your 
family down  
    
Trouble concentrating on things, like 
school work, reading or watching 
television   
    
Moving or speaking so slowly that 
other people could have noticed. Or the 
opposite, being so fidgety or restless 
that you have been moving around a lot 
more than usual.  
    
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My Feelings 
21. Living with diabetes can sometimes be difficult. In day-to-day life, there are 
many hassles with your diabetes. The problems may range from minor hassles to 
major life difficulties. 
Listed below are a variety of possible problem areas which people with diabetes 
may have. Think about how much each of these items below may have upset or 
bothered you DURING THE PAST MONTH and select the appropriate number.  
If you feel that an item is not a bother or a problem for you, you would pick “1”. 
If it is a serious problem for you, you would pick “6”.  Please note we are asking 
how much of a problem each item may be for you NOT whether the item is 
merely true for you.  
 
Not a 
problem 
Moderate 
problem 
Serious 
problem 
Feeling sad when thinking about having 
and living with diabetes  
1 2 3 4 5 6 
Not knowing if the mood or feelings I am 
having are related to my blood glucose 
(blood sugar) levels  
1 2 3 4 5 6 
Feeling overwhelmed by my diabetes 
regimen  
1 2 3 4 5 6 
Feeling angry when I think about having 
and living with diabetes  
1 2 3 4 5 6 
Feeling constantly concerned about food 
and eating  
1 2 3 4 5 6 
Worrying about the future and the 
possibility of serious complications  
1 2 3 4 5 6 
Feeling upset when my diabetes 
management is “off track” 
1 2 3 4 5 6 
Feeling “burned-out” by the constant 
effort to manage diabetes   
1 2 3 4 5 6 
Feeling that I am not checking my blood 
glucose often enough  
1 2 3 4 5 6 
Feeling unclear about exactly what and 
how much I should be doing to take care 
of my diabetes properly  
1 2 3 4 5 6 
Not feeling motivated to keep up with 
my daily diabetes tasks   
1 2 3 4 5 6 
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Not a 
problem 
Moderate 
problem 
Serious 
problem 
Feeling discouraged or defeated when I 
see high blood glucose results on my 
meter  
1 2 3 4 5 6 
Feeling that my friends and family act like 
“diabetes police” (e.g. nag about eating 
properly, checking blood glucose, not 
trying hard enough)  
1 2 3 4 5 6 
Feeling like my parents don’t trust me to 
care for my diabetes  
1 2 3 4 5 6 
Feeling like I must be perfect in my 
diabetes management 
1 2 3 4 5 6 
Missing or skipping blood glucose checks  1 2 3 4 5 6 
Feeling that my blood glucose levels are 
often swinging wildly, no matter how 
hard I try  
1 2 3 4 5 6 
Feeling that I am often failing with my 
diabetes regimen 
1 2 3 4 5 6 
Feeling like my parents blame me for 
blood glucose numbers they don’t like 
1 2 3 4 5 6 
Feeling that my friends or family don’t 
understand how difficult living with 
diabetes can be  
1 2 3 4 5 6 
Feeling that I can’t control my eating 1 2 3 4 5 6 
Worrying about my weight  1 2 3 4 5 6 
Worrying that diabetes gets in the way of 
having fun and being with my friends  
1 2 3 4 5 6 
Fitting my diabetes regimen into my day 
when I am away from home (e.g.. school, 
work, etc.)  
1 2 3 4 5 6 
Worrying about getting low during sports 
activity  
1 2 3 4 5 6 
Feeling like my parents worry about 
complications too much 
1 2 3 4 5 6 
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22. For each of the following questions, select how often the situation applies 
to you or how often you feel this way.      
 All the 
time 
Often Some 
times 
Rarely Never 
How often do you argue with your 
parents about… 
… remembering to check your 
blood glucose / giving injections?  
 
 
 
 
 
 
 
 
 
 
… meals and snacks?       
How often do you feel…      
... you have too much 
responsibility for your diabetes 
care?  
     
... your parents / other people have 
too much responsibility for your 
diabetes care? 
     
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Appendix E: TEAM T1 Participant Information and Consent 
 
 
 
 
 
 
 
Teens Empowered to Actively Manage Type 1 Diabetes (TEAM T1) 
 
(MASTER) INFORMATION AND CONSENT FORM - ADOLESCENTS 
 
You are invited to take part in a study to evaluate the TEAM T1 program, a group education 
program for teenagers with type 1 diabetes and their parents.  We want to know whether 
the TEAM T1 program helps young people to manage their diabetes and if their health is 
improved after the program. This information sheet tells you what is involved so you can 
decide if you would like to take part. 
 
What is the purpose of this research project? 
This study aims to find out how the TEAM T1 program helps young people with type 1 
diabetes, whether there are any changes to how you feel about your life and diabetes, and 
how you manage your diabetes after completing the program. We want to know if these 
changes remain over time, so will be asking you to complete an online questionnaire  
before the TEAM T1 program and  3 months, 12 months and 2 years after the program. 
All TEAM T1 participants around Australia are being invited to complete the study 
questionnaires. This will involve up to 330 teenagers with type 1 diabetes.   
 
Who is conducting the study? 
The study is being conducted by the Australian Centre for Behavioural Research in 
Diabetes (ACBRD), which is a partnership between Diabetes Australia - Vic and Deakin 
University. The study is being led by Professor Jane Speight.  This project is supported 
with funding from the Australian government under the Chronic Disease Prevention and 
Service Improvement Fund. 
 
Who can take part in this study? 
You have been asked to take part in this study because you are enrolled in a TEAM T1 
program at the [site name].  Young people aged between 14 to 18 years, who have type 1 
diabetes are able to attend the TEAM T1 program.  
 
Do I have to take part in this project? 
It is your choice if you would like to take part or not.  Deciding not to take part will not affect 
your diabetes care or your relationship with your diabetes care staff, or anyone else 
involved in this project. If you would like to take part, you and your parent/guardian need 
Project Supervisor: 
Prof Jane Speight  
The Australian Centre for  
Behavioural Research in Diabetes (ACBRD) 
Telephone:  (03) 8648 1850 
e-mail:  jspeight@acbrd.org.au 
 
Co-Investigator: 
Name ….. Telephone:  
 
PHD Student: 
Virginia Hagger … Telephone: (03) 9667 1715 
322  
to sign a short “Consent Form” and return it in the reply paid envelope or bring it with you 
to clinic. If you decide to take part and then you change your mind you can stop being in 
the study at anytime and we will not ask why. If this happens, you can choose to have any 
information that we have already collected from you taken out of the study. If you decide 
to do this it won’t affect your diabetes care.  
 
What does participating in the study involve? 
TEAM T1 is an education program held over 5 week-days (Monday to Friday) from 10am 
to 3pm each day, during school holidays.  Taking part in this evaluation study involves 
completing an online questionnaire a week before you attend the TEAM T1 program, and 
after the program, at three months, one and two years later. You will be given a number 
and password so you can login to the TEAM T1 website. We expect it will take about 30 
minutes to answer all the questions. The questions ask about how you feel about your life, 
social life, family and diabetes, your mood, worries and problems related to your diabetes 
and how you are managing day to day. A written copy of the questionnaire is available if 
you prefer. On the last day of the program we will ask you to answer some written 
questions about your opinion of the TEAM T1 program. Your answers to these questions 
will be anonymous (so we won’t know whose opinion it is).  
 
With you and your parent’s permission, we will ask your doctor or diabetes educator to 
provide us information about your diabetes and treatment, including your HbA1c (average 
blood glucose) results for the 12 months before and after the TEAM T1 program, your 
weight and height, insulin type and doses, and any other medical conditions you may have.  
 
We may also ask you, if you agree, to be interviewed by our researcher, who will ask you 
questions about your experience of the TEAM T1 program, what you found helpful and 
what wasn’t helpful, how you feel about your diabetes and what changes you have made 
(if any) to your diabetes management since attending the program. The interview will last 
for about one hour. We will interview you again one year later. The interview will be audio-
recorded. 
 
Are there any benefits for me personally? 
You will be given your results from before and after the program, which will show you 
how you are going with your diabetes. There are no other direct benefits to you.  
Are there any costs? 
There are no costs associated with participating in this research project. 
Are there any risks? 
We do not believe there are any risks to you. Some people find answering questions 
about their diabetes and life uncomfortable. If you find any questions upsetting or 
concerning, please let the researcher know. They can talk to you about it and help you 
get the right support. Every care has been taken to make sure that the questions are 
relevant and brief. 
Does the study ask for contact or personal details? 
We will only keep a record of your name, address and telephone numbers so that we can 
contact you when it is time to complete the questionnaires again, and to invite you for an 
interview (if you choose to agree to this part of the study).  
What will happen to my information? 
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If you do take part, all the information we collect about you will be used and stored 
according to Australian privacy laws. The database holding your information can only be 
accessed by the research staff involved in this study.  Your paper files will be kept safe in 
a locked cabinet and the computer files will be stored in a password-protected file at 
Diabetes Australia-Victoria. 
The TEAM T1 diabetes educator will be able to see your answers to the questionnaires.  
This is so they can discuss with you any concerns or worries you have about your 
diabetes and offer you support if required. Your parents will not see your answers.  
The research will be published in a journal for health professionals and will be presented 
at a scientific meeting. It will be used as part of the researchers’ university work. 
Anything written about the study will be de-identified – this means it will not have any 
information in it that will allow people to know who you are or what your results are. Your 
name and any personal information that could identify you will not be used in any report 
or publication unless you give us permission to do so. 
How will I be informed about the final results of this research project? 
The Australian Centre for Behavioural Research in Diabetes will post a report of the 
study results on the TEAM T1 website.  
Can I access research information kept about me? 
You will be able to see and update your contact information on the TEAM T1 website if it 
has changed. You can ask the research coordinator for a copy of the information we 
have about you. 
Has this study been approved by an ethics committee? 
Yes. The study has been approved by the Human Research Ethics Committees at 
Deakin University and Hunter New England Human Research Ethics Committee, (ref no 
13/08/21/4.02). 
Who can I contact for more information? 
If you would like further information or have any questions about the study, please 
contact the study coordinator, Virginia Hagger,  at The Australian Centre for Behavioural 
Research in Diabetes on 03 9667 1715 or email: vhagger@diabetesvic.org.au. 
Alternatively, you may contact the study lead, Professor Jane Speight on 03 8648 1850 
or email: jspeight@acbrd.org.au.  If you would like to speak to someone involved at [site 
name] you may contact [name] on [phone] or email:[email address]. 
Who can I contact if I have a concern or complaint about the study? 
Should you wish to discuss the study with someone not directly involved, in particular in 
relation to matters concerning policies, information about the conduct of the study or your 
rights as a participant or you wish to make a confidential complaint, at any time, you may 
contact you may contact Hunter New England Human Research Ethics Committee, on 
(02) 49214950, email hnehrec@hnehealth.nsw.gov.au  or The Manager, Research 
Integrity, Deakin University, 221 Burwood Highway, Burwood Victoria 3125, Telephone: 
03 9251 7129; research-ethics@deakin.edu.au. Please quote project number [2013-
246]. 
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Teens Empowered to Actively Manage Type 1 Diabetes (TEAM T1) 
(MASTER) CONSENT FORM - ADOLESCENTS 
  
• I have read, and I understand the Information Statement, and was given a copy 
to keep. 
• I have had any questions or queries answered to my satisfaction. 
• I give permission for my doctors or other health professionals to release 
information to The Australian Centre for Behavioural Research in Diabetes 
concerning my diabetes and treatment for the purposes of this project. I 
understand that such information will remain confidential.  
• I freely agree to participate in the Teens Empowered to Actively Manage Type 1 
Diabetes (TEAM T1) Evaluation Study according to the conditions in the 
Information Statement.  
• I understand that my personal information will remain confidential to the 
researchers. 
• I do / do not give permission to be interviewed about my experience of TEAM T1. 
(Please cross out the words that do not apply) 
Participant’s Name: 
Signature:    ........................................................…..  Date : 
 
Parent’s Name:         
Signature:    …...........................................................  Date: 
 
Declaration by researcher: I have given a verbal explanation of the research project, its 
procedures and risks and I believe that the participant has understood that explanation. 
Researcher’s Name:  
Signature:     ............................................................  Date: 
Project Supervisor: 
Prof Jane Speight  
The Australian Centre for  
Behavioural Research in Diabetes (ACBRD) 
Phone:  (03) 8648 1850 
e-mail:  jspeight@acbrd.org.au 
 
Co-Investigator: 
[name] …..  Phone:  [ number] 
 
PHD Student: 
Virginia Hagger … Phone: (03) 9667 1715 
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Appendix F: TEAM T1 Study Questionnaire 
 Questionnaire for Adolescents  
 Pre-program   3-months post-program  12 months post-program          
 24 months post-program 
Name ________________________________ Date _________________ 
 
Thank you for taking the time to complete the TEAM T1 questionnaire. The questions we 
are asking will help us to understand how the TEAM T1 program helps young people with 
type 1 diabetes.  
Read the instructions for each set of questions carefully. Some ask you to consider 
different time periods (e.g. two weeks or the past month).  Please pick one box. Please 
answer every question. Remember: it is not an exam, so there are no ‘right’ or ‘wrong’ 
answers. This is about your experience.  
 
General questions about you 
These questions ask about you and your family. 
1. 1. Are you?    a student     working    other _____________ 
 
2. Do you currently live with?  
 both parents   
 mother or father only    
 grandparent/guardian  
 not living at home 
My life in general 10 
3. The following question asks about your quality of life - how good or bad you feel 
your life is right now.  
Here is a picture of a ladder. The top of the ladder ‘10’ is the best possible life for you, and 
the bottom ‘0’ is the worst possible life for you. In general, where do you feel you stand at 
the moment? Circle the number that suits you best. 
 
0 1 2 3 4 5 6 7 8 9 10 
           
Worst possible life             Best possible life 
                                                 
10 Questions 3-37 (with kind permission) from the MIND Youth Questionnaire (MYQ)  
de Wit, M., Winterdijk, P., Aanstoot, H.-J., Anderson, B., Danne, T., Deeb, L., . . . on behalf of 
the, DAWN Youth Advisory Board. (2012). Assessing diabetes-related quality of life of youth 
with type 1 diabetes in routine clinical care: the MIND Youth Questionnaire (MY-Q). Pediatric 
Diabetes, 13(8), 638-646. 
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For each of the following questions, select how often the situation applies to you or how 
often you feel this way. Place a tick in the box you select. 
My Life 
School / work 
 All the 
time 
Often Some 
times 
Rarely  Never 
4. It is hard for me to pay attention in 
class / at work 
     
5.  I can rely on my teacher(s) / 
colleagues to help me with my 
diabetes if they have to 
     
 
Friends 
 All the 
time 
Often Some 
times 
Rarely  Never 
6. How often does diabetes limit your 
friendships and relationships? 
     
7. I get along with other people my age      
8. Other people of my age bully me      
 
Free time 
 All the 
time 
Often Some 
times 
Rarely  Never 
9. How often does diabetes interrupt 
your leisure time activities? 
     
10. Does diabetes prevent you from 
doing activities without your parents 
(party, sleeping over, camp)? 
     
11. How often does diabetes interfere 
with your sports (e.g. football or 
tennis)? 
     
 
Family 
The following questions ask about diabetes and your family 
 
 
 All the 
time 
Often Some 
times 
Rarely  Never 
12. How often does your diabetes 
interfere with your family activities?  
     
13. How often do you feel like a burden to 
members of your family because of 
your diabetes (your parents, brothers 
or sisters or grandparents)? 
     
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Mood 
 
In the past TWO 
WEEKS… 
All 
the 
time 
Most of 
the time 
 
More 
than half 
of the 
time 
Less 
than 
half of 
the time 
Some 
of the 
time 
At no 
time 
21. I have felt cheerful and 
in good spirits 
      
22. I have felt calm and 
relaxed 
      
23. I have felt active and 
vigorous 
      
24. I woke up feeling fresh 
and rested 
      
25. My daily life has been 
filled with things that 
interest me 
      
 
body and weight 
For each of the following questions, select how often the situation applies to you or how 
often you feel this way.  
How often do you feel that your 
parents… 
All the 
time 
Often Some 
times 
Rarely  Never 
14. … do not give you enough help and 
support for managing your diabetes? 
     
15. …worry too much about your 
diabetes? 
     
16. … act like diabetes is their disease, 
not yours? 
     
How often do you argue with your 
parents about… 
All the 
time 
Often Some 
times 
Rarely  Never 
17. … remembering to check your blood 
sugars / giving injections? 
     
18. … meals and snacks?      
Do you feel… All the 
time 
Often Some 
times 
Rarely  Never 
19. …you have too much responsibility 
for your diabetes care? 
     
20. …other people have too much 
responsibility for your diabetes care? 
     
 All the 
time 
Often Some 
times 
Rarely Never 
26. I’m happy with the way I look      
27. I have been trying to control my 
weight or shape in different 
ways 
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My diabetes 
 
Please select how happy or unhappy you feel about your current diabetes treatment. 
 
36. Which 3 parts of your diabetes treatment are hardest to work into your 
daily activities?    
Nothing  
Pricking my finger  
Injecting insulin  
Carbohydrate counting  
Deciding what to eat and drink  
Responding to low blood sugars  
Managing high blood sugars  
Something else….  
 
Events 
37. Has something happened to you in the last 3 months that made you feel happy 
or sad? (this could be related to your family, friends, school or sports) 
________________________________________________________________
________________________________________________________________ 
 
In how many of the past 14 
days… 
No 
days 
1-3 
days 
4-7 
days 
8-11 
days 
12-14 
days 
28. …have you had eating binges?      
29. …have you omitted insulin on 
purpose? 
     
 All the 
time 
Often Some 
times 
Rarely Never 
30. I feel in control of my diabetes      
31. How often do you worry about 
whether you will faint or pass out 
/ have a serious hypo? 
     
32. How often do you worry about 
whether you will get 
complications? 
     
 Extremely 
happy 
Happy Not 
happy, 
not 
unhappy 
Unhappy Not at 
all 
happy 
33. Are you happy with your 
healthcare team? 
     
34. Are you happy with the blood 
sugar control you achieve? 
     
35. Are you happy with your 
current medical treatment 
regimen? 
     
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Problem areas in diabetes 
Living with diabetes can sometimes be difficult. In day-to-day life, there are many hassles 
with your diabetes. The problems may range from minor hassles to major life difficulties. 
Listed below are a variety of possible problem areas which people with diabetes may 
have. Think about how much each of these items below may have upset or bothered you 
DURING THE PAST MONTH and select the appropriate number. 
Please note we are asking how much of a problem each item may be for you NOT 
whether the item is merely true for you. If you feel that an item is not a bother or a 
problem for you, you would circle “1”. If it is very serious problem for you, you would 
circle “6”. 
During the PAST MONTH, I have been upset 
or bothered by… 
Not a 
problem 
Moderate 
problem 
Serious 
problem 
38. Feeling sad when thinking about having 
and living with diabetes. 
1 2 3 4 5 6 
39. Not knowing if the mood or feelings I am 
having are related to my blood sugar levels. 
1 2 3 4 5 6 
40. Feeling overwhelmed by my diabetes 
regimen 
1 2 3 4 5 6 
41. Feeling angry when I think about having and 
living with diabetes. 
1 2 3 4 5 6 
42. Feeling constantly concerned about food 
and eating. 
1 2 3 4 5 6 
43. Worrying about the future and the possibility 
of serious complications 
1 2 3 4 5 6 
44. Feeling upset when my diabetes 
management is “off track”. 
1 2 3 4 5 6 
45. Feeling “burned-out” by the constant effort 
to manage diabetes. 
1 2 3 4 5 6 
46. Feeling that I am not checking my blood 
sugars often enough. 
1 2 3 4 5 6 
47. Feeling unclear about exactly what and how 
much I should be doing to take care of my 
diabetes properly. 
1 2 3 4 5 6 
48. Not feeling motivated to keep up with my 
daily diabetes tasks. 
1 2 3 4 5 6 
49. Feeling discouraged or defeated when I see 
high blood sugar results on my meter 
1 2 3 4 5 6 
50. Feeling that my friends and family act like 
“diabetes police” (e.g. nag about eating 
properly, checking blood sugars, not trying 
hard enough). 
1 2 3 4 5 6 
51. Feeling like my parents don’t trust me to 
care for my diabetes. 
1 2 3 4 5 6 
52. Feeling like I must be perfect in my diabetes 
management. 
1 2 3 4 5 6 
53. Missing or skipping blood sugar checks. 1 2 3 4 5 6 
54. Feeling that my blood sugars are often 
swinging wildly, no matter how hard I try. 
1 2 3 4 5 6 
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During the PAST MONTH, I have been upset 
or bothered by… 
Not a 
problem 
Moderate 
problem 
Serious 
problem 
55. Feeling that I am often failing with my 
diabetes regimen. 
1 2 3 4 5 6 
56. Feeling like my parents blame me for blood 
sugar numbers they don’t like. 
1 2 3 4 5 6 
57. Feeling that my friends or family don’t 
understand how difficult living with diabetes 
can be. 
1 2 3 4 5 6 
58. Feeling that I can’t control my eating. 1 2 3 4 5 6 
59. Worrying about my weight. 1 2 3 4 5 6 
60. Worrying that diabetes gets in the way of 
having fun and being with my friends. 
1 2 3 4 5 6 
61. Fitting my diabetes regimen into my day 
when I am away from home (eg. school, 
work, etc.) 
1 2 3 4 5 6 
62. Worrying about getting low during sports 
activity 
1 2 3 4 5 6 
63. Feeling like my parents worry about 
complications too much. 
1 2 3 4 5 6 
 
Hypos 11 
These questions ask about your experiences of hypoglycaemia (hypo, low blood glucose). 
64. Do you know when your hypos are commencing?  
Please circle a number between 1 and 7, where 1 = always aware and 7 = never 
aware: 
Always aware      Never aware 
 1 2 3 4 5 6 7 
Please enter the number of times that you have experienced the following:  
Note: Some questions ask you to consider different time periods (e.g. one week or 6 
months).  
65. Over the PAST WEEK, how often have you had any hypo (BG less than 3.5 mmol/l 
even if no symptoms, during the day or night)?   _____  number of times  
 
In the past 6 MONTHS, how often did you have a hypo where… 
66. You needed help and were unable to treat yourself?  ____ times (if 0, go to Q. 69) 
67. Emergency services were called to help you?   ____ times 
68. You were taken to hospital (A&E) for treatment?  ____ times 
69. You were admitted to hospital (overnight or longer)?  ____ times 
                                                 
11 Q. 66-73 adapted from the Hypoglycaemia Awareness Questionnaire (Hypo-A-Q)  
Speight, J., Barendse, S. M., Singh, H., Little, S. A., Inkster, B., Frier, B. M., ... & Shaw, J. A. M. 
(2016). Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric 
validation of the Hypoglycaemia Awareness Questionnaire (HypoA‐Q). Diabetic Medicine, 33(3), 
376-385. 
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For each question please select how often this applies to you currently.  
 Never Rarely  Sometimes Often Always 
70. I have symptoms when my 
blood glucose is low 
     
71. I ‘just know’ when I am going 
hypo by the way that I feel 
     
72. I check my blood glucose 
level if I feel ‘low’ 
     
73. Other people recognise I am 
hypo before I do 
     
 
 Strongly 
disagree 
Disagree Neither 
agree nor 
disagree 
Agree Strongly 
agree 
74. In the past 6 MONTHS, I 
have been more aware of 
my hypos coming on than I 
used to be 
     
 
75. In the past 6 MONTHS, how often have you had an episode of diabetic 
ketoacidosis (DKA) where you needed to be taken to hospital?    _____ episodes 
 
76. Over the last 2 weeks, on average how many times have you checked your 
blood glucose each day? _____ number of times 
 
 
Managing my diabetes  
Diabetes Management Self-Efficacy Scale for Adolescents with Type 1 Diabetes 
As a person with diabetes you have to perform several activities on a day-to-day basis in 
order to manage your diabetes as well as possible. The purpose of this scale is to let us 
know how confident you are in performing all these activities. 
There are no good or bad answers. Every item has five response alternatives.   
It is important that you read the items carefully and complete all the items.  
Place a tick in the box which best represents your opinion.  Please tick only one box for 
each item.  
For example - I am able to repair a flat tyre of my bicycle: If your answer is “probably 
not”, then place a tick in the fourth column.  
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 Yes, 
definitely 
 
Probably 
yes 
Maybe 
yes, 
maybe 
no 
Probably 
not 
No, 
definitely 
not 
77. I am able to continually 
alternate my insulin 
injection sites 
     
78. I can inject my insulin in 
all situations, e.g. at 
school, sleeping over, 
when I’m out 
     
79. I know what to do when 
I forget to inject my 
insulin 
     
80. I can inject my long-
acting insulin at the 
right time of the day  
     
81. I am able to do an extra 
check of my blood 
sugar before exercise 
or playing sport  
     
82. I am able to adjust my 
insulin dose and/or diet 
when playing sport / 
exercise 
     
83. I can choose what to 
eat or not 
     
84. I can adjust my insulin 
dose in relation to what 
I eat and drink 
     
85. I am able to control my 
blood sugar in case of 
skipping a meal or 
eating at a later point in 
time 
     
86. I know how to handle 
lollies and chocolate 
when offered by friends 
     
87. I am able to manage 
my diabetes when at a 
party 
     
88. I am able to regularly 
do sufficient exercise or 
sports 
     
89. I am able to adjust my 
diet and/or insulin 
dose correctly when 
getting up late 
     
90. I can attend regular 
visits with my doctor 
for diabetes 
management 
     
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 Yes, 
definitely 
 
Probably 
yes 
Maybe 
yes, 
maybe 
no 
Probably 
not 
No, 
definitely 
not 
91. I am able to check my 
blood sugar as many 
times as advised by 
my doctor or the 
diabetes team, and not 
only when I feel that 
my blood sugar is too 
high or too low 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92. I am able to discuss 
the results of my blood 
sugar tests with my 
doctor or with 
somebody on the 
diabetes team, even 
when they are not 
satisfactory 
     
93. I can feel when my 
blood sugar is too low 
     
94. I am able to take hypo 
treatment (or sugar, 
food, juice) with me 
when I go out 
     
95. I can feel when my 
blood sugar is too high 
     
96. I am able to eat a 
snack in the classroom 
in case of a hypo, 
even when my 
classmates are 
watching 
     
97. I am able to adjust my 
insulin dose and/or 
diet when having 
exams or difficult tests 
     
98. I am able to treat my 
hypos with the right 
amount of 
carbohydrate 
     
99. I can tell others that I 
have diabetes 
     
100. I am able to tell my 
friends what I have to 
do and not do because 
of my diabetes 
     
101. I can adjust my insulin 
dose correctly in case 
of illness 
     
102. I am able to manage 
my diabetes when 
staying with friends, as 
well as when I am at 
home. 
     
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Appendix G: Additional File for Chapter 2 
Systematic Review Search Terms 
1 Stress, psychological.sh 
2 Emotions or Expressed emotions.sh 
3 (affective or depressive) N1 symptoms.sh 
4 (affective or mood or depressive) N1 disorders.sh 
5 Depression.sh 
6 Quality of life.sh,ab,ti 
7 
(emotional distress or emotional problems or emotional adjustment or 
negative affect or negative emotion) N4 diabetes).tx 
8 
(fear* or worry* or worrie* or emotion* or anxi* or guilt* or shame or 
burn?out or burnout or burden or feeling* or anger) N4 diabetes .tx 
9 (well?being or “well being”) N4 diabetes .tx 
10 Diabetes N1 (distress or stress).tx 
11 
diabetes-specific N1 (distress or stress or problem or concern or worry* or 
worrie*).tx OR diabetes-related N1 (distress or stress or problem or 
concern or worry* or worrie*).tx 
12 
diabetes-related emotional N1 (distress or stress* or problem*).tx OR   
diabetes-specific emotional N1 (distress or stress* or problem*).tx 
13 diabetes distress N2 (scale or measure or questionnaire).tx 
14 diabetes stress N2 (scale or measure or questionnaire).tx 
15 “problem areas in diabetes”.tx 
16 (DDS or PAID or DSQ) N1 (scale or measure or questionnaire)).tx 
17 
("Health education" or "patient education" or "diabetes education" or 
psychoeducation or psycho-education) OR SU (Health education or Self-
help techniques or Self-management or health knowledge or Client 
education or Family therapy).tx  
18 
(Psychotherapy or Group intervention or Group psychotherapy or 
Psychotherapeutic techniques or Psychoeducation or Cognitive therapy or 
Cognitive restructuring).sh  
19 
(psych$ or behavi#r change or self-management or education*) N1 
intervention.tx 
20 (patient or structured or self-management) N1 education.tx 
21 (diabet* or "type 1 diabetes" or "insulin dependent" or IDDM or T1DM).tx 
22 ("Diabetes Mellitus, Type 1" or "diabetes mellitus").sh 
23 
(adolescen* or p#ediatric or child* or teen* or youth* or young person or 
young people or juvenile or puberty*.tx 
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24 21 OR 22 
25 Or/1-20 
26 23 AND 24 
27 25 AND 26 limit to (english language and yr="1995 -Current") 
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Self-report measures of diabetes distress  
Table 2. 3: Self-report measures of diabetes distress used in the included studies  
Name of scale and 
reference 
Description Rating scale and scoring method 
 
Age group 
validated 
Diabetes Distress Scale 
(DDS) 
Polonsky, et al. 2005 [3] 
Fisher, et al.  2008 [77] 
17-item measure of diabetes distress, 
producing 4 factors: ‘emotional burden’ 
‘regimen-related distress’, ‘physician-
distress’ and ‘interpersonal distress’ 
Items are scored 1-6 (‘not a problem’ to ‘serious 
problem’). Items are averaged to produce a mean item 
score (range: 1-6). Higher scores indicate greater 
distress. Scores ≥3 indicate moderate-severe diabetes 
distress. 
adults 
Diabetes Stress 
Questionnaire (DSQ)  
Boardway, et al., [78] 
Delamater, Smith, 
Lankester [79] 
Renamed Diabetes Stress 
Questionnaire for Youths 
(DSQY) Delamater, et al. 
2013, [56] 
65-item measure of diabetes-related 
stress, producing 8 factors: 
i Diabetes-Worry (13 items); ii Peer 
Stress (8 items); iii Adverse Inter-
personal Effects (9 items); iv Parental 
Stress (7 items); v Hyperglycaemia (8 
items); vi Self Care (8 items); vii Diet 
(5 items); viii Hypoglycaemia (3 items).  
Items are scored 0-3 (‘very little’ to ‘very much’) 
An overall score is calculated by summing the items 
and dividing by the total number of items (range 0-3). 
Subscale scores are calculated by summing the items 
and dividing by the number of items in the subscale. 
Higher scores indicate greater distress. 
 
NB: some studies reported the summed score (range 0-
195)  
9-20 years 
Issues in Coping with 
IDDM (ICD) Child 
version – Upset subscale  
Kovacs, 1981 [80] 
12-item measure of emotional responses 
to issues related to living with diabetes. 
[The ‘difficulty coping’ subscale of the 
ICD was not included in this review]  
Items are scored 1-3 (‘not very upsetting’ to ‘very 
upsetting’). Item scores are summed to produce a total 
score (range: 12-36). 
Higher scores indicate greater distress. 
8-12 years 
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Problem Areas in 
Diabetes (PAID)  
Polonsky, et. al.1995 [30] 
Welch, et. al., 1997 [81] 
20-item measure of emotional responses 
to aspects of living with diabetes 
forming a single scale total. 
i) In the original version, items are scored 1-6 (‘not a 
problem’ to ‘a serious problem’). Items are summed to 
form a total distress score (range: 24-144). 
ii) In the revised scale (1997), items are scored 0-4 
(‘not a problem’ to ‘a serious problem’), summed and 
multiplied by 1.25, to form a total score (range: 0-100). 
Higher scores indicate greater distress. Scores ≥40 
indicate severe diabetes distress. 
adults 
Problem Areas in 
Diabetes – Teen version 
(PAID-T) 
Weissberg-Benchell & 
Antisdel-Lomaglio, 2011  
[24] 
26-item measure, modified from 
original (adult) PAID, with additional 
items for adolescents 
Items are scored 1-6 (‘not a problem’ to ‘serious 
problem’). Items are summed to form a total distress 
score (range: 26-156). Unlike the adult version, there is 
no established cut-off for severe diabetes distress. 
Higher scores indicate greater distress. 
11-19 years 
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Appendix H: Additional File for Chapter 3 
Table 3. 3: Description of scales used in the Diabetes MILES Youth Study 
Name  Description 
BMI-based Silhouette 
Matching Test (BMI-
SMT) [64, 65] 
The BMI-based-Silhouette Matching Test (BMI-
SMT) uses gender-specific silhouette figures with 
reference points on a 27-point scale. Each point 
corresponds with a BMI score ranging between 14 to 
40. The sets of silhouettes are presented three times 
and respondents are asked to choose a point on the 
scale that is (1) ‘closest to the size you are now’ 
(current); (2) ‘closest to the size you would like to 
be’ (ideal); (3) ‘closest to the size you would be 
without diabetes’ (a study-specific item). Body 
dissatisfaction is calculated by subtracting the ideal 
size score from the current size score.  
Diabetes Eating 
Problem Survey-
Revised (DEPS-R) [63] 
A 16-item, diabetes-specific measure of disordered 
eating. Items are rated on a 6-point scale (0= Never; 
5=Always). Item scores are summed, with total 
scores ranging from 0 to 80, and higher scores 
indicating more disordered eating behaviours.  
Diabetes Family 
Responsibility 
Questionnaire (DFRQ) 
[57] 
Five items from the DFRQ were used to identify 
parental perceptions about how diabetes self-care 
responsibilities are shared within the family. For 
each task parents choose: (i) child is mainly 
responsible, (ii) responsibility is shared, or (iii) the 
parent is mainly responsible. Items are analysed 
individually. 
Diabetes Strengths and 
Resilience Measure for 
Adolescents (DSTAR-
Teen) [70] 
A 12-item self-report measure of adaptive attitudes 
and behaviours related to living with T1D. There are 
slight wording variations between the 9-13 years and 
14-18 years versions that were used for the 10-12 
year and 13-19 year age groups of the MILES Youth 
surveys respectively. Items are rated on a 5-point 
scale (0=Never; 4=Almost always). Item scores are 
summed (range 0-48), with higher scores indicating 
greater resilience. 
Generalised Anxiety 
Disorder Scale (GAD-
7) [55] 
A 7-item scale that measures generalised anxiety 
symptoms. Respondents rate the frequency of 
anxiety symptoms over the past two weeks on a 4-
point scale (0=Not at all, 3=Nearly every day). Item 
scores are summed to form a total score (range 0-
21). Severity of anxiety symptoms is assessed using 
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cut-off scores of 5, 10 and 15 representing mild, 
moderate, and severe anxiety symptoms 
respectively. 
Gold score [61] The single-item Gold score measures awareness of 
hypoglycaemic symptoms. Using a 7-point scale, 
respondents rate the extent to which they know 
when their ‘hypos’ are commencing (1=Always 
aware; 7=Never aware). A score of 4 or more 
implies impaired awareness. 
Hypoglycaemia Fear 
Survey for parents 
(PHFS) and children 
(CHFS) [62] 
The 25-item child and parent questionnaires adapted 
from the HFS-II assess childrens’ and parents’ 
worries (15-item subscale) and behaviours (10-item 
subscale) related to hypoglycaemia. Items are rated 
on a 5-point scale (0=Never; 4=Almost always). 
Subscale and total scores are obtained by summing 
the items for the worry subscale (range 0–60), the 
behaviour subscale (range 0–40) and the total score 
(range 0–100). Higher scores indicate greater fear of 
hypoglycaemia. 
Maternal Self-Efficacy 
for Diabetes 
Management Scale 
(MSEDSM) [71] 
A 17-item scale that assesses perceived parental 
confidence with specific diabetes management tasks. 
Each item is rated on a 5-point scale (1=Not 
confident at all; 5=Very confident without help). 
Scores are averaged across items with higher mean 
scores indicating greater self-efficacy.  
Monitoring Individual 
Needs in Diabetes 
Youth Questionnaire 
(MY-Q) [7] 
 
8 items from the MY-Q assess general QoL (1 item), 
diabetes responsibility (2 items) and family conflict 
(2 items), and treatment satisfaction (3 items). Items 
are rated (QoL, 0=Worst possible life; 10=Best 
possible life); diabetes responsibility and family 
conflict (1=All the time; 5=Never) and treatment 
satisfaction (1=Not at all happy; 5=Extremely 
happy); Treatment satisfaction for parents was rated 
1=Very dissatisfied; 5=Very satisfied. Individual 
item scores are analysed, with higher scores 
indicating greater satisfaction/less conflict and 
treatment burden. 
Patient-Centred 
Communication (PCC) 
[66, 67] 
A 5-item version of the Health Care Climate 
Questionnaire modified for adolescents with 
diabetes and their parents, which measures 
adolescent and parent perceptions of collaborative 
decision-making with their diabetes health care 
professional. Items are rated on a 5-point scale 
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(1=Strongly disagree; 5=Strongly agree). Scores are 
averaged across items with higher scores indicating 
higher PCC.  
Patient Health 
Questionnaire for 
Adolescents (PHQ-A) 
[53, 54] 
An 8-item version* of the PHQ-9 scale, which 
assesses the presence and severity of depressive 
symptoms. Respondents rate the frequency with 
which they have experienced symptoms of 
depression over the past two weeks on a 4-point 
scale (0=Not at all; 3=Nearly every day). Items 
scores are summed to form a total score out of 24. 
Scores of 5, 10, 15 and 20 represent cut-off points 
for mild, moderate, moderately-severe and severe 
depressive symptoms respectively.  
* the suicide ideation item was omitted. 
Problem Areas in 
Diabetes – Teen (PAID-
T) [19] 
A 26-item scale that measures the perceived 
emotional burden of living with diabetes, known as 
diabetes distress. The PAID-T was adapted from the 
adult version. Items are rated on a 6-point scale 
(1=Not a problem; 6=Serious problem). Item scores 
are summed to form a total score (range 26-156), 
with higher scores indicating greater diabetes 
distress.  
Problem Areas in 
Diabetes –Parents of 
Teens version (P-PAID-
T) [29] 
The P-PAID-T was adapted from the PAID-T to 
measure the perceived emotional burden of caring 
for an adolescent with diabetes. The rating scale, 
method of scoring and interpretation are the same as 
for the PAID-T.  
WHO-5 Wellbeing 
Scale [7, 50-52] 
 
A positively-worded 5-item scale that measures 
general emotional well-being. Each item is scored 
on a 6-point scale (0=All of the time; 5=At no time). 
The item scores are summed and multiplied by 4 to 
form a total score (range 0-100) with higher scores 
indicating better well-being. A total score <50 
suggests impaired emotional well-being.  
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Supplementary Figure 
 
 
Figure 4. 3: Flow diagram of Diabetes MILES Youth Australia Study recruitment, 
inclusion and exclusion criteria, and final sample 
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Supplementary Table 
Table 4. 3: Problem Areas in Diabetes–Teen (PAID-T) items (ranked by frequency of endorsement as a ‘serious problem’), mean scores and 
associations with psychological and clinical variables  
 Item rated 
a ‘serious’ 
problem 
Item rated a 
‘moderate’ 
problem 
Item score 
N=537 
PHQA-8 
N=537 
HbA1c 
N=452 
SMBG 
frequency 
N=527 
PAID-T item number and wording N (%) N (%) Mean±SD  Correlation coefficient (r) 
20 
Feeling that my friends or family don’t understand how difficult 
living with diabetes can be 
219 (41) 144 (27) 3.72 ± 1.8 .449** .227** -.151** 
22 Worrying about my weight 197 (37) 116 (22) 3.41 ± 2.0 .516** .197** -.143** 
7 Feeling upset when my diabetes management is “off track” 164 (31) 187 (35) 3.41 ± 1.7 .425** .223** -.095* 
13 
Feeling that my friends and family act like “diabetes police” (e.g. 
nag about eating properly, checking blood sugars, not trying hard 
enough) 
160 (30) 143 (27) 3.23 ± 1.8 .286** .215** -.094* 
6 
Worrying about the future and the possibility of serious 
complications. 
143 (27) 169 (32) 3.23 ± 1.7 .445** .218** -.134** 
11 Not feeling motivated to keep up with my daily diabetes tasks 142 (26) 150 (28) 3.03 ± 1.8 .539** .375** -.430** 
15 Feeling like I must be perfect in my diabetes management 138 (26) 156 (29) 3.09 ± 1.7 .355** .189** -.124** 
9 Feeling that I am not checking my blood sugars often enough. 134 (25) 152 (28) 2.98 ± 1.8 .435** .350** -.452** 
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 Item rated 
a ‘serious’ 
problem 
Item rated a 
‘moderate’ 
problem 
Item score 
N=537 
PHQA-8 
N=537 
HbA1c 
N=452 
SMBG 
frequency 
N=527 
PAID-T item number and wording N (%) N (%) Mean±SD  Correlation coefficient (r) 
17 
Feeling that my blood sugars are often swinging wildly, no 
matter how hard I try 
133 (25) 164 (31) 3.11 ± 1.7 .474** .340** -.230** 
12 
Feeling discouraged or defeated when I see high blood sugar 
results on my meter 
131 (24) 183 (34) 3.13 ± 1.6 .423** .262** -.184** 
16 Missing or skipping blood sugar checks 130 (24) 186 (35) 3.13 ± 1.7 .406** .379** -.457** 
24 
Fitting my diabetes regimen into my day when I am away from 
home (eg. school, work, etc.) 
127 (24) 162 (30) 3.04 ± 1.7 .474** .218** -.171** 
23 
Worrying that diabetes gets in the way of having fun and being 
with my friends 
126 (24) 171 (32) 3.01 ± 1.7 .417** .158** -.123** 
25 Worrying about getting low during sports activity 125 (23) 169 (32) 3.01 ± 1.7 .250** .003 .049 
8 Feeling “burned-out” by the constant effort to manage diabetes 121 (23) 163 (30) 2.98 ± 1.7 .572** .259** -.228** 
18 Feeling that I am often failing with my diabetes regimen 115 (21) 140 (26) 2.82 ± 1.7 .537** .437** -.352** 
21 Feeling that I can’t control my eating 114 (21) 110 (21) 2.69 ± 1.8 .563** .280** -.267** 
19 
Feeling like my parents blame me for blood sugar numbers they 
don’t like 
98 (18) 126 (24) 2.56 ± 1.7 .344** .196** -.148** 
5 Feeling constantly concerned about food and eating 96 (18) 156 (29) 2.72 ± 1.6 .440** .193** -.066 
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 Item rated 
a ‘serious’ 
problem 
Item rated a 
‘moderate’ 
problem 
Item score 
N=537 
PHQA-8 
N=537 
HbA1c 
N=452 
SMBG 
frequency 
N=527 
PAID-T item number and wording N (%) N (%) Mean±SD  Correlation coefficient (r) 
4 Feeling angry when I think about having and living with diabetes 93 (17) 158 (29) 2.73 ± 1.6 .455** .272** -.236** 
26 Feeling like my parents worry about complications too much 93 (17) 150 (28) 2.67 ± 1.6 .332** .143** -.088* 
14 Feeling like my parents don’t trust me to care for my diabetes 91 (17) 131 (24) 2.56 ± 1.7 .308** .166** -.116** 
3 Feeling overwhelmed by my diabetes regimen 78 (15) 169 (32) 2.62 ± 1.5 .540** .277** -.216** 
2 
Not knowing if the mood or feelings I am having are related to 
my blood sugar levels 
69 (13) 213 (40) 2.77 ± 1.2 .479** .172** -.134** 
1 Feeling sad when thinking about having and living with diabetes 68 (13) 201 (37) 2.76 ± 1.4 .477** .255** -.157** 
10 
Feeling unclear about exactly what and how much I should be 
doing to take care of my diabetes properly 
53 (10) 141 (26) 2.30 ± 1.4 .420** .249** -.216** 
 PAID total score   76.7 ± 30.4 0.62** .34** -.28** 
 Mean item score   2.95    
* p<0.05; ** p<0.001 
A serious problem: PAID-T rated 5 or 6; Moderate problem: PAID-T rated 3 or 4; 
PHQA-8: 8-item Patient Health Questionnaire for Adolescents; SMBG: self-monitoring of blood glucose 
HbA1c and SMBG are self-reported; Top 5 highest correlation coefficients shown in bold text
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Supplementary Table 1 
Table 6.6: Number of TEAM T1 programs and participants by centre and state 
Geographical location 
Centre 
number 
Programs 
conducted 
(intended)  
Participants  
Adolescents   Parents 
New South Wales 
regional  
A 3 (2) 16 17 
New South Wales 
regional 
B 7 (6) 41 39 
New South Wales 
metropolitan  
C 4 (4) 20 23 
Northern Territory 
metropolitan  
D 1 (4) 2 0 
Queensland           
metropolitan  
E 6 (6) 27 31 
Queensland           
regional  
F 2 (4) 9 9 
Tasmania          
regional  
G 3 (2) 11 6 
Tasmania   
metropolitan  
H 3 (2) 19 13 
Victoria             
regional  
I 3 (6) 18 17 
Victoria      
metropolitan  
J 2 (2) 14 17 
Victoria             
regional 
K 4 (2) 30 35 
Total 11 38 207 207 
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Supplementary Table 2 
Table 6. 7: Change in psychological outcomes and A1C from baseline to Time 1 and Time 2  
 N Baseline Time 1 p N Baseline Time 2 p 
Diabetes distress (PAID-T) 74 74.0 ± 25.0 70.8 ± 24.5 0.14 61 68.6.0 ± 23.3 68.1 ± 25.2 0.87 
Baseline PAID-T ≥70 30 98.9 ± 14.9 89.0 ± 20.6 0.008 22 93.9 ± 11.8 88.5 ± 22.1 0.29 
Diabetes-related family 
conflict (DRFC) 
77 3.1 ± 1.2 3.2 ± 1.1 0.25 63 3.3 ± 1.2 3.4 ± 1.2 0.57 
Diabetes management self-
efficacy (DMSE) 
74 4.2 ± 0.5 4.3 ± 0.5 0.002 60 4.3 ± 0.5 4.3 ± 0.6 0.20 
A1C mmol/mol 93 77.9 ± 21.8 75.2 ± 20.6 
0.19 81 
71.5 ± 20.8 74.0 ± 20.2 
0.21 
A1C %  9.3 ± 2.0 9.0 ± 1.9 8.7 ± 1.9 8.9 ± 1.8 
Data are reported as mean ±  SD  
PAID-T: higher scores indicate greater diabetes distress (range 26-156; ≥70 moderate-to-high diabetes distress) 
DRFC: higher scores indicate less diabetes-related family conflict (range 1-5)  
DMSE: higher scores indicate better diabetes-specific self-efficacy (range 1-5) 
 
 
 
